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Abstract 
Introduction:  The removal of skin cancer is paramount to the reduction of 
morbidity and mortality rates associated with this skin disease.  However, performing 
surgical procedures does not come without risk. 
Background and significance:  In general surgical literature the lower limb 
experiences some of the highest complication rates.  The cost of surgical site failure 
and chronic wound care is not only a burden on the patient, but the health care 
service.  Up until now, there was very little known about what contributes to surgical 
site failure in the lower limb dermatological surgery population.   
Aim:  The aims of this research were to determine the incidence of lower limb split 
skin graft failure and primary closure dehiscence; and to explore the predictors of 
poor wound healing in the lower limb which contribute to post-operative split skin 
graft failure or primary closure dehiscence in the dermatological surgery day-case 
cohort. 
Method:  A prospective observational study design was used to investigate the two 
aims of this research.  Data was collected from 73 participants over a 20 month 
period from July 2010 till March 2012.  Incidence was determined as a percentage of 
failure from the total population.  The predictors were determined by the use of a 
binary logistic regression model. 
Results:  There was a total surgical site failure rate of 53.4%.  Split skin grafting had 
a higher failure rate than primary closures, 66% versus 26.1% respectively.  The 
predictors of lower limb split skin graft failure and primary closure dehiscence were 
identified as the surgical procedure of split skin graft (X
2
=10.9, p<0.00), increasing 
age (r=0.25, p=0.03), surgical site infection (X
2
=10.1, p=0.01) presence of 
haematoma (X
2
=12.08, p<0.00) and the presence of chronic sharp shooting leg pain 
(Fisher’s exact test p=0.06).   
Conclusions:  This study confirmed that the lower limb is at high risk of surgical site 
failure.  Predictors of surgical site failure from this cohort were determined.  
Recommendations were made to improve care for patients undergoing lower limb 
dermatological surgeries and highlighted the need for further research in this field. 
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Chapter 1: Introduction 
1.1 INTRODUCTION 
Queensland exhibits the highest worldwide incidence of skin cancer, with 
approximately 142,500 people diagnosed in each year (Viertel Centre for Research in 
Cancer Control [VCRCC], 2004 - 2008).  To reduce morbidity and mortality rates 
from skin cancer, removal of the lesion is essential (VCRCC, 2004-2008).  Success of 
the surgery depends on many factors such as the skill of the surgeon and 
intraoperative management of bleeding (Franz, Steed & Robson, 2007; World Health 
Organisation [WHO], 2009).  However surgical site complications which cannot be 
controlled may also arise due to patient factors such as multiple medical co-
morbidities, poor circulation or poor lifestyle choices (Australian Wound 
Management Association [AWMA], 2010); European Wound Management 
Association [EWMA], 2008; Franz et al., 2007).  
A significant volume of research has contributed to the development of local and 
international guidelines for surgery which endeavour to guide best practice, good 
surgical care and outcomes and to reduce surgical site complications (WHO, 2009).  
However there is very little known specifically about lower limb surgical site 
complications which may facilitate failure of the surgical site.  The lower limb is a 
unique healing environment due to many singular factors, such as mobility, arterial 
permeability, venous and lymphatic drainage (Basheer, Wilson, Lewis & Herbert, 
2008; Franz et al., 2007; Lawrence, 1996; Mohmoud, Mohamed, Mahdi & Ahmed, 
2008).   
It is hypothesised that the lower limb surgical population are at greater risk of 
surgical site complications due to changes that occur in the lower limb with increased 
patient comorbidities.  This study sought to determine the incidence of lower limb 
split skin graft failure and primary closure dehiscence in day-case dermatological 
surgery patients and to identify the predictors of poor wound healing in the lower limb 
which contributes to post-operative split skin graft failure or primary closure 
dehiscence. 
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1.2 SIGNIFICANCE 
All surgical site complications result in prolonged care, which in turn increases 
pressure on hospital resource utilisation, costs of care and costs to patients.  Further, 
surgical site complications are potential psychological stressors for the patient (Dindo, 
Demartines & Clavien, 2004; Franz et al., 2007; Smith & McGuiness, 2010; Robles, 
2007; Urpe, Buggiani & Lotti, 2005).  To ameliorate these adverse effects 
considerable research has identified risk factors for general surgical site 
complications.  These have been identified as increasing age (Kaye, Schmit, Pieper, et 
al., 2005; Talbot & Schaffner, 2005; WHO, 2009), uncontrolled diabetes (Mahmoud 
et al., 2008; WHO, 2009), smoking (Basheer et al., 2007; WHO, 2009) and factors 
affecting haemostasis (Basheer et al., 2007; Dubay & Franz, 2003; Franz, Kuhn, 
Wright, Wachtel & Robson, 2000; Leung & Fish, 2009; WHO, 2009).  However a gap 
exists in the current understanding of risk factors for general surgery and their 
relationship to lower limb surgery.  
Interestingly, lower limb surgery is often a result of chronic conditions and 
healing may be compounded by issues of chronic conditions (Basheer et al., 2007; 
Franz, Steed & Robson, 2007; Jones & Nelson, 2010; Mahmoud et al., 2008; Rooke, 
Hirsch, Misra et al., 2011; Smith & McGuiness, 2010).  Further, there is a plethora of 
specialty clinics and sub-specialities providing care for patients with chronic wounds 
such as diabetic foot clinics, ‘leg clubs’ and vascular specialists, but very few focus 
on preventative medicine.   
Currently, it is estimated that $60.9 billion of the Australian health care budget is 
spent on chronic disease management with $49.2 billion spent on chronic disease 
recurrence (Australian Institute of Health and Welfare [AIHW], 2012).  The AIHW 
(2012) highlights the importance of chronic disease prevention, and has identified that 
those people living with one chronic disease are at greater risk of developing and 
dying from another chronic disease.  The associated risk factors for this include poor 
diet, low physical activity and obesity, smoking, alcohol misuse, hypertension and 
hypercholesterolaemia; which are some of the same risk factors associated with 
chronic wounds and lower limb ulceration (AIHW, 2012; Mekkes, Loots, Van der 
Wal & Bos, 2003).   
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Failure of the lower limb acute surgical wound to heal may result in a chronic 
wound.  The AWMA (2012) estimates that 3% of the total national healthcare budget 
is spent on chronic wound care, with over 400,000 sufferers costing approximately 
AUD$10,000 per annum per patient.  Mekkes and colleagues (2003) suggested that 
this could even be as high as USD$27,500 (AUD$28,363) for difficult to heal 
wounds.  This study utilised these chronic disease risk factors which may inhibit 
healing of the acute surgical wound, to identify those ‘at risk’ of lower limb surgical 
site complications.  For knowledge of ‘risk factors’ and their identification through 
vigilant pre-operative assessment and surgical site care would inform preventative 
strategies to minimise surgical site complications. 
  
1.3 STUDY AIM 
The aim of this study was 1) to determine the incidence of lower limb split 
skin graft failure and primary closure dehiscence; and 2) to explore the predictors of 
poor wound healing in the lower limb which contributes to post-operative split skin 
graft failure or primary closure dehiscence in the dermatological surgery day-case 
cohort. 
 
1.4 RESEARCH QUESTIONS 
The two research questions underpinning this study were: 
1) What is the incidence of failed split skin grafts and primary closure dehiscence in 
patients undergoing lower limb dermatological surgery in a day procedure unit? and 
2) What are the predictors associated with failed lower limb split skin grafts and 
primary closure dehiscence in patients undergoing lower limb dermatological surgery 
in a day procedure unit? 
 
1.5 STUDY DEFINITIONS 
 Throughout this thesis are a number of terms which will be repeatedly used.  
Consequently, descriptors or definitions are provided below to afford clarity to the 
reader.  The definitions of terms include: 
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Lower limb surgical site 
The surgical site is the area from which a suspicious lesion has been removed 
from the skin to preserve life and restore cutaneous function.  This study investigated 
dermatological surgeries of the lower limb (below the knee).  Several methods are 
utilised to achieve closure of the surgical site, reduce the course of treatment and 
improve function and appearance of the skin (Carville, 2005; Dubay & Franz, 2003; 
Marek, Copeland, Zlowodzki & Cole, 2005; Leung & Fish, 2009).  The two methods 
of closure commonly used on the lower limb include split skin graft or primary 
closure.  These two methods of closure were investigated in this study.  Surgical site 
failure will be further explored in chapter two, literature review. 
 
Complication 
A complication is defined as a medical or surgical accident or reaction which 
has deviated from the normal course of illness or procedure (Soanes, 2002).  It is an 
occurrence which has not met the desirable outcome originally intended (Dindo et al., 
2004; Soanes, 2002).  For the purpose of this study, complete wound closure via split 
skin graft or primary closure is the intended outcome for dermatological surgery.  
Complications include surgical site infection, haematoma formation, tissue necrosis, 
and in this study group, failed split skin graft and primary closure dehiscence. These 
are further defined in chapter three, methodology. 
 
Primary closure 
 Primary closure occurs when the lesion is removed via aseptic technique with 
a scalpel blade and the two edges of the excised area are brought together 
(approximation of the edges) (Carville, 2005; Marek et al., 2005).  Usual methods of 
closure are sutures, staples, skin glue or combination of all (Carville, 2005; Marek et 
al., 2005).  Primary closure is favoured over split skin grafting due to reported lower 
risks of bleeding and infection (Marek et al., 2005).  There is also improved cosmesis 
(Carville, 2005).  However, this procedure relies on the availability of relaxed (loose) 
skin and tension lines, which are skin lines created from underlying muscle 
contraction running perpendicular to muscle movement (Carville, 2005; Marek et al., 
2005; Leung & Fish, 2009).  If the surgical site edges are unable to be approximated 
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due to an excessive amount of tissue removed, a split skin graft will be performed 
(Leung & Fish, 2009). 
 
Split skin graft 
A split skin graft is defined as a transplantation of the harvested skin over the 
excised area (Carville, 2005; Leung & Fish, 2009; Shimizu & Kishi, 2012).  The 
‘donor site’ is taken from an area of healthy skin and incorporates the epidermis and 
part of the dermis (Leung & Fish, 2009; Shimizu & Kishi, 2012).  This is taken from 
the same patient minimising the risk of rejection (Leung & Fish, 2009; Shimizu & 
Kishi, 2012).  The skin is purposely fenestrated and can extend to over nine times its 
size (Leung & Fish, 2009; Shimizu & Kishi, 2012).  The ‘donor skin’ is secured to the 
surgical site by use of sutures or staples and bolster dressing to minimise 
complications (Leung & Fish, 2009; Shimizu & Kishi, 2012).  Complications 
associated with the split skin graft include bleeding, infection, loss of graft (graft 
failure) and nerve damage (Carville, 2005; Leung & Fish, 2009; Shimizu & Kishi, 
2012).   
The ‘donor site’ will heal by secondary intention, through the process of 
granulation, epithelialisation and contraction (Leung & Fish, 2009; Shimizu & Kishi, 
2012).  Wound management products are utilised to optimise healing and this can take 
up to a few weeks to heal (Carville, 2005; Shimizu & Kishi, 2012). 
 
Acute wound healing 
 The wound healing cascade is complex and begins at initial injury.  With 
regards to surgical procedures, this commences from when the scalpel blade 
penetrates the skin to remove the lesion.  The phases of healing are well-orchestrated 
and overlapped; they included haemostasis, inflammation, reconstruction and 
maturation (Hunt, Hopf & Hussain, 2000).  Complete wound closure should occur 
within days to weeks of initial injury, however scar maturation continues from weeks 
to months in order to restore most of the skin tensile strength, integrity and skin 
function (Carville, 2005; Vowden & Vowden, 2002).  Acute wound healing requires 
good perfusion, oxygen tension (the partial pressure of oxygen required to deliver 
oxygen to the tissues) and appropriate level of nutrient delivery to the wound bed 
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(Hunt et al., 2000).  The acute wound healing trajectory will be further explored in 
chapter two, literature review. 
 
Chronic wound healing 
 A chronic wound is a deviance from the acute wound healing cascade; rather 
than progressing through the stages of acute wound healing, the wound remains 
‘stuck’ in one phase, such as the inflammatory phase (Alizadeh, Pepper, Modarressi et 
al., 2007; Ballas & Davidson, 2001).  A chronic wound can form from a multitude of 
causes, mostly related to ischaemia, reduced nutrient availability and altered 
metabolism and cellular dysfunction (Carville, 2005; Hunt et al., 2000).  The chronic 
wound will take much longer to heal or fail to heal altogether unless the causative 
factor is rectified (Carville, 2005; Hunt et al., 2000). 
 
1.6 STUDY OVERVIEW 
 This thesis contains six chapters.  Each chapter focuses on each step of the 
research process. 
 Chapter one introduced the background and significance of the research.  The 
study aims and research questions were identified, terminology defined and a layout 
for the thesis was presented. 
 Chapter two elaborates on the definitions of acute wound healing and surgical 
site failure.  It also presents the conceptual framework which has been developed 
through theoretical models of acute surgical wound healing and lower limb disease 
changes.  The conceptual framework will present potential risk factors of poor wound 
healing, nine of which will be explored more for the purpose of this research and 
study outcome.  The theoretical and empirical literature surrounding these nine risk 
factors is then presented. 
 Chapter three presents a discussion on the methodological approach used to 
investigate and answer the two research questions.  It also explains the research 
objectives, study design, setting, population and participants, data collection including 
dependent, independent and confounding variables, the instrument used for data 
collection, procedure, data management and data cleaning, data analysis and ethical 
considerations. 
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 Chapter four presents the results from this study.  Firstly participant 
demographics and surgery descriptors will be reported, followed by the outcomes 
relating to the two research questions investigated.  The predictors of lower limb skin 
graft failure and primary closure dehiscence will be reported. 
 Chapter five presents a discussion around the results of the research.  This 
chapter firstly describes the incidence of lower limb split skin graft failure and 
primary closure dehiscence according to other published literature.  Secondly, the 
predictors which were identified in chapter four will be explored.  The study’s 
limitations will also be presented in this chapter. 
  Chapter six presents a conclusion for this thesis.  It provides a reflection on the 
results arising from this study and recommendations for nursing practice, education 
and future research are presented. 
 
1.7 CONCLUSION 
The removal of skin cancers is paramount to patient survival (VCRCC, 2004-
2008).  This can be achieved through simple excision and closure of the area by 
primary closure or split skin graft.  Although the acute surgical wound healing 
cascade is complex, it is expected that complete wound closure will be achieved.  
However this process can be easily disrupted by many factors and the lower limb may 
experience higher complications due to disease changes that create a suboptimal 
environment for the wound to heal.  The objective of this study is to determine the 
incidence of lower limb split skin graft failure and primary closure dehiscence; and to 
determine if general poor health risk factors and lower limb disease changes are 
predictors for surgical site complications in those patients undergoing day-case 
dermatological surgeries of the lower limb. 
This chapter introduced the clinical problem at hand, reported the study aims, 
research questions, identified and defined key terms which governed this study and be 
reported in this paper; an outline for the thesis was also presented.  Chapter two will 
elaborate on the definitions of acute wound healing and surgical site failure.  It will 
also present a conceptual framework and review of the literature which underpins the 
study’s research aim.  
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Chapter 2: Literature Review 
2.1 INTRODUCTION 
Removal of the cancerous lesion is essential in reducing morbidity and mortality 
rates associated with skin cancers (Henderson, Fancourt, Gilkison, Kyle & Mosguera, 
2009; Paradela, Pita-Fernandez, Pena et al., 2010; VCRCC, 2004-2008). However, 
surgical interventions to remove cancerous lesions are not without complications, 
particularly when surgery involves the lower limb.  In dermatological literature the 
lower limb exhibits some of the highest rates of surgical site complications 
(Henderson et al., 2009; Paradela et al., 2010; VCRCC, 2004-2008).  Success of the 
surgery is important in preventing poor surgical outcomes which result in prolonged 
care, increased pressure on hospital resource utilisation, increase cost of care, increase 
cost to patients and potentially psychological stress to the patient as a result of 
unexpected post-operative complications (Dindo et al., 2004; Smith & McGuiness, 
2010; WHO, 2009).   
Universal surgical guidelines, theoretical literature and empirical literature 
which highlight risk factors associated with poor surgical outcomes are reported for 
the general population rather than specific cohorts, and consequently do not include 
disease changes which are specific to lower limbs (Basheer et al., 2008; Franz et al., 
2007; Lawrence, 1996; Mangram, Horan, Pearson, Silver & Jarvis, 1999; WHO, 
2009).  Currently, risk factors specifically for lower limb split skin graft failure or 
primary closure dehiscence have not been reported in the literature.   
This chapter will provide a brief synopsis on the physiology of acute wound 
healing, examine causes for surgical site failure and discuss the conceptual framework 
crafted from general acute wound healing and lower limb disease changes.  Following 
this the theoretical and empirical literature for potential risk factors of lower limb split 
skin graft failure and primary closure dehiscence will be presented. 
 
2.2 THE PHYSIOLOGY OF WOUND HEALING 
 The surgical site healing trajectory, should be prompt, ordered and without 
complication, known as acute wound healing (Jones, Harding, Stechmiller & Schultz, 
2008).  The acute wound healing cascade is a complex, well-ordered physiological 
 Chapter 2: Literature Review 10 
process (Jones et al., 2008).  Surgical wound healing progresses through four phases: 
haemostasis, inflammation, reconstruction and finally maturation (Jones et al., 2008).  
Complete surgical site closure will occur within days from the initial injury; however 
scar maturation and strengthening will take months to complete (Carville, 2005; 
Vowden & Vowden, 2002).   
 
Haemostasis 
 Haemostasis, the first phase of healing commences at the time of injury, in 
order to prevent blood loss (Clark, 2002; Jones et al., 2008).  Platelets (blood clotting 
cells) aggregate at the site to assist with clotting, forming a fibrin clot and 
vasoconstriction occurs to reduce blood volume.  Platelet aggregation releases 
chemokines (proteins which signal movement to other cells) (Hart, 2000a; Hart, 
2000b).  Chemokines attract inflammatory cells to commence wound cleansing (the 
removal of waste products and foreign debris) (Dubay & Franz, 2003; Hart, 2000a; 
Hart, 2000b).  Macrophages (inflammatory cells) attracted by chemokines regulate 
growth factors and gradually increase in number until the reconstructive phase (third 
phase) to assist wound repair and healing (Franz et al., 2000).  To assist with surgical 
site haemostasis blood vessels may be cauterised prior to primary wound closure or 
split skin grafting. 
 
Inflammation 
 The second phase of healing, the inflammatory phase commences moments 
after haemostasis has been achieved (Clark, 2002; Jones et al., 2008).  Macrophages 
continue to remain responsible for the mediation of immunological defence against 
foreign matter (Dubay & Franz, 2003; Sorensen, Karlsmark, & Gottrup, 2003).  
Neutrophils (most abundant type of white blood cell) and lymphocytes (white blood 
cell) also responsible for cleansing the surgical site, are attracted and drawn to the 
area of injury by the pro-inflammatory markers produced by platelet aggregation 
(Dubay & Franz, 2003; Franz et al., 2000).  During this time histamine is released 
(Franz et al., 2000).  This promotes vasodilation and increased capillary permeability 
to allow transfer of inflammatory cells and growth hormones (peptides stimulating 
cell growth) to filter through damaged tissue and to prevent surgical site infection 
(Franz et al., 2000).  During this phase the surgical site will appear red and inflamed 
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as the wound is cleansed (Dubay & Franz, 2003).  This phase is usually completed 
approximately three to five days after injury (Dubay & Franz, 2003). 
 
Reconstruction 
 The third phase of healing, the reconstructive phase, also termed the 
proliferation phase, is marked by angiogenesis, the development of new vessels and 
cells, commencing approximately day three post-operatively (Clark, 2002; Jones et 
al., 2008).  Angiogenesis is vital for nutrient and oxygen delivery in order to promote 
skin integrity, approximation of surgical edges and success of the primary closure or 
split skin graft (Dubay & Franz, 2003; Franz et al., 2000).  Macrophages stimulate 
fibroblast production during this phase of healing (Diegelmann, 2001; Dubay & 
Franz, 2003).  Fibroblasts are responsible for the production of protein connective 
tissue fibres such as collagen (type III) (Diegelmann, 2001).  Collagen type III is 
important to increase wound tensile strength (Diegelmann, 2001).  During this 
reconstructive phase the wound begins to contract with the migration of cells which 
move along these collagen fibres to assist with adhesion of the primary closure or 
attachment of the split skin graft to the host (Dubay & Franz, 2003; Franz et al., 
2000).  Epithelial cells also migrate along these collagen fibres to fill deficits and 
complete wound closure (Dubay & Franz, 2003; Franz et al., 2000). 
 
Maturation 
 The final phase of healing, the maturation phase is also known as the 
remodelling phase (Clark, 2002; Jones et al., 2008).  This phase of healing improves 
the breaking tensile strength (maximum amount of cell stress before breaking) of the 
surgical site and restores skin function as a protective organ (Franz et al., 2000).  
Myofibroblasts (scar mediating cells) assist with reconfiguring collagen type III to 
collagen type I (Alizadeh et al., 2007; Diegelmann, 2001).  Although this process 
starts around day three post-operatively, it will continue for months after the surgery 
(Diegelmann, 2001).  The scar tissue (new tissue) will only return to 80% of the 
original strength and functioning of normal skin (Clark, 2002; Jones et al., 2008).  
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2.3 SURGICAL SITE FAILURE 
 The four phases of acute wound healing haemostasis, inflammation, 
reconstruction and maturation are imperative to restore the surgical site to relatively 
normal function and protective mechanism of uninjured skin (Hunt et al., 2000; Loots, 
Lamme, Zeegelaar et al., 1998).  These phases of healing require adequate cellular 
oxygen tension and nutrient delivery, which assist with cellular chemotaxis (the 
movement of cells responding to mediators in their environment for healing and 
repair), which are dependent on vessel permeability, vascularity of the surgical area, 
host-immune responses, host nutritional status and surgical site closure techniques 
including surgical site care (Dubay & Franz, 2003; Franz et al., 2000; Sorensen et al., 
2003).  However surgical interventions are not without complication and many factors 
can disrupt the wound healing cascade, leading to surgical site breakdown.   
General risk factors for surgical site failure relate to decreased oxygen tension, 
reduction in nutrient delivery and altered immunity (Franz et al., 2007; WHO, 2009).  
The lower limb may be at greater risk of surgical site failure due to accelerated 
comorbid changes altering cellular activity, hardening of arteries or lipid deposition, 
vein dilation, effects of gravitational pull and increased tissue oedema, which will be 
elaborated under the heading ‘theoretical evidence’ for each suspected risk factor 
(Basheer et al., 2008; Franz et al., 2007; Mohmoud et al., 2008).  Table 2.1 identifies 
general risk factors which may disrupt the acute wound healing cascade. 
 
 
  
Table 2.1 Conditions disrupting phases of acute wound healing 
Phase of healing Phase dominated by: Factors disrupting 
healing 
Associated comorbidity and mechanism of surgical site failure 
Haemostasis Platelet aggregation 
Fibrin clot 
Vasoconstriction 
-Poor surgical 
haemostasis 
Comorbidity: platelet disorders (Mangram et al., 2006). 
Comorbid medications: anticoagulants, antiplatelet, non-steroidal anti-
inflammatories (Franz et al., 2007; Lawrence, 1996). 
Mechanism for failure: decrease in platelet aggregation and minimisation of a 
fibrin clot formation, therefore increases bleeding leading to haematoma 
(Mangram et al., 2006; WHO, 2009). 
Inflammation Vasodilation 
Phagocytosis 
-Cutaneous bacterial 
load 
-Diminished host 
response to 
inflammation 
-Reduced vascular 
supply 
-Vasoconstriction 
Comorbidity: diabetes, peripheral vascular disease, hypertension, 
hypercholesterolaemia, inflammatory diseases (Franz et al., 2007). 
Comorbid medications: anti-inflammatories, corticosteroids (WHO, 2009). 
Other factors: increasing age, prophylactic antibiotics, smoking (WHO, 2009) 
Mechanism for failure: poor circulation is the result of comorbid changes 
which decreases vascular permeability preventing the transfer of necessary 
inflammatory cells to clear the wound of foreign matter and bacteria 
(Association of periOperative Registered Nurses [AORN], 2004; Straten, 
Carrasco, Paterson et al., 2001; Snyder, 2005).  Further impeding the 
inflammatory response is the use of medication which supress the response  
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Table 2.1 Conditions disrupting phases of acute wound healing continued 
Phase of healing Phase dominated by: Factors disrupting 
healing 
Associated Comorbidity and mechanism of surgical site failure 
   actions (Mangram et al., 1999; WHO, 2009).  Smoking is related to 
both these factors due to its vasoconstrictive effects and the noxious 
chemicals which it releases (Franz et al., 2007; Snyder, 2005).  
Increasing age is associated with slower cellular response (Gosain & 
DiPietro, 2004).  These factors predispose the patient to surgical site 
infection (Franz et al., 2007). 
Skin aseptic technique is essential to reduce bacterial load pre-
operatively (Mangram et al., 1999).  On the other hand the use of 
prophylactic antibiotics maybe a protective factor assisting the body 
in preventing bacterial proliferation (Mangram et al., 1999). 
Proliferation Angiogenesis 
Fibroblast proliferation 
Collagen cross-linking 
Epithelialisation 
-Reduced vascularity 
-Prolonged 
inflammation 
-Tissue oedema 
Comorbidity: diabetes, peripheral vascular disease, hypertension, 
hypercholesterolaemia.  Circulatory problems: poor venous return, 
lymphoedema or obesity (increased adipose tissue) (WHO, 2009). 
Other factors:  poor nutrition, smoking (WHO, 2009). 
Mechanism for failure: poor circulation again leads to reduced vessel 
permeability decreasing the transfer of necessary nutrients, oxygen 
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Table 2.1 Conditions disrupting phases of acute wound healing continued 
Phase of healing Phase dominated by: Factors disrupting 
healing 
Associated Comorbidity and mechanism of surgical site failure 
   and other cellular activity required to assist with wound repair 
(Ramasastry, 2005; Snyder, 2005).  Diabetes and anti-inflammatory 
medications and immunosuppressant medication may continue to 
prevent the proliferatory phase from commencing due to prolonged 
inflammatory responses (Mangram et al., 2006; Snyder, 2005; WHO, 
2009).  Tissue oedema may be present due to poor circulation (lymph 
drainage or vessel permeability or vessel dilation) preventing 
proliferatory cells from migrating across the surgical site and in this 
instance the foundation for collagen will be weak (EWMA, 2008; 
Humphreys, Stewart, Gohel et al., 2007; Rooke et al., 2011).  These 
cellular processes occurring at this stage require adequate nutrient 
support which will be inhibited by poor nutritional intake and reduced 
vessel permeability (Franz et al., 2007; Ramasastry, 2005; Snyder, 
2005).  Adipose tissue which has reduced vascularity also predisposes 
the surgical site to the above risks.  Again the noxious chemicals 
released by cigarette smoke will interfere with wound repair, cellular 
signalling and reduce oxygen availability required for this phase 
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 Table 2.1 Conditions disrupting phases of acute wound healing continued 
Phase of healing Phase dominated by: Factors disrupting 
healing 
Associated Comorbidity and mechanism of surgical site failure 
   of healing (Franz et al., 2007; Ramasastry, 2005).  These risk factors 
may lead to failure of the surgical site due to reduced cellular and 
vessel development and impaired tensile strength (Ramasastry, 2005). 
Maturation Collagen type III change 
to collagen type I 
-Persistent trauma 
-Weakening of collagen 
cross-linking 
-Reduction in essential 
nutrients 
-Tissue oedema 
Comorbidity: circulatory problems – poor venous return, 
lymphoedema, obesity (increased adipose tissue) (Carville, 2005). 
Comorbid medications: Corticosteroids and immunosuppressants 
(WHO, 2009). 
Other factors:  poor nutrition, increasing age (WHO, 2009). 
Mechanism for failure: these risk factors will continue to impact on 
the maturation phase.  Corticosteroids and immunosuppressants 
directly interfere with collagen cross linking with other comorbid 
conditions leading to a poorly diffuse and weak scar tissue 
continuously prone to invasion of harmful bacteria and increased risk 
of tear as the normal skin functioning is never restored (Franz et al., 
2005; Ramasastry, 2005; Snyder, 2005). 
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2.4 CONCEPTUAL FRAMEWORK 
Acute wound healing is multifaceted and the surgical site can experience 
complications due to a multitude of causes.  Preventing the lower limb surgical site 
from failure should be as simple as recognising risk factors.  Due to a dearth of 
literature which focuses on risk factors for patients undergoing lower limb split skin 
grafting and primary closure following removal of skin cancers, a conceptual 
framework was developed from acute wound healing and lower limb disease models.  
The conceptual framework was then used to guide the direction of the literature 
review and identified risk factors which may predict split skin graft failure and 
primary closure dehiscence lower limb dermatological surgeries of day case surgical 
patients.   
The conceptual framework is presented as a flow chart in Figure 2.1. The 
conceptual framework is constructed around risk factors that can occur throughout 
the pre-operative, intra-operative, post-operative stages of surgical patient care.  The 
risk factors are characterised into (a) intrinsic patient factors, (b) extrinsic patient 
factors, (c) extrinsic post-operative care factors, and (d) extrinsic procedural factors.  
Intrinsic factors are established patient factors, such as diagnostic comorbidities. 
Extrinsic patient factors include those which can be altered or changed by both the 
patient and healthcare professional, such as smoking (patient factor), the use of 
compression therapy (post-operative care factor), or skill of the surgeon (procedural 
factor).  It is suspected that these risk factors may lead to surgical site failure as 
reported in section 2.3.  An exploration of this conceptual framework will now be 
offered with risk factors for surgical site failure highlighted at each stage of patient 
care.   
Pre-operative stage 
The pre-operative stage in the surgical patient trajectory is the period from 
identification of the cancerous lesion to the commencement of the procedure.  During 
the phase, pre-operative assessment, an important part of the trajectory of care for the 
surgical procedure, identifies patient comorbidities which may impede healing and 
the success of the surgery (Tappen, Muzic & Kennedy, 2001).  It also allows for a 
plan of care to be developed to minimise post-operative complications, such as 
bleeding (through management of anticoagulants), and infection (pre-operative skin 
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preparation and prescription of prophylactic antibiotics) (Mangram et al., 2006; 
Tappen et al., 2001; Otley, Fewkes, Frank & Olbricht, 1996; WHO, 2009).   
Suspected patient risk factors for poor surgical site healing include comorbidities 
such as hypertension, hypercholesterolaemia, diabetes, inflammatory disease 
processes, increasing patient age and medication used to treat disease processes 
(Franz et al., 2007; WHO, 2009).  These risk factors impact on the healing cascade 
through altering immunity and cellular functioning, reducing nutrient delivery and 
oxygen tension which are important during the acute wound healing cascade (Hunt et 
al., 2000; Jones et al., 2008).  Those at greater risk of surgical site infection include 
diabetics and the immunosuppressed (associated with medication treatment or 
inflammatory disease processes), smokers, malnourished, those with poor circulation 
and extremes of age (Franz et al., 2007).  Lower limb disease changes which impede 
arterial and venous circulation are also influenced by these comorbid conditions, 
however little is known of their impact on lower limb dermatological surgeries 
(Basheer et al., 2008; EWMA, 2008; Humphreys et al., 2007; Rooke et al., 2011). 
Intra-operative stage 
The intra-operative stage is the period from the commencement of the surgical 
procedure until the end of the procedure.  Factors confounding the success of the 
surgical site include lack of skin asepsis, aseptic technique or failure to obtain 
haemostasis, which are impacted by the skill of the surgeon (WHO, 2009).  This 
study focuses on the patient and comorbid changes as risk factors of surgical site 
failure and therefore it is out of the scope of this study to investigate extrinsic 
procedural factors, such as skills of staff performing procedures.   
 
Post-operative stage 
The post-operative stage is the period after the completion of the surgical 
procedure and extends until the patient has complete surgical site closure.  To 
improve the surgical outcome, the clinician should apply post-operative compression 
therapy to assist with venous return and reduction of lower limb oedema; however 
the absence of arterial disease should be determined prior to application (Jones & 
Nelson, 2010; Sharpe et al., 1983).  In addition, a balance between bed rest and 
ambulation are essential to assist with lymph, arterial and venous blood flow (Hosoi, 
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Zukowski, Kakkos & Nicolaides, 2002; O’Brien, Edwards, Finlayson & Kerr, 2012).  
Signs and symptoms of lower limb disease changes should be identified pre-
operatively to assist with the development of an individualised post-operative plan of 
care (Bonham, 2003; Tappen et al., 2001).  During the phases of healing 
(haemostasis, inflammation, reconstruction and maturation), the role of micro and 
macronutrients are important factors in achieving complete surgical site closure and 
maintaining skin integrity (Braga, Gianotti, Radaelli et al., 1999; Giles, Hamdan, 
Pomposelli et al., 2010).  Obesity and cachexia are risk factors which potentially may 
lead to surgical site failure. 
If the surgical site fails, a chronic wound may result and will require ongoing 
care and management.  A chronic wound develops due to intrinsic and extrinsic 
factors which disrupt one or all of these phases of the acute wound healing cascade 
(Carville, 2005; Hunt et al., 2000).  Other factors affecting the acute healing cascade 
is the over production of pro-inflammatory cytokines which prolong the 
inflammatory phase (Robles, 2007; Urpe, Buggiani & Lotti, 2005).  There is 
evidence linking anxiety and depression to increased pro-inflammatory cytokines in 
non-healing chronic wounds (EWMA, 2008; Douglas, 2001; Mulder & Vande Berg, 
2002; Robles, 2007; Urpe et al., 2005), however their influence on acute wound 
healing is not well documented and as this study focuses on acute healing rates it is 
not in the scope of this study to investigate this. 
 To date, risk factors for poor wound healing specifically for lower limb 
dermatological surgeries has not been investigated. However, risk factors for poor 
general surgical outcomes amalgamated with lower limb disease change assessment 
could assist with predicting those at risk of surgical site failure in this area.  For ease 
of reporting, nine major categories have been identified and therefore these nine risk 
factors are as follows: diagnostic comorbidities; surgical comorbidities; medications; 
infection; antibiotic prophylaxis; malnutrition and obesity; smoking; presence of 
lower limb disease; and post-operative mobilisation and the use of compression 
therapy.  The theoretical and empirical literature for each risk factor will now be 
discussed including the literature search strategy used to investigate empirical 
literature for each risk factor. 
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2.5 LITERATURE SEARCH STRATEGIES  
The electronic databases used to identify research in this area.  OvidSP and 
the Cochrane Library were searched first with late searches conducted in other 
databases to find any potential missed articles not found in the initial search.  
Reference lists of articles found were then hand searched for potentially useful 
articles.  Databases searched were: 
 OvidSP (searched till 12th of March 2012) 
 the Cochrane Library (searched till 12th of March 2012)  
 CINAHL with full text (1982- till 12th of March 2012)  
 Medline via EBSCOHost (1966- till 12th of March 2012)  
 ProQuest Health and Medical Complete (searched till 12th of March 2012)  
 Google Scholar (searched till 12th of March 2012) 
There were no restrictions based on research study design, date or publication 
status, however for reasons of cost non-English (untranslated) publications were not 
included.  Medical subject headings (MeSH) and boolean operators (AND, OR, 
NOT) were used for relevant databases.  The following key terms were used to 
search all databases: skin surgery, cutaneous surgery, primary closure, skin graft, 
dermatology.  These terms were used in conjunction with the following terms to 
assist narrow the search strategy: 
 complication 
 comorbidity 
 knee replacement, fracture, vein surgery 
 medication, steroid, anticoagulant, antiplatelet, chemotherapy 
 antibiotic prophylaxis, antibiotic, infection, surgical site infection 
 obesity, bariatric, malnutrition, cachexia, nutrition 
 smoking, tobacco, cessation 
 venous disease, vein stripping, circulation 
 arterial disease, peripheral vascular disease, peripheral arterial disease 
 post-operative, early mobilisation, ambulation 
 
Following this search, nine established risk factors for failed surgical sites and lower 
limb disease were identified and will now be reported. 
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2.6 THEORETICAL AND EMPIRICAL LITERATURE ON POTENTIAL 
RISK FACTORS FOR LOWER LIMB SURGICAL SITE FAILURE 
The theoretical and empirical literature around risk factors for acute wound 
healing and lower limb chronic wound healing theoretical literature and potentially 
for lower limb split skin graft failure and primary closure dehiscence in 
dermatological surgeries as identified in the conceptual framework will now be 
examined. 
 
2.6.1 Risk factor: diagnostic comorbidities 
The first risk factor for lower limb split skin graft failure and primary closure 
dehiscence includes diagnostic (medical) comorbidities.  
Theoretical literature 
The lower limbs are subjected to physiological and accelerated vascular 
changes from disease processes due to their distal aspect from major organs, effects 
of gravitational pull and extensive microvascular system, the latter of which is also 
influenced by muscle-pump function and dorsi-foot flexion (Franz et al., 2007; Loots 
et al., 1998).  Physiological and vascular changes are further compounded by a 
myriad of comorbidities which ultimately lead to acute wound failure and the 
transition to a chronic wound (Franz et al., 2007; Loots et al., 1998).    
WHO (2009) guidelines stipulate that aged related changes impact on tissue 
repair and regeneration, therefore increasing age becomes a potential risk factor for 
poor surgical outcomes.  WHO (2009), EWMA (2008) and AWMA (2010) 
guidelines highlight that  uncontrolled disease processes, such as hyperglycaemia and 
multiple comorbid conditions are risk factors for surgical site complications as they 
impact negatively on healing due to ischemia or disrupted cellular function which 
impairs the trajectory of healing.  Other medical conditions which are suspected to 
affect healing include (refer Table 2.1):  
 cardiac disease: ischaemic heart disease (IHD), hypertension, 
hypercholesterolaemia (Paradela et al., 2010; Stienberg, Popa, Michalek et 
al., 2008) 
 diabetes (Franz et al., 2007; Loots et al., 1998; Paradela et al., 2010) 
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 peripheral vascular disease (PVD): arterial occlusion, varicose veins, deep 
vein thrombosis (DVT), cerebrovascular accident (CVA), and neuropathic 
changes (Franz et al., 2007; Paradela et al., 2010) 
 inflammatory conditions, such as rheumatoid arthritis (Franz et al., 2007; 
Stienberg et al., 2008) 
 malignant haematological conditions, such as thrombocytopaenia (Franz et 
al., 2007; Stienberg et al., 2008). 
 
Empirical literature 
 Two studies reported on comorbid risk factors of cutaneous surgeries in 
ambulatory patients.  A prospective observational study by Henderson and 
colleagues (2009) recruited 85 patients, all with skin grafts completed by surgeons at 
the general surgical department in a New Zealand hospital between December 2005 
and December 2006.  The aim of the study was to audit current skin graft practice.  
Of these 85 grafts, 24.7% (n=22) experienced complications.  Patient medical 
comorbidities collected in this study included diabetes, PVD and venous disease.  
There was no statistical relationship between diabetes and surgical site failure 
(p=0.247).  Although surgical site failure (n=22) was higher amongst patients who 
had surgeries on the lower limb (65%, n=11), there was no statistical relationship 
between poor lower limb surgical outcomes and PVD (p=0.589), nor venous disease 
(p=0.247).   
 A similar prospective observational study by Paradela and colleagues (2010), 
investigated relationships between patient demographics, medical history and 
surgical procedure morbidity in the aged patient population (>85years).  Data was 
collected from 2003-2005 at an ambulatory surgery unit.  Of the 247 patients over 
the age of 85, medical comorbidities were reported in 81% (n=208) of participants.  
Hypertension accounted for the highest comorbidity with 73.1% (n=152); CVA, IHD 
and peripheral arteriopathy were suggestive of atherosclerosis, and reported in 34.6% 
(n=72), hypercholesterolaemia 22.1% (n=46), diabetes mellitus 20.2% (n=42) and 
cardiac congestive failure in 16.3% (n=34).  Reported surgical site complications 
were 8.5% (n=21).  There was no statistical relationship between medical 
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comorbidities or increasing age with poor surgical outcomes.  This study did not 
report on statistical relationships associated with lower limb surgical failure.   
 Guidelines by WHO (2009), AWMA (2010) and EWMA (2008) report risk 
factors of increasing age, hyperglycaemia and many comorbid conditions for surgical 
site complications.  Both studies (Henderson et al., 2009; Paradela et al., 2010), 
aimed to report on associated comorbid risk factors with poor cutaneous surgical site 
outcomes, however did not find any statistical significant relationships between the 
variables investigated; comorbidities and cutaneous surgical outcomes.  Interestingly, 
Henderson and colleagues (2009) did highlight that the lower limb appeared to be at 
greater risk of surgical site problems than other sites of the body with a higher 
complication rate occurring in 11 lower limbs from the total 22 poor surgical 
outcomes.   
 
2.6.2 Risk factor: Surgical comorbidities 
 The second risk factor for lower limb split skin graft failure and primary 
closure dehiscence is a patient history of surgical procedures on the same limb as the 
cutaneous procedure. 
Theoretical literature 
Guidelines by AWMA (2010) identified reduced mobility as a risk factor for 
poor healing.  Reduced mobility may be due to previous trauma or surgical 
procedures, which may impact on movement, reducing circulatory or lymphatic 
drainage.  Those associated with this change in the lower limb include knee or hip 
replacement, previous trauma or amputation and varicose vein stripping (AWMA, 
2010, EWMA, 2009; Moffatt & Franks, 2004; Wu & Armstrong, 2005).   
Despite the theoretical suggestion that these surgeries may impact on vascular 
and lymphatic systems, no empirical literature was found to support this. 
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2.6.3 Risk factor: Medication 
The third risk factor for lower limb split skin graft failure and primary closure 
dehiscence is medication. 
Theoretical literature 
 Acute wound healing is a well ordered physiological process and after the 
initial surgery the surgical wound will progress through stages of haemostasis, 
inflammation, granulation and finally remodelling (Jones et al., 2008).  These phases 
rely on chemotaxis, but can be easily disrupted by extraneous sources such as 
medication (Karukonda, Flynn, Boh et al., 2000a; Karukonda, Flynn, Boh et al., 
2000b).  Medications which inhibit the wound healing cascade include antiplatelet 
medication such as aspirin and non-steroidal anti-inflammatories (NSAID), 
anticoagulants such as warfarin, immunosuppressant and chemotherapeutic 
medication such as methotrexate, also corticosteroid and glucosteroids (Karukonda et 
al., 2000a; Karukonda et al., 2000b). 
The use of anticoagulants, such as warfarin inhibits haemostasis (Khalifeh & 
Redett, 2006; Stables & Lawrence, 2002).  With warfarin administration vitamin K is 
reduced and coagulation at the surgical site is unable to be achieved (Khalifeh & 
Redett, 2006; Stables & Lawrence, 2002).  For patients prescribed anticoagulation 
therapy such as warfarin, the recommended international normalised ratio (INR [the 
standardised result of prothrombin clotting time]) for minor cutaneous surgeries of 
<3.5 (normal range 0.8-1.2) is considered acceptable for patients to continue with the 
surgical procedure (Khalifeh & Redett, 2006; Lawrence, 1996; Stables & Lawrence, 
2002).  This abnormally high level has been recommended as adverse effects of 
cutaneous surgical site failure are considered of minor importance when compared to 
adverse effects of ceasing or reducing the medication due to increased risk of stroke 
(Khalifeh & Redett, 2006; Stables & Lawrence, 2002).  For major surgeries 
therapeutic INR levels are lower, between 2 – 2.5 (Khalifeh & Redett, 2006; Stables 
& Lawrence, 2002).   
Adverse outcomes in cutaneous surgeries from these medications are 
increased haematoma and seroma formation and ultimately surgical site failure 
(Khalifeh & Redett, 2006; Stables & Lawrence, 2002).  Heparin therapy is an 
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alternative therapy to warfarin due to a significantly short half-life and decreased 
long term adverse effects, but should also be discontinued around the day of the 
surgery (Khalifeh & Redett, 2006; Stables & Lawrence, 2002; Stewart & Langtry, 
2009).   
Antiplatelet medications such as clopidogrel, aspirin and non-steroidal anti-
inflammatories (NSAIDs) inhibit platelet aggregation and clotting during the 
haemostatic phase of wound healing (Bordeaux, Martires, Goldberg et al., 2011; 
Stewart & Langtry, 2009).  These medications are also used for their anti-
inflammatory effects which may inhibit macrophage functioning increasing the risk 
for surgical site infection (Bordeaux et al., 2011; Stewart & Langtry, 2009).  Other 
adverse outcomes from these medications are increased haematoma and seroma 
formation (Bordeaux et al., 2011; Stewart & Langtry, 2009).   
Current recommendations for anticoagulant and antiplatelet medication 
management pre-operatively specify that the risk of thromboembolic events such as 
cerebrovascular accident or cardiovascular event take precedence over surgical site 
haematoma or seroma (Khalifeh & Redett, 2006; Stables & Lawrence, 2002; Stewart 
& Langtry, 2009).  It is suggested that these medications should not be ceased but 
titrated or substituted; also with an increased attention to the surgical site through 
increased cauterisation, and the use of dressings with haemostatic properties such as 
alginates and bolster dressings which can increase pressure post-operatively 
(Khalifeh & Redett, 2006; Nelms, Wooten & Heckler, 2009; Stables & Lawrence, 
2002; Stewart & Langtry, 2009).  Non-opioid pain relieving medication can be 
exchanged for NSAIDs to assist with pain management (Khalifeh & Redett, 2011). 
Immunosuppressant and chemotherapeutic medications, such as 
methotrexate, inhibit ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) 
synthesis, which impair collagen synthesis and reduce wound tensile strength 
(Dissemond, Hoeft, Knab et al., 2006; Fuerst, Mohl, Baumgartel & Ruther, 2006; 
Howe, Gardner & Kadel, 2006).  These medications also inhibit T-cell and B-cell 
functioning which suppress inflammatory responses increasing ones risk of surgical 
site infection (Dissemond et al., 2006; Howe et al., 2006).  EWMA (2008) report 
immunosuppressant medication as a risk factor for poor wound healing. 
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Similarly poor surgical site outcomes are also associated with corticosteroid 
and glucosteroid use, including reduced collagen synthesis, poor wound tensile 
strength and decreased immunity (Howe et al., 2006; Karukonda et al., 2000b).  The 
WHO (2009) has reported systemic steroids as a risk factor for surgical site 
complications.  The use of retinoids for adjunct treatment with steroidal medication 
is recommended to restore vitamin A levels which aid collagen synthesis and re-
epithelialisation (Karukonda et al., 2000b).  A lab-controlled rat-model trial study by 
Akkus and colleagues (2009), investigated the adjunct treatment of carnitine, an 
amino acid supplement, in reducing the effects of glucosteroids (methylprednisolone) 
which reduces the tensile strength of healed wounds.  The study design used a three 
group comparison and investigated the effects on wound strength, glucosteroid plus 
carnitine versus glucosteroid use alone versus no medication.  The primary outcome 
was primary closure tensile strength.  The authors reported a lower tensile strength in 
the glucosteroid only group (p<0.05) suggesting a lower tensile strength results in 
poor tissue quality and increased risk of surgical site dehiscence and graft failure.  
It is important to highlight that whilst these medications can affect the wound 
healing cascade, their role as mediators in controlling inflammatory disease 
processes such as rheumatoid arthritis cannot be dismissed (Howe et al., 2006).  A 
retrospective surgical audit by Luessenhop and colleagues (1996) reported that the 
relative risk of developing a surgical site infection in patients receiving arthroscopy 
were ‘significantly’ higher (P<0.001) in rheumatoid arthritis patients when compared 
with patients who had non-inflammatory disease processes such as osteoarthritis.  
Bilateral arthroscopy site infection was also highly correlated with rheumatoid 
arthritis and corticosteroid use, but not corticosteroid use alone. 
 
Empirical literature 
 There are no randomised controlled trials (RCT) investigating surgical site 
complications with medications versus placebo, perhaps due to ethical issues which 
may arise from major side effects such as thromboembolic event.  However, some 
studies have examined relationships which assessed the risk of anti-thromboembolic 
medication use on dermatology surgical sites, through either prospective 
observational methods (Bordeaux et al., 2011) or retrospective chart audit (Nelms et 
al., 2009; Otley et al., 1996).  One observational study reported on surgical site 
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outcomes with anticoagulant, antiplatelet and immunosuppressant medication use as 
part of a larger risk analysis (Henderson et al., 2009).   
 Otley and colleagues (1996) conducted a retrospective chart audit across four 
dermatology institutions to review outcomes of surgical site complications on 653 
patients who were prescribed anticoagulant and antiplatelet therapy.  Mohs surgery, a 
lengthy procedure which incorporates surgeon and pathologist working together to 
remove the lesion over several surgeries on one patient usually over the course of 
one day, was also reported in the data analysis but for the purpose of this chapter 
excisional surgical outcomes were the outcome of interest (n=384).  The primary 
outcome of interest was haemostasis and outcomes were reported as mild, moderate 
or severe surgical site complications.  This study did not report on anatomical 
position of the surgical site.  The four comparative groups for surgical excision 
included patients taking warfarin (n=12) versus patients who had ceased warfarin > 2 
days pre-operatively including in this patient group were those given heparin therapy 
as a substitutive therapy (n=40); and patients taking aspirin or NSAID (n=159) 
versus patients who ceased aspirin or NSAID >5 days pre-operatively (n=71).  The 
authors also reported on complications in a group of 102 patients who were not 
taking any of these medications.  In this group a complication rate of 17% (n=2) was 
reported; but these were considered ‘mild complications’.  In the group still taking 
warfarin, a reported 25% (n=3) participants had moderate complications and severe 
complications were seen in 8% (n=1) of the patients remaining on warfarin.  In the 
group of those who had ceased warfarin, only 2.5% (n=1) reported a severe 
complication. For the group receiving aspirin or NSAID, 0.6% (n=1) reported 
moderate complication and 1.8% (n=3) reported a severe complication compared 
with no (n=0) moderated or severe complications in the withheld group.  There was 
an increase in surgical site complications in patients who continued warfarin when 
compared to the other groups, this was statistically significant (X
2
=11.8, df=4, 
p=0.02). 
 A prospective observational study by Bordeaux and colleagues (2011) 
examined the rate of bleeding, infection, necrosis and dehiscence in 1,911 patients 
recruited from one dermatology practice over a 15 month period.  Of the 1911 
patients 38% (n=726) were on anticoagulant and antiplatelet medication, a further 
8% (n=152) were on two or more anticoagulant and antiplatelet medication.  
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Coagulation complications occurred in 0.89% (n=17).  Univariate analysis for 
bleeding, showed a statistically significant relationship between warfarin (OR 9.42, 
CI 95% 3.53-25.15, p<0.0001) and clopidogrel (OR 6.55, 95% CI 1.83-23.4, 
p=0.004), however there was no relationship between aspirin and coagulation 
complications (p=0.27).  There was no statistical relationship between anticoagulants 
or antiplatelet medication with infection, necrosis or dehiscence rates.  
 In contrast, a retrospective chart audit by Nelms and colleagues (2009) 
assessed endpoints of bleeding, haematoma formation, graft success and other 
complications in 26 patients who continued to take warfarin therapy throughout 
cutaneous surgeries, from the period of 2000-2006 at a general hospital in Pittsburgh, 
United States of America.  There was one 3.8% (n=1) minor complication of ‘ooze’ 
at the surgical site.  There were no other major findings in this chart audit. 
Another prospective observational study by Henderson and colleagues (2009) 
85 patients with grafts were recruited for analysis. The number of patients on 
anticoagulation medication were 10.8% (n=8); antiplatelet medication was used by 
41.9% (n=31) of participants.  Data on immunosuppressant medication was also 
collected with 8.1% (n=6) patients taking this medication.  Of these 85 grafts 24.7% 
(n=22) had complications.  There was no statistical relationship found between the 
use of anti-thromboembolic (p>0.05) or immunosuppressant medication (p>0.05) 
and graft failure.   
From the four studies presented above, Otley and colleagues (1996) and 
Bordeaux and colleagues (2011) research highlighted warfarin and clopidogrel as a 
risk factor for poor surgical site outcomes.  Nelm and colleagues (2009) and 
Henderson and colleagues (2009) research found no statistically significant 
relationships with warfarin and surgical site failure quite possibly due to low 
participant numbers in these studies which may have led to the discrepancies.  
Despite EWMA (2008) guidelines reporting immunosuppression as a risk factor for 
poor healing, Henderson and colleagues (2009) reported that there was no 
statistically significant relationship with immunosuppression and surgical site failure.  
Again however, this difference may be due to low participant numbers.  Surgical site 
failure is multifaceted and the decision to cease medication which may affect wound 
healing is based on the clinicians own judgement and can be guided by haematology 
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findings or other disease processes.  The evidence here suggests that warfarin and 
clopidogrel therapy may be a risk factor of poor cutaneous surgical site outcomes. 
 
2.6.4 Risk factor: Infection 
 The fourth risk factor for lower limb split skin graft failure and primary 
closure dehiscence is the development of surgical site infection. 
 
Theoretical literature 
During the inflammatory phase of healing the body protects itself through 
phagocytic migration, where foreign matter and bacteria are removed from the 
surgical site (Dubay & Franz, 2003; Franz et al., 2000).  The host’s response protects 
the patient from infection, however this may be inhibited when there is lower 
immunity or changes in cellular structure which inhibit this response as reported in 
Table 2.1. 
Cutaneous surgical site infection can include cellulitis or the presence of 
inflammation, purulent discharge, heat, surgical site dehiscence or graft failure 
(Mangram et al., 1999; WHO, 2009).  This occurs within 30 days of the surgical 
intervention being performed and is a significant surgical site complication 
prevention goal of the World Health Organisations guideline to safe surgery 
(Mangram et al., 1999; WHO, 2009). 
 
Empirical literature 
 Surgeries on the lower limb and skin grafts are considered to be of high risk 
for surgical site infection (Wright et al., 2008).  Heal and colleagues (2006) reported 
in a prospective observational study of 857 patients, that there was a total infection 
incidence of 8.6% (n=74) (95% CI 3.5%-13.8%).  From this incidence rate a total of 
34% (n=25) of infections occurred in the lower limb.  The total number of lower 
limb surgeries was 167 with 15% of this group (n=25) developing an infection 
compared to other surgical site locations.  A relative risk was calculated and it was 
determined those who have surgery in locations other than the lower limb have half 
the chance of developing infection (RR 1.9, 95% CI 1.1-3.1, p<0.05).  Prophylactic 
antibiotics were not used in any patients.   
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A prospective observational study by Dixon and colleagues (2006) also found 
a relationship between lower limb surgeries and infection rates.  Of the 5,091 lesions 
removed the overall incidence of infection for this study was 1.47% (n=75).  From 
the 448 patients who had lower limb surgeries, the total incidence of infection was 
6.92% (n=31) (p<0.05), which was the highest when compared with other locations 
for surgery.  Skin grafts also reported the highest infection rates; from the 69 patients 
who received a skin graft an infection incidence of 8.7% (n=6, p<0.05) was reported, 
compared with 0.54% (n=16) infection incidence from the 2974 primary closures.  
The authors reported that infection rates between those with diabetes (p=0.54), those 
taking anticoagulants and antiplatelet medication (p=0.57) and smokers (p=0.24) 
were the same when compared with the rest of the study population.  Prophylactic 
antibiotics were not used on this patient population. 
Another prospective observational study by Amici and colleagues (2005) 
reported similar overall incidence of infection of 2% (n=79) from 3788 dermatology 
surgeries.  Surgery on the ‘limbs’ was not stratified into arms or lower legs, but the 
incidence of infection for both combined was 0.003% (n=15).  When compared with 
infection rates with other locations, ‘limb’ infections accounted for 18.9% (n=15) 
(OR 1.1, CI 0.6-1.9).  The authors did not report on complications or surgical success 
related to prophylactic antibiotics, despite this data being collected during the study 
period.   
In the three studies by Heal and colleagues (2006), Dixon and colleagues 
(2006) and Amici and colleagues (2005), the incidence of infection rates were higher 
in lower limb surgical groups when compared with other surgical site locations, with 
the highest risk reported in Heal and colleagues study who found a two times higher 
risk rate for surgical site infection in the lower limb surgical group.  However these 
studies did not suggest if the prophylactic use of antibiotics would reduce this 
infection rate. 
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2.6.5 Risk factor: Antibiotic prophylaxis 
 The fifth risk factor for lower limb skin graft failure or primary closure 
dehiscence is the use or absence of prophylactic antibiotics. 
Theoretical literature 
 The prophylactic use of antibiotics for all cutaneous lower limb surgeries is 
debateable.  This decision to administer prophylactic antibiotic therapy is often based 
on clinicians own judgement as the risk of infection is multifaceted (Mangram et al., 
1999).   
The use of prophylactic antibiotics in surgery is to prevent secondary 
infection in prosthetic joints, heart valves and to prevent surgical site infection 
(Mangram et al., 1999).  The WHO (2009) guidelines stipulate prophylactic use of 
antibiotics are not necessary for Class 1 clean wounds (a surgical wound created to 
non-inflamed skin with appropriate sterile technique, and closed by primary 
intention) (Babcock & Grekin, 2003; Maragh, Otley, Roenigk & Phillips, 2005; 
Moorhead & Torres, 2009).  Comorbid conditions reported to increase the risk of 
surgical site infection include the immunocompromised, poorly controlled diabetics 
or those on immunosuppressant medications such as methotrexate, and smokers 
(Babcock & Grekin, 2005, WHO, 2009).  Strict guidelines for surgical site 
preparation aim to minimise contamination of the surgical site by surgeons, nurses 
and the patient’s normal flora (Babcock & Grekin, 2005; Mangram et al., 1999, 
WHO, 2009).  Post-operative care of covering the surgical site with wound care 
dressings is also important to prevent infection (Mangram et al., 1999).  
 A well-established disadvantage of antibiotic use is the emergence of multi-
resistant organisms (MRO) (Maragh et al., 2005).  A survey conducted by George 
(1995) highlighted a discrepancy in antibiotic regimes which were used for 
prophylactic treatment in preventing the surgical site infection amongst patients 
undergoing cutaneous surgeries and therefore increasing the risk of MRO.  In this 
survey, a total of 24 different antibiotics were used.  Guidelines for prophylactic 
antibiotic use aim to minimise complications of MRO resistance, medication side 
effects and assist the clinician to determine if their prescription is of benefit or 
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hindrance to the patient and the surgical site (Mangram et al., 1999; Wright, 
Baddour, Berbari et al., 2008; WUWHS, 2008b; WHO, 2009).   
 
Empirical literature 
An advisory statement by Wright and colleagues (2008) highlighted the need 
for pre-operative stat dose and post-operative oral antibiotics prescribed for duration 
of 7-10 days for high risk surgeries, to which lower limb surgeries maybe 
categorised.  In investigating the use of prophylactic antibiotics in clean 
dermatological surgeries, a prospective observational study was conducted by 
Rogues and colleagues (2007) on 3491 patients recruited from 73 dermatologists.  
Patients had benign or malignant tumours removed via ‘simple’ excision of lesion 
with primary closure, skin graft or skin flap.  Average follow-up was 10 days.  The 
aims of this research was to determine the incidence of haemorrhagic and infection 
rates.  Data regarding antibiotic prophylaxis was recorded.  Antibiotic prophylaxis 
was administered to 0.7% (n=26) of participants.  The infection rate from the overall 
population was 1.9% (n=67).  It was reported that, there was no association between 
prophylactic antibiotics and infection rates.  However, in regards to these two 
variables, the incidences of both these were low, possibly impacting on the study’s 
ability to demonstrate a relationship between the two variables.  The authors did 
highlight that patients who sustained complications of haematoma were six times 
more likely to develop an infection (OR 6.6, 95% CI 2.52-17.3, p<0.001).  Those 
with known risk factors were more likely to receive prophylactic antibiotics: 
diabetics (6.4% versus 1.8%, p<0.05), immunocompromised patients (12.5% versus 
1.7%, P<0.05) and skin graft or skin flap versus primary closure (6% versus 1.4%, 
P<0.05).   
The incidence for lower limb surgical site infection was up to two times 
higher in lower limb surgical groups when compared with other cutaneous surgery 
anatomical locations.  Rogues and colleagues (2007) reported that there was no 
statistically significant relationship found between the use of prophylactic antibiotics 
and cutaneous surgical site infections, although the presence of haematoma at the 
surgical site increased the risk of infection by six-fold, with the diabetic, 
immunocompromised and split skin graft patients most likely to receive prophylactic 
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antibiotics.  Lower limb surgeries are considered to be of high risk, but balancing 
patient comorbidities, treatment cost and the risk of multi-resistant microbes need to 
be outweighed before antibiotic prophylaxis are prescribed. 
 
2.6.6 Risk factor: Malnutrition  
  The sixth risk factor for lower limb skin graft failure and primary closure 
dehiscence is malnutrition. 
Theoretical literature 
Malnutrition is defined as a significant reduction in necessary nutrients and 
proteins creating an environment where metabolic disturbances and anthropometric 
changes occur (Shepherd, 2009).  Malnutrition can be caused by the inadequate 
consumption of energy, fats and protein, which maybe multifactorial due to patient 
factors such as loss of appetite, financial situations, gastrointestinal obstructions and 
mechanical issues – loss of teeth or restricted hand to mouth movement (Shepherd, 
2009).  Furthermore chronic disease related processes, such as gastroenterological 
disturbances, may inhibit the adequate digestion and absorption of protein, vitamins, 
and trace elements (Green & Watson, 2006).   
Obesity related malnutrition is two-fold; the bariatric patient requires higher 
levels of minerals, vitamins and energy during stress, such as the stress caused by 
surgery, but also poor dietary choices which have caused obesity need to be 
addressed in this patient group (AORN, 2004; Shankar et al., 2010).  The metabolic 
changes during acute stress such as surgery are greater in the obese patient due to 
increased energy requirements for cellular repair and regeneration in this patient 
group (AORN, 2004; Shankar et al., 2010).  Bariatric patients also have a higher 
degree of adipose tissue, which has reduced vascularity and therefore nutrient and 
oxygen transfer to cutaneous tissue is inhibited and tissue necrosis more likely 
(Tobon, Whitney & Jarrett, 2008).  Giles and colleagues (2010) highlighted the 
complications to the bariatric patient after surgery, these included increased infection 
rates and increased primary closure dehiscence and graft failure (Giles et al., 2010). 
WHO guidelines (2009) report obesity as a risk factor for surgical site complications. 
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Dermatological surgeries increase local need for nutrients and oxygen to 
promote healing, graft take, and prevent surgical site dehiscence (Arnold & Barbul, 
2006). The process of wound healing is complex; inflammatory, biochemical 
markers and oxygen tension promote the sequential phases of wound healing and the 
role of micro and macronutrients is pivotal for the maintaining normal cellular 
functioning and repair (Campos, Groth & Branco, 2008).  Micronutrients, zinc, 
vitamin A & C, and macronutrients, amino acids such as arginine, carbohydrates and 
protein are the major contributors to the wound healing process (Campos et al., 
2008). 
Zinc is required for RNA and DNA replication, cellular proliferation and protein 
synthesis (Gray, 2003a).  Vitamin A is an anti-inflammatory agent, stimulating 
epithelisation (Gray, 2003b).  Vitamin C is essential for collagen synthesis, 
neutrophil functioning and prevention of infection (Gray & Whitney, 2003).  Amino 
acids, such as arginine, are essential for protein synthesis, stimulate revascularisation 
and promote T-lymphocyte function, a vital aspect of the immune system (Desneves, 
Todorovic, Cassar & Crowe, 2005; Witte & Barbul, 2003).  Carbohydrates are 
required for energy to fuel the wound healing cascade and protein, to support 
collagen, a major extra-cellular matrix component (Arnold & Barbul, 2008; 
Legendre, Debure, Meaume, Lok et al., 2008).  
 
Empirical literature 
Several studies worth noting, reported that blood tests conducted on patients 
randomised to a supplement containing an amino acid ‘arginine, omega-3 fatty acids 
and RNA-enriched’ showed lower levels of inflammatory cytokines, therefore 
suggestive of improved immunity and reduced complications such as surgical site 
infection (Braga et al., 1999; Gianotti, Braga, Fortis et al., 1999).  Braga and 
colleagues (1999) reported that both the malnourished and even those not considered 
being ‘at risk’, showed improvement in post-surgical outcomes with nutritional 
supplementation.   
The American College of Surgeons database audit for the National Surgical 
Quality Improvement Program in 2005-2007 highlighted that the obese patient 
(indicated by high body-mass index [BMI >30]) had twice the development of 
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surgical site infection when compared with those whose BMI was of normal range 
(Giles et al., 2010).  Several methods can be used to measure obesity.  The most 
common being a result of BMI; an overall body measurement which is calculated by 
the person’s weight in kilograms divided by their height in metres squared 
(kg/ht(ms)
2
).  Another measurement is waist-hip-ratio (WHR); a measure or truncal 
obesity and calculated by the smallest circumferential waist divided by the largest 
circumferential hip (W/H).   
Penington and Morrison (2007) conducted a consecutive prospective study on 
head and neck surgical patients requiring full-thickness skin grafts (of less than 
10cm²) comparing BMI versus WHR to predict skin graft failure.  Failure was 
defined as a clinical estimation of the ‘percentage of the whole graft showing 
capillary return at the one-week follow up and when this was not clear at one week it 
was reassessed at two weeks’.  Significant graft loss was indicated to be ten percent.  
Fourteen individual patients were recruited over a nine month period.  Four of 14 
patients had a WHR greater than 1 (considered high risk). All four patients had 
significant graft failure.  Two of 14 patients had a BMI greater than 30 (considered 
obese).  One of these two had significant graft failure.  A Pearson’s correlation 
statistic was used to compare BMI and WHR with graft take.  A negative correlation 
was found between graft take and WHR (r=-0.760, p=0.002), and therefore the 
utilisation of WHR would be a useful measurement marker to assess the obese 
patient and risk of lower limb surgical failure. 
Penington and Morrison’s (2007) study identified WHR as a predictor of poor 
graft healing.  An increased WHR, the obese and undernourished patients are 
predisposed to reduced immunity, poor acute inflammatory responses and weakened 
epithelialisation, but also altered normal bodily responses leading to poor cutaneous 
surgical site outcomes.  
 
2.6.7 Risk factor: Smoking 
The seventh risk factor for lower limb skin graft failure and primary closure 
dehiscence is smoking.   
 
 Chapter 2: Literature Review 37 
Theoretical literature  
Smoking, through lung cancer, is the leading cause of death in many 
countries (Delgado-Rodriguez, Medina-Cuadros, Martinez-Gallego et al., 2003).  
The negative effects of smoking have been reported in medical journals since the 
1950s.  Historically focus was on direct results of smoking such as lung cancer and 
other cancers; however the importance of smoking on ill health has now been 
recognised for a plethora of disease processes such as PVD, cardiovascular disease 
and respiratory illnesses (VCRCC, 2010; Just, Monso, Ribera et al., 2005; Rayner, 
2006; Sorensen et al., 2003).  These disease processes reduce oxygen availability to 
tissues and alter endothelial functioning, altering cellular repair at the integumentary 
level, which hinders the acute healing cascade of the surgical wound (Rayner, 2006; 
Sorensen et al., 2003; Straten et al., 2001).  Smoking is a well reported risk factor for 
poor surgical outcomes. 
Chronic tobacco use releases nicotine, carbon monoxide, hydrogen cyanide 
and thousands of other toxic chemicals into the blood stream resulting in tissue 
toxicity, peripheral vasoconstriction, poor oxygen attachment to haemoglobin, and 
platelet adhesion which facilitates chronic inflammatory processes and tissue 
hypoxia (Just et al., 2005; Saetzler, Arfors, Tuma et al., 1999).  Straten and 
colleagues (2001) highlighted that smoking reduced vitamin C, oxygen and iron, 
required for collagen cross-linking to complete closure of the surgical site, this would 
impede this healing process and ultimately graft take.  Straten and colleagues (2001) 
also reported that smoking greater than one pack per day per person was likely to 
cause tissue necrosis, and a three-fold increase in complications was reported when a 
comparison was made between smokers and the non-smoking population (Straten et 
al., 2001). 
The effects of tissue ischaemia have been highlighted in animal models 
(Alizadeh et al., 2007).  Alizadeh and colleagues (2007) reported slower granulation 
and formation of type 1 collagen in the ischaemic limb of rodents.  Although 
complete wound closure was achieved in this animal model, it occurred over a 
prolonged period and it was highlighted that the healing process was only 
complicated by one factor: surgically induced ischaemia (Alizadeh et al., 2007).  
Tissue ischaemia from secondary health issues from smoking, such as PVD and 
cardiac disease, and in the presence of a myriad of tobacco toxins, the healing 
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cascade would further be impeded (Just et al., 2005; Straten et al., 2001; 
Willigendael et al., 2005). 
 
Empirical literature 
A recent systematic review and meta-analysis was conducted by Mills and 
colleagues (2011) to determine the optimal smoking cessation period prior to 
surgery.  All types of surgeries were included.  Mills and colleagues (2011) 
determined with the use of a meta-regression plot, that four weeks smoking cessation 
prior to surgery had significant reduction on all post-operative complications, with a 
relative risk reduction of 41% (95% CI 15-59, p=0.01).  Wound healing 
complications were also significantly reduced (RR 0.73, 95% CI 0.61-0.87, 
p=0.0006, I
2
 = 0%).   
Mills and colleagues (2011) meta-analysis highlighted that smoking 
continues to be a predictor of poor surgical outcomes.  In order to reduce graft 
failure, infection and primary closure dehiscence, a recommendation of four weeks 
pre-operative cessation of smoking has been indicated.   
 
2.6.8 Risk factor: Lower limb disease 
The eight risk factor for lower limb split skin graft failure and primary 
closure dehiscence is the presence of lower limb disease.  This includes skin changes 
and presence of lower limb pain.   
Theoretical literature 
The healing and success of a skin graft or primary closure depends on good 
circulation to the lower limb.  Guidelines by EWMA (2008) and AWMA (2010) 
report this as a risk factor for poor wound healing, as healing is dependable on 
healthy vessel endothelium and movement of blood pumped by arterial vessel 
contraction and functioning venous vessel valves, which promote oxygen tension and 
nutrient delivery (Wipke-Tevis, Stotts, Williams, Froelicher & Hunt, 2001).  These 
healthy circulatory outcomes promote fibroblast and capillary growth, collagen 
deposition, epithelialisation and prevention of infection (Wipke-Tevis et al., 2001).  
The clinical assessment of the lower limb identifies lower limb disease (Bergan, 
Schmid-Schonbein, Smith et al., 2006; Henderson et al., 2009; Paradela et al., 2010).  
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 Arterial, venous and mixed disease can lead to chronic wound formation.  If a 
surgical wound occurred on a poorly perfused limb then failure is likely and a 
chronic wound will form (AWMA, 2010; EWMA, 2009).  The assessment of the 
lower limb is based on clinical presentation, pain history and medical history 
(Bonham, 2003).  The ankle-brachial pressure index (ABPI) (normal range between 
0.8-1.2) and toe pressures (normal range with no arterial disease >0.7) are reliable 
tests to aid the clinician in their diagnosis but are not routinely recommended prior to 
minor procedures (AWMA, 2010; Bendermacher, Teijink, Willigendael et al., 2007; 
Wipke-Tevis et al., 2001). 
The clinical manifestations of venous disease include: 
 lipodermatosclerosis – chronic venous insufficiency results in the skin, 
usually the gaiter area of the lower limb becoming sclerotic incorporating all 
the below venous changes (Bergan et al., 2006; Eklof, Rutherford, Bergan et 
al., 2004; Harding, Comerota & Partsch, 2008) 
 haemosiderin staining – represented by a brown discolouration to the lower 
limb from the extravasation of haemoglobin from the venules causing 
interstitial iron deposition giving the skin a ‘rusty’ appearance (Bergan et al., 
2006; Eklof et al., 2004; Harding et al., 2008) 
 atrophe blanche – areas of avascular and acellular skin which clinically 
appears as white areas with red spots, these areas are easily prone to skin 
breakdown and can be painful for the patient when ulceration occurs (Bergan 
et al., 2006; Eklof et al., 2004) 
 venous flare - smaller veins prominent over the dorsum (Bergan et al., 2006; 
Eklof et al., 2004; Harding et al., 2008) 
 varicose veins (Bergan et al., 2006; Eklof et al., 2004; Harding et al., 2008) 
 venous stasis eczema (Bergan et al., 2006; Eklof et al., 2004) 
 leg oedema (Bergan et al., 2006; Eklof et al., 2004; Harding et al., 2008). 
A medical history including obesity, pregnancy, deep vein thrombosis, prolonged 
episodes of standing and poor mobility or ankle fusion, contribute to venous disease 
(Bergan et al., 2006; Eklof et al., 2004; Harding et al., 2008).  Patients will often 
report pain as a throbbing leg pain alleviated with laying supine and elevating the leg 
(Bergan et al., 2006).  Venous disease can be diagnosed with these clinical 
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manifestations and an ABPI within ‘normal’ limits, reported by the guidelines 
developed by the American College of Cardiology Foundation (ACCF) and 
American Heart Association (AHA) Task Force (2011) to be 0.9 to 1.4.  Measures to 
improve perfusion and reduce complications from venous disease include the use of 
compression hosiery or bandages and bed rest (Rooke et al., 2011; Wipke-Tevis et 
al., 2001). Wipke-Tevis and colleagues (2001) reported optimal transcutaneous tissue 
oxygen (TcPO2) when the patient was in the supine position and legs not elevated. 
 The clinical manifestations of peripheral arterial disease (PAD) include pale, 
cold, shiny, hairless limbs (Callum & Bradbury, 2000; Hinchliffe, Andros, Apelqvist 
et al., 2011).  The ischaemic limb will present with pallor when the limb is elevated 
above 45 degrees, known as dependent rubor (Callum & Bradbury, 2000; Hinchliffe 
et al., 2011).  Pedal pulses may not always represent peripheral arterial disease due to 
oedema or being congenitally absent (Callum & Bradbury, 2000; Hinchliffe et al., 
2011).  A medical history indicating PAD includes hypertension, 
hypercholesterolaemia, cardiovascular disease, diabetes, smoking, poor nutrition and 
increasing age over 65 years (Hinchliffe et al., 2011; Rooke et al., 2011).   An 
abnormal ABPI reading is characteristic of arterial disease; as per ACCF and AHA 
(2011) this reading is <0.9 or if calcification is present the ABPI will be >1.4, and 
toe-brachial index is recommended for those with calcified arteries or ABPI >1.4.  
Ischaemic pain manifests as nocturnal sharp stabbing pain relieved when the patient 
sits out of bed; also claudication of the calf and thigh can occur during exercise 
(Bendermacher et al., 2007; Wang, Criqui, Denenberg et al., 2005).  Intermittent 
sharp shooting pain may also be a symptom of arterial disease or the presence of 
peripheral neuropathy (Bonham, 2003; Callum & Bradbury, 2000).   An ABPI of 
<0.5 requires intensive vascular surgeon input and the consideration for surgical 
intervention to prevent limb loss (Humphreys et al., 2007). 
Patients exhibiting both signs and symptoms of mixed arterial-venous disease 
become increasingly complex (Humphreys et al., 2007).  In this instance venous 
disease is inadequately managed due to complications from applying of high levels 
of compression in the presence of arterial disease (Humphreys et al., 2007).   
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Empirical literature relevant to venous disease 
 Compression therapy is the mainstay treatment for venous disease (Bergan et 
al., 2006; Eklof et al., 2004; Harding et al., 2008).  To improve venous supply post-
operatively there are currently no randomised controlled trials exploring outcomes of 
lower limb dermatological surgeries with differing levels of compression therapy.  
An observational study by Henderson and colleagues (2009) reported on surgical site 
failure in the patient with venous disease.  Four of eight patients with venous disease 
had graft failure, however this was not statistically significant (4/8, p=0.247).  The 
authors reported that patients with venous disease were placed into compression 
therapy with leg elevation post-operatively. 
In exploring lower limb surgical outcomes for patients with severe venous 
disease with ulceration, Jones and Nelson completed a systematic review (2010).  
Jones and Nelson (2010) highlighted the importance of compression therapy as part 
of adjunct treatment post-skin graft to assist in improving venous circulation.  This 
systematic review determined that there was no benefit for skin grafting of venous 
leg ulcers; patients who received skin grafts had no significant difference to complete 
wound closure than those who healed with conventional treatment of compression 
therapy alone.    
 
Empirical literature relevant to arterial disease 
 Revascularisation of the critically ischaemic foot is recommended for limb 
salvage (Hinchcliffe et al., 2011; Rooke et al., 2007).  However in the asymptomatic 
patient this surgery would be considered unnecessary due to increased mortality 
related to major amputation (Hinchliffe et al., 2011).  Two prospective observational 
studies reported on these risk factors.  Henderson and colleagues (2009) reported that 
none of the six patients diagnosed with PAD had graft failure, although this was not 
statistically significant (p=0.589) when compared with those that did not have PAD 
and graft failure.  However, in this patient population PAD was diagnosed with 
absence of pedal pulses. This is not clinically relevant, as PAD diagnosis is complex 
and requires the use of instruments such as the ABPI and arterial and venous Doppler 
studies (Armstrong, Tobin & Matangi, 2010; Bendermacher et al., 2007; Wipke-
Tevis et al., 2001).  Another prospective observational by Paradela and colleagues 
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(2010) highlighted risk factors associated with atherosclerosis, including stroke, 
ischemic coronary disease and peripheral arteriopathy; however did not find a 
statistically significant relationship between surgical site failure and PAD. 
In Henderson and colleagues (2009) and Paradela and colleagues (2010) 
research, PVD and venous disease were not risk factors for surgical site failure.  
Clinically however, we know that venous disease presentations and wounding on the 
lower limb are improved with compression therapy alone when compared with 
surgical intervention (skin grafting), such as that identified in Jones and Nelson’s 
(2010) meta-analysis.  In the absence of larger studies, the presence of venous 
disease and diagnosed PVD may assist the clinician to decide whether 
dermatological surgeries of the lower limb are closed via primary intention, skin 
grafting or remained open to heal by secondary intention with the use of adjunctive 
treatments, such as high levels of compression therapy for venous disease patients. 
 
2.6.9 Risk factor: Post-operative mobilisation and compression therapy 
The ninth and final risk factor for lower limb split skin graft failure and 
primary closure dehiscence is the post-operative mobilisation compared with rest and 
elevation of the patient’s lower limb.   
Theoretical literature  
The haemodynamics of the foot allows the body to work against gravity by 
assisting the vascular system through muscle contraction during movement and 
walking (Kan & Delis, 2001).  There are three major pumping systems in the leg 
which help to do this; the thigh-pump, the calf-muscle-pump and the foot-pump (Kan 
& Delis, 2001).  Normal flexion and movement of the ankle and foot is necessary for 
these muscle pumps to work effectively (Kan & Delis, 2001).   
Exercises incorporating dorsi-flexion and plantar flexion have been reported 
as non-surgical methods in assisting to improve rest pain and claudication due to 
diminished blood flow from arterial disease (Kan & Delis, 2001).  Delis and 
Nicolaides (2005) reported the use of intermittent pneumatic compression to assist 
with improving walking distance, vascular haemodynamics and reducing pain 
associated with arterial disease.  Furthermore, venous hypertension and venous valve 
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incompetence result in increased oedema to the legs with an abundance of senescent 
cells; the use of compression therapy has been the most effective method for 
improving venous return as discussed in section 2.4.8 (Kan & Delis, 2001; McNally, 
Bahadur, Cooke & Mollan, 1997).  Adverse effects at the surgical site occur as a 
result of increased venous pressures and include haematoma, seroma formation and 
ultimately graft failure or primary closure dehiscence.  These arterial and venous 
disease processes can both result in a hypoxic cutaneous system with poor nutrient 
supply; this poor cellular environment is a risk factor for poor surgical outcomes.   
The issues around graft healing involve both the patient ‘resting the leg’ but 
also relate to stimulating the three leg-pumps to assist vascular circulation.  Budny 
and colleagues (1993) were concerned that prolonged bed rest would disrupt normal 
mobility.  Secondary outcomes from this study measured the changes in mobility 
function pre and post bed rest.  A reported 32% (n=10) of patients randomised to bed 
rest had reduced mobility functioning scores pre and post bed rest; whereas no 
patients (n=0) were affected in the early ambulation group.  Conversely it has been 
reported that standing and prolonged walking will create a sub-optimal environment 
for the grafted leg (Henderson et al., 2010; Wood & Lees, 1994).  A patient’s social 
environment may further impact on this, if ‘resting the leg’ cannot be adhered to and 
non-compliance with bed-rest due to this lack of social supports may require the 
patient to continue life as ‘normal’ (EWMA, 2008; Persoon, Heinen, Vleuten et al., 
2004).   
Empirical literature 
There is controversy in the literature with regard to early ambulation versus 
bed rest after lower limb skin grafting.  Historically immobilisation of the patients 
affected limb was preferred (Sharpe et al., 1983).  However with increasing demand 
on hospital beds for major surgeries as well as the increased risks of deep vein 
thrombosis (DVT) and pulmonary embolism from immobility; patients with minor 
surgeries are often now treated as day cases (Budny, Lavelle, Regan et al., 1993; 
McNally et al., 1997).  On the contrary to this Henderson and colleagues (2009), in a 
one-year prospective observational study, reported that those patients with lower 
limb skin grafts were admitted to hospital for five days post-operative as they were 
considered high risk.   
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 In comparing bed rest versus early ambulation, one case-controlled study and 
two RCTs were reported in the 1990s.  A case-control study by Wells and colleagues 
(1995) investigated the effects of Unna (Zinc, gelatine and gauze strip) paste semi-
rigid bandage system, applied after skin grafting post burn on the lower limb; 
patients were discharged home with instructions to ‘move freely’.  A total of 13 
burns patients were recruited prospectively for early discharge.  Patients were 
assessed around day seven and day 14.  The control group were recruited through 
retrospective chart audit, matched with similar lower limb surgeries and matched 
baseline characteristics of the experimental group.  Completed graft take was 
reported at greater than 95%, with both groups having ‘complete skin graft ‘take’.  
Due to low participant numbers in this study, there was not enough statistical 
evidence provided to draw scientific conclusions from the authors reported 
outcomes. 
An RCT to compare early mobilisation versus bed rest for graft take of pre-
tibial lacerations closed by split skin grafting was conducted by Budny and 
colleagues (1993).  Random allocation occurred by year of birth; odd years were 
randomised to bed rest (n=55) and even numbers randomised to early mobilisation 
(n=28).  The early mobilisation group were discharged the same day as their surgery, 
with ‘simple paraffin dressing’ and ‘double layer TubigripTM’ (straight tubular single 
layer bandage offering 5-10mmHg of compression).  Those randomised to bed rest, 
for seven days, were given subcutaneous heparin injections to prevent DVT, paraffin 
gauze to the split skin graft with back-slab and Velband
TM
 (soft padded bandage) to 
immobilise the limb.  Graft assessment was measured at one week and three weeks 
for both groups.  Those randomised to bed rest had an average graft take of 93.7% at 
week one, and 92.8% at week three.  In the early ambulation group the average 
percentage of graft take at week one was 88.7% with 80.7% average at week three.  
Despite disparity in numbers of participants between treatment groups, the authors 
reported that there was no statistical significant differences in healing between bed 
rest versus early ambulation at week one (r=0.89, p=0.29), nor at week three (r=0.91, 
p=0.55). 
 In a similar but underpowered study on split skin grafts for pretibial 
lacerations, Woods & Lees (1994) assessed time to healing, as their primary 
outcome.  A secondary outcome was reported as graft take.  A total of 36 patients 
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were randomised to early mobilisation consisting of one nights bed rest post-
operatively, followed by discharge the next day and were informed to ‘avoid long 
periods of standing and elevate the legs when sitting’.  In the control group, a total of 
39 patients were randomised to 10 days bed rest with mobilisation only allowed on 
the tenth day.  All patients were placed in Tubigrip
TM
 compression post-operatively 
with the graft reviewed at day seven, day 10 and day 14.  The average graft take at 
day seven was 87.3% and 82.4% at day 14 in the early mobilisation group.  In the 
late mobilisation group, graft take at day seven was reported at 88.0% and at day 14, 
90.0%.  The authors reported that these results were not presented statistically due to 
low recruit numbers; however concluded that the time to complete healing between 
the two groups ‘was in fact less than one day’. 
 In all the studies patients had their split skin grafts secured with staples or 
sutures; common practice to help with graft stabilisation.  No studies reported on 
primary closure outcomes.  The mode of which extra support was delivered varied; 
however the early mobilisation groups all had compression applied for venous 
support.  Tubigrip
TM
 is a light tubular bandage reported to deliver 5-10mmHg 
constant pressure, highest at the ankle.  The Unna’s past bandage system is a semi-
rigid zinc and gelatine bandage system which delivers 40mmHg to the superficial 
vascular system when the patient walks (Scheuren & Mohr, 2008; WUWHS, 2008a).  
The use of Unna’s paste bandage with higher level of compression and higher level 
of venous support may be a reason why investigators allowed patients to ‘move 
freely’ upon discharge.  However when comparing early mobilisation versus 
prolonged bed rest to prevent graft failure, there is not enough evidence to indicate 
which method assists with greater graft take, due to poor reporting and low study 
numbers.  No studies reported the economic, functional or hospital costs associated 
with these differing practices.  Therefore there was no difference in surgical site 
failure between patients who had bed-rest or patients who wore compression therapy 
(Unna’s or one to two layers of TubigripTM).  The studies did not report on patients 
who did not wear compression therapy versus ‘moving freely’, and therefore a risk 
factor of surgical site complications may in fact be the absence of supportive 
compression therapy. 
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2.7 SUMMARY OF THE LITERATURE 
It has been hypothesised that the lower limb is at high risk of surgical site 
complications.  It has also been hypothesised that risk factors may assist in predicting 
patients who are at risk of lower limb surgical site failure.  When investigating 
literature to support this, it was evident that very little has been reported on this 
cohort.  The AIHW (2012) and WHO (2009) have reported on risk factors for poor 
health outcomes which ultimately affect acute surgical outcomes and lead to chronic 
wound formation.  The major known risk factors include poor diet, low physical 
activity and obesity, smoking, alcohol misuse, hypertension and 
hypercholesterolaemia.  However, there is little known and reported about risk 
factors for lower limb surgeries.  
From acute wound healing and lower limb disease models a conceptual 
framework was developed to guide a literature search for potential risk factors of 
lower limb surgical site failure.  Nine major risk factor groups were identified as 
suspected predictors for lower limb surgical site failure.  These risk factors included 
diagnostic and surgical comorbidities, medications, presence of infection, use of 
prophylactic antibiotics, malnutrition, smoking, clinical disease changes of the lower 
limb and post-operative mobilisation and compression therapy.   
The literature review conducted, identified that lower limb dermatological 
surgeries exhibited the largest complication rates when compared to other anatomical 
locations.  Other findings highlighted that skin grafts had higher complication rates 
than primary closures; warfarin, clopidogrel, increasing waist-hip-ratio, smoking, 
were associated with increased surgical site complications.  Post-operative 
ambulation in the presence of compression therapy for lower limb surgeries may 
have assisted with success of the surgical site.   
Elaborating on these findings with theoretical concepts, warfarin and 
clopidogrel inhibit platelet aggregation and the formation of thrombus (Bordeaux et 
al., 2011; Stewart & Langtry, 2009).  This may lead to haematoma formation as 
haemostasis cannot be maintained (Otley et al., 1996).  Empirical literature 
supporting increasing waist-hip-ratio results increased metabolic stress to the body, 
which ultimately impedes the acute healing cascade due to changes in oxygen 
tension, microbe resistance and impaired cellular repair and regeneration (Penington 
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& Morrison, 2007; Shankar et al., 2010; Tobon et al., 2008).  Finally, smoking is a 
well-documented risk factor for its negative effects on health and surgical site 
success.  Not only do noxious chemicals from tobacco smoke impede healing and 
increase the risk of infection, but accelerate cellular dysfunction such as that seen 
with cancers or PVD (Alizadeh et al., 2007; Just et al., 2005; Mills et al., 2011; 
Rayner, 2006).  Mills and colleagues (2011) highlighted in a systematic review that 
decreased surgical site complications were noted in participants who had ceased 
smoking four weeks prior to surgical intervention.   Despite these findings however, 
the lower limb was not the primary focus of many studies, which inhibits its 
generalizability to this cohort. 
On the contrary, a finding specific to lower limb surgical outcomes highlighted 
from empirical literature, indicated a protective factor for surgical site success was 
the use compression therapy and ambulation (Budny et al., 1993; Wells et al., 1995; 
Woods & Lees, 1994).  This may be due to improvements in circulation, notably 
venous return and decreased tissue oedema which would assist primary closure 
adherence or with graft take, which can be achieved through compression therapy 
and movement of the lower limb (Kan & Delis, 2001; McNally et al., 1997).  
Unfortunately these studies had small sample sizes, which lead to caution when 
interpreting results to identify risk factors for the lower limb surgical cohort.   
 
2.8 CONCLUSION 
Surgical procedures such as split skin grafting or primary closure safely remove 
the cancerous lesions from the patient to prolong mortality and reduce morbidity.  
However these surgeries also require optimal surgical, environmental and patient 
factors to assist with acute wound healing and to maintain complete wound closure.  
General surgical risk factors for poor surgical outcomes are well documented, but 
none are specific for lower limb dermatological surgeries which may be at greater 
risk of complication due to anatomical location and accelerated disease changes.  A 
conceptual framework was developed from acute wound healing and lower limb 
disease models due to a dearth of literature focusing on risk factors for patients 
undergoing lower limb split skin grafting and primary closure to remove skin 
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cancers.  Nine major risk factors were reported to be suspected predictors for surgical 
site failure.   
A literature search was conducted based on these nine risk factors and this 
chapter reported on the findings from both theoretical and empirical literature 
identified.  Due to a lack of evidence for this specific cohort the nine risk factors 
identified and investigated in this literature review were tested in this study to 
determine their efficacy as predictors for lower limb split skin graft failure and 
primary closure dehiscence in the ambulatory dermatology-surgical cohort. 
The following chapters will discuss methods used for this research, results and 
discussion of outcomes from this study. 
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Chapter 3: Methods 
3.1 INTRODUCTION 
 Chapter two presented a brief synopsis of acute wound healing and factors 
which may impede healing of the lower limb surgical site.  A conceptual framework 
was then developed and reported, followed by a literature review of identified risk 
factors for lower limb split skin graft failure and primary closure dehiscence.  It was 
reported by several authors that the lower limb has higher complication rates when 
compared with other areas of the body (Amici et al., 2005; Bordeaux et al., 2011; 
Dixon et al., 2006; Heal et al., 2006; Henderson et al., 2009).  Several risk factors for 
surgical site complications post cutaneous surgery were highlighted in the literature 
review; however these were not determined based on lower limb dermatological 
procedures alone.   
This chapter will present the research objectives, study design, setting, 
population and participants, data collection, procedure, data management and data 
cleaning, data analysis and ethical considerations underpinning this study. 
 
3.2 RESEARCH OBJECTIVES 
The objectives of this study were twofold: 
1) To determine the incidence of failed split skin grafts and primary closure 
dehiscence in patients undergoing lower limb dermatology surgery in a day 
procedure unit; and 
2) To identify predictors associated with failed lower limb split skin grafts and 
primary closure dehiscence in patients undergoing lower limb dermatology surgery 
in a day procedure unit. 
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3.3 STUDY DESIGN 
This study used a prospective observational cohort design.  A prospective 
observational design follows a cohort with the aim of determining factors or risk 
factors which may predict an outcome of interest (Crosby, DiClemente & Salazar, 
2006; Kirkwood & Sterne, 2010; Mann, 2003; Oleckno, 2008; Vandenbroucke, Elm, 
Altman et al, 2007).  An observational design is important in determining aetiology 
of a disease process or health event and also to determine the incidence or prevalence 
of a disease process or health event (Crosby et al., 2006; Kirkwood & Sterne, 2010; 
Mann, 2003; Oleckno, 2008; Vandenbroucke et al., 2007).   
Prospective observational study outcomes may assist in controlling for 
confounding in further research, specifically intervention studies (Crosby et al., 
2006; Mann, 2003; Oleckno, 2008).  In regards to level of hierarchy, a prospective 
study is ranked higher than retrospective observational studies (Crosby et al., 2006; 
Mann, 2003; National Health and Medical Research Council [NHMRC], 2008-2009; 
Oleckno, 2008).   
This study design was chosen as it was able to determine the incidence of the 
problem being investigated, in this instance, lower limb split skin graft failure and 
primary closure dehiscence in day case surgical patients for dermatological skin 
cancer removal.  In regards to the prospective study design, this allowed for the 
collection of additional risk factors which may not have been identified pre-
operatively, or due to poor documentation or affected by patient recall bias (Crosby 
et al., 2006; Oleckno, 2008; Vandenbroucke et al., 2007).   
Other observational study designs considered for this research included a 
retrospective chart audit, cross-sectional study design and case-controlled study.  A 
retrospective chart audit involves the collection of existing data which has been 
recorded in patient notes or databases (Crosby et al., 2006; Mann, 2003; Oleckno, 
2008).  Retrospective studies are considered inferior to prospective studies in the 
hierarchal level of evidence due to the limited data which can be retrieved (Crosby et 
al., 2006; Mann, 2003; NHMRC, 2008-2009; Oleckno, 2008).  In regards to this 
study, although a retrospective chart audit may have assisted in recruiting higher 
numbers of participants for analysis, it would not however been appropriate for this 
study as lower limb disease presentations, discussion about social situations, weight 
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loss or the documentation of the percentage of split skin graft failure or primary 
closure dehiscence is not common practice and would not have been able to be 
retrieved after the event from the patient’s chart (Crosby et al., 2006; Mann, 2003; 
Oleckno, 2008).   
A cross-sectional study design allows for observational data to be collected 
for a specific cohort at one moment in time (Crosby et al., 2006; Mann, 2003; 
Oleckno, 2008).  A cross-sectional study design will determine the prevalence of a 
condition (Crosby et al., 2006; Mann, 2003; Oleckno, 2008).  In regards to this study, 
the decision against a cross-sectional study design was due to the nature of the 
problem investigated and a cross-sectional study design would have identified the 
prevalence rather than the incidence of the problem (Crosby et al., 2006; Mann, 
2003; Oleckno, 2008).   
The prevalence of lower limb split skin graft failure and primary closure 
dehiscence would not have identified potential split skin graft failures and primary 
closure dehiscence outcomes and therefore an underestimation of the risk factors 
being assessed, and the utilisation of a cross-sectional study design would not have 
allowed for risk factors to be determined, as only associations between variables are 
identified (Crosby et al., 2006; Mann, 2003).  Another downfall of the cross-
sectional study design, is that a larger field of study is required to ensure that data is 
collected for the required number of participants, in this instance many other 
departments and hospitals would have had to have been accessed, however this 
would have been labour intensive and resource intensive (Crosby et al., 2006; Mann, 
2003) and it is beyond the scope of this study.   
The final design considered for this research included the case-controlled 
study design.  A case-controlled study design is a comparative study of two groups 
with differing outcomes; the ‘suspected’ risk factors are examined for presence and 
frequency to validate a hypothesis (Crosby et al., 2006; Mann, 2003; Oleckno, 2008).  
A case-controlled study is useful in validating risk factors for rare events/diseases 
(Crosby et al., 2006; Oleckno, 2008).  A case-controlled study is similar to a 
retrospective chart audit, in which specific data may not have been able to be 
extracted from charts; also participants may be prone to recall bias due to unreliable 
information of events and risk factors over the period of time (Oleckno, 2008).  In 
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regards to this study, although the use of a case-controlled study design may have 
allowed for the incidence to be determined and predictors of lower limb split skin 
graft failure and primary closure dehiscence to be verified, it was not chosen as there 
is currently no empirical literature identifying risk factors for lower limb surgical site 
complications and it was the aim of this study to determine this (Crosby et al., 2006; 
Mann, 2003; Oleckno, 2008).   
 
3.4 SETTING 
The study setting was a major Queensland metropolitan hospital, 
dermatology outpatient department.  The hospital provides 929 beds and is a tertiary 
referral teaching hospital, which covers the majority of the state including parts of 
neighbouring states and the Pacific Rim.  As a tertiary teaching hospital this site 
provides extensive services unable to be provided by smaller rural hospitals.  As 
such, patients will often be referred from smaller facilities for specialist consultation 
and management, such as procedural dermatology.  These patients therefore need to 
travel to the study setting to receive treatment.   
Throughout Australia in 2010-2011, the Australian Institute of Health and 
Welfare (2012) reported that there were 89,768 day-case dermatological and plastics 
procedures carried out in public hospitals.  The total number of day case 
dermatological surgeries carried out at this hospital, from the 1
st
 of July 2010 till the 
30
th
 of June 2011, totalled 1436 (ORMIS database, 2012).  The dermatology 
outpatient department has a dressing clinic attached with specialist nursing services 
to review patients post-operatively.  In this clinic a total of 576 patients were 
reviewed in 2010, 244 in 2011 and 61 patients in 2012 (up till the 12
th
 of March, 
2012) (OSIM Database, figures downloaded 29
th
 of June 2012).   
 
3.5 POPULATION AND PARTICIPANTS 
The study population eligible for inclusion were all patients who had a lower 
limb split skin grafting or primary closure in the day-case surgical suite at the 
hospital; and then who subsequently presented to the dermatology dressing clinic for 
lower limb (below knee and excluding the knee) split skin graft management and 
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primary closure management.  Exclusion criteria included patients who had 
previously been recruited for the same type of lower limb surgery and those who 
received curette and cauterisation, where the wound is left open to heal by secondary 
intention.   
Patients were able to be recruited twice if the second surgery type was 
different to the first, such as split skin graft versus primary closure.  During the study 
period from 2
nd
 of July 2010 till 12
th
 of March 2012, a total of 593 patients presented 
to the clinic, of which 91 patients were booked into the dermatology dressing clinic 
for lower limb post-operative split skin graft and primary closure review.  A 
trajectory of this care is presented in Figure 3.1. 
 
3.5.1 Sample size 
An a-priori sample size calculation for binary logistic regression was used to 
determine the minimum number of participants required to identify a statistically 
significant relationship between nine risk factors of lower limb split skin graft failure 
and primary closure dehiscence (http://www.danielsoper.com/statcalc/cal01.aspx).  
The minimum number of participants required was calculated to be 113 participants 
with failed lower limb surgical sites.  This was determined based on an alpha level of 
0.05, a desired statistical power of 0.8, an anticipated effect size (f2) of 0.15 and nine 
identified risk factors. 
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Figure 3.1 Trajectory of patient care 
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3.6 DATA COLLECTION 
 
3.6.1 Dependent variables 
The dependent variable of interest was failed split skin grafts and primary closure 
dehiscence. 
A failed split skin graft or primary closure dehiscence was defined as one that 
had a greater than 20% failure at any assessment point (within the allocated first 
three visits), which then required ongoing wound management.  This baseline 
measurement of 20% was chosen based on seminal research by Henderson and 
colleagues (2008).  Their prospective observational study used the 20% graft loss as 
an acceptable unit of measure for a successful surgery.  In this study the clinical 
appearance of the failed split skin graft or dehisced primary closure, was a >20% 
exposure of the dermis or devitalised tissue which required removing and prolonged 
care.   
All nursing staff assisting in recruiting patients and documenting the success 
of the surgery were highly skilled wound/surgical care nursing clinicians, with 
advanced knowledge in post-operative management of surgical wounds and 
management of chronic wounds.  All nursing staff attended study information 
sessions on the study and these were provided throughout data collection to ensure 
consistency of documentation and reporting of the split skin graft and primary 
closure success or failure.   
Where the 20% split skin graft failure or primary closure dehiscence could 
not be easily determined, the wound size was assessed using a gridded acetate tracing 
of the incision line or graft, including both the ‘open and failed area’ and the use of 
the Visitrak
TM
 machine.  This machine was able to calculate the total surface area of 
the wound and percentage comparison of the area which failed to the healed area of 
the surgical site.  Patients referred to the chronic wound clinic had their failed split 
skin grafts and primary closure dehiscence photographed and these were stored at the 
clinic. 
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3.6.2 Independent variables 
 Data was collected on a number of independent variables and these will be 
reported as intrinsic patient factors, extrinsic patient factors and extrinsic post-
operative factors as highlighted in the study’s conceptual framework, Figure 2.1 
chapter two. 
Intrinsic patient factors 
 The independent variables collected in this study relating to intrinsic patient 
factors include age, diagnostic comorbidities, lower limb surgical history, infection, 
lower limb disease and haematoma.  These variables are always present and cannot 
be changed by the patient or influenced by post-operative care.  Table 3.1 will 
present these independent variables, variable measure and rationale for collection in 
relation to the study’s dependent variable and outcome of interest: lower limb failed 
split skin graft and primary closure dehiscence.  
  
 
Table 3.1 Independent variables: intrinsic patient factors 
Variables Variable measure Rationale 
Age Continuous variable 
Potential confounder 
Increasing age is related to a reduction in collagen deposition therefore leading to reduced 
surgical site tensile strength and impaired immunity increasing the risk of surgical site 
infection (Gosain & DiPietro, 2004; Kaye et al., 2005).  It also increases the likelihood of 
peripheral vascular disease predisposing the surgical site to ischaemia (Gosain & DiPietro, 
2004; Kaye et al., 2005). 
Diagnostic comorbidities 
 diabetes - insulin and 
non-insulin dependent 
 hypercholesterolaemia  
 hypertension 
 cardiac disease - IHD 
 history of stroke 
 DVT 
 PVD  
 inflammatory diseases 
- rheumatoid arthritis  
Dichotomous 
measure (yes/no) for 
each diagnostic 
comorbidity. 
Due to multiple 
comorbidities 
highlighted as a 
potential 
confounder, this data 
was collected as a 
dichotomous 
measure if three or  
A disease free body is important to promote the orderly phases of acute wound healing (Hunt, 
Hopf & Hussai, 2000).  The haemostasis phase can be impacted by clotting disorders and a 
patient’s history of DVT or stroke may indicate this (Hunt, Hopf & Hussai, 2000; Williams & 
Harding, 2003).  The next phase of healing is inflammation and inflammatory diseases which 
may inhibit the inflammatory disease process and assist with the development of infection 
such as diabetes or rheumatoid arthritis (Hart, 2002a; Hart, 2002b).  The pro-inflammatory 
environment prevents collagen deposition and prevents the strengthening of the wound (Hart, 
2002a; Hart, 2002b). Angiogenesis occurs during the proliferative phase (the third phase of 
acute wound healing) and relies on adequate oxygen and nutrient supply which can be affected 
by high cholesterol and high blood pressure which predispose the patient to PVD and therefore 
lower limb ischemia (Hunt, Hopf & Hussai, 2000; Loots et al., 1998).  PVD may also develop 
in the presence of multiple comorbidities and is most commonly seen in the diabetic 
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Table 3.1 Independent variables: intrinsic patient factors continued 
Variables Variable measure Rationale 
or inflammatory bowel diseases 
 
more of these comorbid conditions present (yes) population (Wu & Armstrong, 2005). 
Surgical history 
Independent variables included previous 
procedures on the same limb as a split 
skin graft or primary closure: bone 
fractures, knee and hip replacements or 
vein stripping.  
Other independent surgical variables 
related to medical comorbidities: cardiac 
surgery and lower limb arterial bypass 
grafting. 
 
Dichotomous measure (yes/no) for each surgical 
comorbidity 
These independent variables may alter 
structures, create circulatory issues or reduce 
movement of the lower limb, therefore 
affecting the calf muscle pump which is 
required to promote circulation, therefore 
creating an ischaemic environment and 
impeding wound healing (AWMA, 2010; 
EWMA, 2009; Moffatt & Franks, 2004 & Wu 
& Armstrong, 2005). 
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Table 3.1 Independent variables: intrinsic patient factors continued 
Variables Variable measure Rationale 
Infection Dichotomous measure (yes/no) for presence or 
absence of infection 
Well-established clinical signs of infection 
include increased erythema, increased heat, 
pain and purulent discharge at the graft site or 
primary closure site or cellulitis; leading to 
antibiotic prescription by a dermatologist 
(Mangram et al., 1999; WHO, 2008). 
Infection impedes the wound healing cascade 
by prolonging the inflammatory responses and 
ultimately reducing wound tensile strength 
(Hart, 2002a; Hart, 2002b). 
 
Lower limb disease 
Skin changes: haemosiderin staining, venous 
flare, venous eczema, varicose veins, atrophe 
blanche, lipodermatosclerosis, pale/shiny, 
mottled or previous lower limb ulcer/failed  
Dichotomous measure (yes/no) for each 
individual independent variable related to 
lower limb disease (such as nine skin change 
variables)  
 
These independent variables were collected 
based on theoretical and empirical evidence 
associated with poor wound healing and 
chronic wound formation on the lower limb 
(Bergan et al., 2006; Humphreys et al., 2007; 
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Table 3.1 Independent variables: intrinsic patient factors continued 
Variables Variable measure Rationale 
surgical site. 
Pain assessment: throbbing sensation, sharp 
shooting pain, nocturnal pain, and claudication 
occurring during ambulation. 
Limb pain managed by: leg elevation and bed rest, 
compression garments, pain medication, ‘hanging’ 
the legs over the bed/’dependence’, sleeping in a 
chair and/or stopping exercise with rest. 
Dichotomous measure (yes/no) for each 
individual independent variable related to 
lower limb disease (such as four pain 
variables and five pain management 
variables) 
 
 
Rooke et al., 2011).  Disease changes indicate 
reduced vessel permeability, altered cellular 
functioning and therefore a potential for 
reduced oxygen and nutrient supply (Wipke-
Tevis et al., 2001).    A holistic approach was 
used and data collected relating to clinical 
appearance, pain presentation and pain 
management. 
Haematoma Dichotomous outcome for presence of 
haematoma at surgical site (yes/no) 
Due to a suspected strong association between 
anticoagulant and antiplatelet medication the 
presence of haematoma will be explored in 
Table 3.2 “extrinsic patient factors’. 
 
C
h
ap
ter 3
: M
eth
o
d
s 
6
0
 
 Chapter 3: Methods 61 
Extrinsic patient factors 
 The independent variables collected in this study relating to extrinsic patient 
factors include patient medications, prophylactic antibiotics, nutrition and smoking.  
These variables can be influenced by patient choices.  Table 3.2 will explain these 
independent variables, variable measure and rationale for collection in relation to the 
study’s dependent variable and outcome of interest: lower limb failed split skin graft 
and primary closure dehiscence. 
 
  
 
Table 3.2 Independent variables: extrinsic patient factors 
Variables Variable measure Rationale 
Patient medication: 
 corticosteroids 
 immunosuppressants 
 anticoagulants,  
antiplatelet medication 
 NSAIDs 
Dichotomous measure 
(yes/no) for each 
medication related to 
poor healing. 
Data was also collected 
as a dichotomous 
measure (yes/no) for 
the cessation of 
antiplatelet (>7 days) 
and anticoagulant (>2 
days) medication pre-
operatively. 
The use of corticosteroids, immunosuppressants and anti-inflammatory medications impede 
the body’s inflammatory response and predispose the patient to surgical site infection 
(Dissemond et al., 2006; Fuerst et al., 2006).  
The use of antiplatelet and anticoagulant medication has been related to surgical site 
haematoma as haemostasis is unable to be achieved (Khalifeh & Redett, 2006; Lawrence, 
1996).  The presence of haematoma reduces the adhesion of the graft to the host or primary 
closure creating an ischaemic environment due to increased devitalised cellular products 
inhibiting circulation to the surgical site (Pagan & Hunter, 2011). 
Corticosteroids are associated with altered collagen deposition and therefore inhibit wound 
tensile strength (Karukonda et al., 2000b). 
Prophylactic antibiotics Dichotomous measure 
(yes/no). 
 
The prescription of prophylactic antibiotics is used to prevent surgical site infection for the 
‘at risk’ population such as diabetics, those with an inflammatory condition and poor 
circulation, such as peripheral vascular disease (Babcock & Grekin, 2005; WHO, 2009).  
The aim is to assist the host response which may potentially be diminished due to these 
disease processes and associated medications (Babcock & Grekin, 2005; WHO, 2009). 
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Table 3.2 Independent variables: extrinsic patient factors continued 
Variables Variable measure Rationale 
Nutrition: 
 Malnutrition Screening 
Tool (MST) 
 Waist-hip-ratio (WHR) 
 Weight in kilograms 
 
MST data was collected as an ordinal 
measure ranging from 0-2+. 
WHR data was collected as a 
continuous measure. 
A dichotomous measure of this 
independent variable (yes/no) was also 
determined based on ‘at risk’ (yes) 
woman who is determined by an 
elevated WHR of >0.8, and the ‘at risk’ 
(yes) male WHR of >0.9. Weight of the 
patient was collected as a continuous 
measure.  
 
The acute phases of wound healing rely on adequate supply of 
nutrients to the surgical site (Arnold & Barbul, 2006).    
Micronutrients, zinc, vitamin A and C, and macronutrients including 
fat, protein and amino acids are required during the healing process 
such as DNA and RNA replication but also cellular immunity (Gray 
& Whitney, 2003).  Iron, copper and vitamin C are required for 
collagen synthesis and improving wound tensile strength (Campos, 
Groth & Branco, 2008).  The bariatric and malnourished patient are 
at risk of infection and impaired collagen synthesis and therefore 
diminished surgical site tensile strength which may lead to surgical 
site failure (Braga et al., 1999; Gianotti et al., 1999).  
The bariatric patient also has a higher degree of adipose tissue which 
is avascular and acellular in nature and therefore healing tensile 
strength is reduced, predisposing the patient to split skin graft failure 
and primary closure dehiscence (Penington & Morrison, 2007). 
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Table 3.2 Independent variables: extrinsic patient factors continued 
Variables Variable measure Rationale 
Smoking Dichotomous measure: currently smoking 
(yes) or non-smokers (no) 
Smoking is associated with many poor health 
outcomes (Alizadeh et al., 2007; VCRCC, 
2010).  However its role in the wound healing 
cascade affects the host’s inflammatory 
response and predisposes the patient to 
infection (Just et al., 2005; Rayner, 2006).   
The many noxious chemicals inhibit cellular 
functioning therefore impacting on 
angiogenesis and collagen synthesis (Straten et 
al., 2001).  The overall impact would prevent 
the success split skin graft and primary closure 
including the promotion of other 
complications such as post-operative surgical 
site infection. 
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Extrinsic post-operative factors 
 The independent variables collected in this study relating to post-operative 
extrinsic factors include the use of post-operative compression and post-operative 
ambulation.  These variables are able to be assessed during the patient’s first visit 
and can be influenced by the clinician’s explanation of the importance of post-
operative compression therapy and patient concordance with treatment.  Table 3.3 
will explain these independent variables, variable measure and rationale for 
collection in relation to the study’s dependent variable and outcome of interest: lower 
limb failed split skin graft and primary closure dehiscence. 
 
  
  
Chapter 3: Methods 66 
Table 3.3 Independent variables: Extrinsic post-operative factors 
Variables Variable measure Rationale 
Compression 
therapy 
Dichotomous measure 
(yes/no) for the 
presence or absence of 
Tubigrip
TM 
(5-
10mmHg) at the first 
review in clinic.  This 
occurred at day 5-10 
post operatively. 
The use of Tubigrip
TM
 (5-10mmHg) of 
compression post-operatively aims at 
improving superficial venous return; by doing 
so removes inflammatory and senescent cells, 
improving oxygen and nutrient delivery to the 
site (Kan & Delis, 2001; McNally, Bahadur, 
Cooke & Mollan, 1997).  It also assists with 
graft and primary closure stability therefore 
preventing shear and friction at the surgical site 
(Jones & Nelson, 2010).  This is standard care. 
Post-operative 
ambulation 
Social situation:  
Did the patient 
receive care by a 
loved one, did they 
care for themselves, 
or are they a carer 
for someone else? 
Was the patient able 
to rest and elevate 
their legs? 
Post-operative 
transportation home: 
via ambulance/taxi, 
loved one, public 
transport or self-
drive.   
Data relating to a 
patients social 
situation was collected 
as a nominal measure. 
Dichotomous 
measures (yes/no) for 
each variable relating 
to a patients reporting 
adherence to bed rest 
and nursing staff 
perception to 
adherence to bed rest. 
Data relating to mode 
of transport post-
operatively was 
collected as a nominal 
measure. 
Prolonged standing predisposes the leg to 
increased arterial and venous pressures and 
potential for oedema, therefore creating a sub-
optimal environment for the split skin graft and 
primary closure (Budny et al., 1993; Henderson 
et al., 2010; Wood & Lees, 1994).  However 
prolonged bed rest can also impact negatively 
through development of DVT and reduced 
circulation (Budny et al., 1993; McNally et al., 
1997; Sharpe et al., 1983).  An amalgamation 
of effective calf muscle pump, movement and 
leg elevation and the use of supportive 
bandages appear to be beneficial for improving 
circulation, reducing lower limb oedema and 
therefore improving the success of the surgery 
(Budny et al., 1993; Henderson et al., 2010; 
O’Brien, Edwards, Finlayson & Kerr, 2012; 
Scheuren & Mohr, 2008; Wells et al., 1995). 
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3.6.3 Confounders 
In prospective observational studies, Mann (2003) reported that there are a 
“virtually infinite number of potential confounding variables” which could explain 
the outcome result. Identified from chapter two are nine risk factors which may 
impact on surgical site success and from these it was considered that age, diabetes, 
multiple comorbidities and prophylactic antibiotics could potentially confound this 
study’s results; these will now be reported in Table 3.4. 
 
Table 3.4 Potential study confounders 
Confounder Domain Rationale 
Age Independent 
variable 
Increasing age is related to cutaneous changes 
such as decreased collagen deposition therefore 
reducing the surgical sites tensile strength 
(Ballas & Davidson, 2001). 
Increasing age increases the likelihood of a 
patient having more medical comorbidities 
which may impact on all aspects of the wound 
healing cascade (Kaye et al., 2005; Paradela et 
al., 2010). 
Decreasing arterial flow or peripheral vascular 
disease is associated with increasing age and 
therefore may lead to local decrease in blood 
flow creating an ischaemic wound (Clark, 
2002; Dubay & Franz, 2003). 
Diabetes Independent 
variable 
Diabetes is associated with reduced 
permeability and vascularity of the lower limb 
arteries (Mahmoud, Mohamed, Mahdi & 
Ahmed, 2008).  Diabetes impedes and 
prolongs the inflammatory phase of healing 
therefore increasing the risk of surgical site 
infection (Mahmoud et al., 2008).   
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Table 3.4 Potential study confounders continued 
Confounder Domain Rationale 
Multiple comorbidities Independent variable The presence of multiple 
comorbidities as presented in 
Table 3.1 may accelerate other 
disease processes which may 
impede the healing process 
(Synder, 2005). 
Prophylactic antibiotics Independent variable The use of prophylactic 
antibiotics may protect the 
patient from developing the 
outcome of interest, surgical site 
failure (Mangram et al., 1999; 
WHO, 2009). 
 
It was recognised that the variables of increasing age, diabetes, multiple 
comorbidities and prophylactic antibiotics may confound the study’s outcomes.  This 
study did not adjust for suspected confounders as confounding can represent ‘risk 
factors’ and risk of disease.  This study aims to determine the risk factors for lower 
limb spit skin graft failure and primary closure dehiscence and therefore we do not 
wish to adjust for these possible confounders (Crosby et al., 2006; Groenwold, 
Nelson, Nichol, Hoes & Hak, 2010; Mann, 2003; Oleckno, 2008).   
 
3.6.4 Instrument 
Currently there are no validated screening tools to assess risk factors for 
failure of acute wounds.  A purpose designed instrument was developed for this 
study.  A validated tool, the ‘malnutrition screening tool (MST)’, was incorporated 
into the purpose designed instrument and is further elaborated below.  Although the 
tool was not piloted on study participants, it was derived from a tool used by the 
chronic wound clinic with the addition of surgical demographics which are routinely 
documented at the study site. 
  
Chapter 3: Methods 69 
The instrument consisted of eight patient demographic variables and nine risk 
factors which were further separated into 31 variables.  Eight variables related to 
patient and surgical demographics.  Data was collected on the following 
demographic variables: age (in years), gender, location of lower limb surgery (shin, 
gaiter, calf, foot, malleolus), type of surgery (split skin graft or primary closure), type 
of skin cancer (basal cell carcinoma, squamous cell carcinoma, melanoma, other-
malignancy, non-malignancy), and the type of practitioner involved in the surgical 
procedure (dermatology or surgical registrar, dermatology consultant, procedural 
dermatology nurse practitioner), the number of days which a patient received care at 
the dressing clinic, and finally to whom the patient was discharged.   
Data was collected on the following 31 variables which formed the nine risk 
factors.  Eight variables pertaining to diagnostic comorbidities, four variables 
pertaining to lower limb related surgical history, four variables pertaining to 
medication, three variables pertaining to nutrition, and one variable for each of the 
following categories: prophylactic antibiotics, infection, smoking, compression and 
haematoma.  As patient concordance is difficult to measure accurately a series of 
clinical investigatory questions were asked (as per Table 3.3), totalling seven 
variables. 
Surgical site and wound assessment was also recorded at each visit to the 
dressing clinic and finally discharge details were recorded.  This tool is reported in 
Appendix A. 
 
Malnutrition screening tool (MST) 
 The malnutrition screening tool (MST) has been a validated by Ferguson and 
colleagues (1999) in the acute adult healthcare setting.  It is a quick and easy tool to 
use, using a three point response scale ranging from 0-2.  Scores 0-1 indicate that the 
patient is not at risk of malnutrition while a score greater than two highlights the 
patient ‘at risk’ (Ferguson et al., 1999; Isenring, Bauer, Banks & Gaskill, 2009).  A 
comparative study utilising the subjective global assessment tool (SGA), a lengthy 
screening tool used by skilled clinicians or dietitians to determine the nutritional 
status of a patient, was compared with the MST for sensitivity and specificity 
(Ferguson et al., 1999).  A total of 408 acute adult participants were recruited into the 
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study from one hospital in Brisbane, Australia over a three month period.  Several 
clinicians collected data on all participants independently using SGA or MST tools.  
Study outcomes indicated that the MST was able to strongly predict malnutrition 
with a 93% (kappa=0.84, p<0.01) sensitivity and specificity being reported, 
indicating the MST had 93% agreement with the SGA. 
 
3.7 PROCEDURE 
Prior to the commencement of the study, the project was discussed with and 
approval sought from, senior research staff, departmental directors and nurse 
managers.  The study was granted ethics approval by two institutions (refer to section 
3.10).  Study information sessions were conducted for the dermatologists, surgical 
nursing staff and departmental nursing staff specifically addressing inclusion criteria, 
recruitment, documentation, and assessment of the surgical site.  Posters to promote 
the research were also placed on walls around the day procedure unit and 
dermatology outpatient department.  Staff information sessions occurred every six 
months and a formal update was provided to the director and nurse managers of the 
department after one year due to an extension of the data collection period. 
Prior to data collection, patients meeting the inclusion criteria were 
approached by nursing staff working in the clinic to take part in the research project 
on their first visit to the dressing clinic.  Patients were given time to read the patient 
information and consent form (Appendix B: previously referred to as the GRAFT 
Study) and consenting patients were recruited at initial consultation or second 
consultation at the clinic.   Following consent, data collection commenced. 
Patients were asked a series of questions about their general health and waist 
hip ratio (WHR) was calculated at this time.  Data was also extracted from their 
medical record to supplement and corroborate information provided by the patient 
and surgical procedure.  The surgical site was then assessed and all data was 
documented on the study data collection tool.  All patients followed their normal care 
pathway as per current practice (Figure 3.1). This included the patient remaining 
under the care of the dermatology dressing clinic until there was a satisfactory level 
of split skin graft and primary closure success which allowed the patient to continue 
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care without any extensive interventions.  This assessment was completed by nursing 
staff working in the dressing clinic and the definition of surgical site failure has 
previously been reported in section 3.6.1.  However, if a patient experienced split 
skin graft failure or primary closure dehiscence then the patient was referred onto the 
chronic wound clinic for arterial Doppler, ABPI, health and lower limb assessment, 
or to their general practitioner or community nurses for continuing care and at this 
point they were discharged from the study.  The outcome of interest was recorded: 
healed or failed split skin graft or primary closure dehiscence. 
 
3.8 DATA MANAGEMENT AND DATA CLEANING 
Data management 
At the end of the data collection period, all data was entered and later 
analysed using SPSS version 17.0.  SPSS data ‘definitions’ were modified to 
minimise any incorrect and invalid responses from being entered (Griffith, 2010).  A 
code manual was developed to reflect data ‘definitions’ in SPSS (Higgins & Green, 
2009).  Every attempt was made to source incomplete data; this included phoning 
patients and reviewing patient charts and surgical notes.   
 
Data cleaning 
Prior to data analysis, several strategies were used to ensure the completeness 
and accuracy of the data file.  The data file was cleaned through rechecking of every 
variable entered to ensure there was no missing data, incorrect and invalid responses.  
Continuous data was checked for extreme outliers and categorical data was checked 
through invalid responses through an exploratory descriptive analysis including 
counts, frequencies, histograms and boxplots (Griffith, 2010; Higgins & Green, 
2009; Kirkwood & Sterne, 2010).  Suspected invalid responses were checked against 
the original data collection tool for verification of correct data entry. 
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3.9 DATA ANALYSIS 
Descriptive statistics 
Categorical demographic and risk factor variables are reported as counts and 
percentages.  Continuous variables are reported as means (ẋ) and standard deviation 
(SDs) if normally distributed; median and range if not normally distributed 
(Kirkwood & Sterne, 2010).  Distribution of data was assessed by plotting variables 
on a histogram, with bell curve appearance indicating normality, the skewness and 
kurtosis were also assessed for symmetry and flatness of data distribution on the bell 
curve (Griffith, 2010).  Data was also classified normally distributed if the sampling 
distribution fell into 3±SDs of the central figure (ẋ) (Kirkwood & Sterne, 2010). 
 
Bivariate statistics 
Relationships between variables to determine associations were initially 
explored with a two-tailed Pearson correlation (r) for continuous independent 
variables, with the dichotomous dependent outcome and a chi square test for 
dichotomous independent and dependent variables.  If a contingency table cell count 
was less than five for this chi square test, then a two-tailed Fisher’s exact test was 
reported due to an increased sensitivity of this test with small sample sizes and 
unequal distribution of categorical data to determine the relationship between 
variables; this will be reported as a p value only (Kirkwood & Sterne, 2010).  
Statistically significant relationships (p<0.05) between variables were further 
explored via t-tests to compare the means of one categorical variable with one 
continuous variable or analysis of variance (ANOVA) for not normally distributed 
data of one categorical and one continuous variable; and for two continuous variables 
a correlation method of analysis was used (Kirkwood & Sterne, 2010).  Table 3.5 
reports the variable measures, independent variables pertaining to each measure, 
assumptions for measure and methods of analysis performed with the dependent 
variable and outcome of interest: failed split skin graft and primary closure 
dehiscence (binary outcome). 
 
  
 
Table 3.5 Bivariate statistics and independent variables 
Variable 
measures 
Independent variables Assumptions Methods of analysis 
Continuous Age 
WHR 
Weight in kilograms 
Means and standard deviation 
if data is normally distributed. 
Median and range if data is 
not normally distributed. 
Normally distributed: 
t-test 
Not normally 
distributed: Analysis 
of variance (ANOVA) 
Categorical: 
dichotomous  
Comorbidities: hypercholesterolaemia,  hypertension, diabetes, cardiac 
disease, DVT, PVD,  history of stroke, inflammatory disease, bone fractures, 
replacement of knee or hip, varicose vein stripping, cardiac surgery, lower 
limb arterial bypass grafting. 
Medications: corticosteroids, immunosuppressants, anticoagulants & 
antiplatelet medication, anti-inflammatories. 
Limb disease: haemosiderin staining, venous flare, venous eczema, varicose 
veins, lipodermatosclerosis, atrophe blanche, pale/shiny, mottled, previous 
lower limb ulcer/failed surgical site. 
Limb pain: throbbing sensation, chronic sharp shooting pain, nocturnal pain, 
claudication and surgical site pain. 
Normality not expected. All 
cell counts must have >5 or 
more counts. 
 
Chi square  
For cell counts <5 a 
Fisher’s exact test was 
performed. 
Table 3.5 Bivariate statistics and independent variables continued 
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Variable measures Independent variables Assumptions Methods of analysis 
Categorical: dichotomous 
continued. 
Pain relieved by leg elevation and 
bed rest, compression garments, 
medication, ‘hanging’ the legs 
over the bed (dependence), 
sleeping in a chair and/or stopping 
exercise with rest. 
Other: haematoma; prophylactic 
antibiotics; infection; smoking; 
did the patient adhere to bed rest? 
Normality not expected. All cell 
counts must have >5 or more 
counts. 
 
Chi square  
For cell counts <5 a Fisher’s exact 
test was performed. 
Categorical: nominal MST 
Social situation: did the patient 
receive care by a loved one, did 
they care for themselves, or are 
they are carer for someone else? 
Transportation home post-op: via 
ambulance/taxi, loved one, public 
transport or self-drive? 
Normality not expected. All cell 
counts must have >5 or more 
counts. 
Chi square 
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Multivariate statistics: 
A binary logistic regression model was selected due to its ability to examine 
relationships with multiple independent variables, with varying number of participants per 
variable, in predicting the dependent outcome variable of interest (Dobson & Barnett, 2008; 
Hong & Mitchell, 2007).  A binary logistic regression model assists to answer this study’s 
research question to determine the relationship between independent variables to predict the 
dependent variable (outcome: healed versus failed) (Dobson & Barnett, 2008).   
Firstly, bivariate statistics with statistically significant relationships (p<0.05) with the 
dependent variable were chosen for the binary logistic regression method of analysis.  There 
was no limitation by the number of count data for the independent variables selected for the 
binary logistic regression model, however excluded were those independent variables with no 
count data (p>0.05).  For the binary logistic regression model, a backward elimination 
method was used to remove non-statistically significant (p>0.05) variables one step at a time, 
to achieve an overall model (Balakrishnan, 2006; Hong & Mitchell, 2007).  The Akaike’s 
Information Criterion (AIC) and deviance were assessed at each step to measure ‘goodness of 
fit’; with a decrease in AIC and deviance indicating an improvement in the model (Dobson & 
Barnett, 2008).  The final model was validated by the lowest AIC and deviance, however 
models were considered indifferent if the AICs are less than 10 units (Dobson & Barnett, 
2008).  For predictors of split skin graft failure and primary closure dehiscence in a binary 
logistic regression model, adjusted odds ratios which accounts for multiple potential predictor 
variables, were calculated with 95% confidence intervals for the proportion of patients who 
developed a skin graft failure and primary closure dehiscence for demographic variables and 
each of the risk factors measured. 
Collinearity between variables was not assessed prior to the binary logistic regression 
model.  This was due to a lack of indication for collinearity, as all independent variables were 
measured with difference and independently (Belsley, Kuh & Velsch, 2004).  If collinearity 
exists between independent variables it would be expected that this would contribute to a 
failure of the binary logistic regression analysis, with estimated coefficients reporting large 
standard errors (confidence intervals) (Belsley et al., 2004; Noes & Mevik, 2001). 
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3.10 ETHICAL CONSIDERATIONS 
Ethical approval to commence the study was obtained from the hospitals Human 
Research Ethics Committee (HREC) and Queensland University of Technology (QUT) 
University Human Research Ethics Committee (UHREC) (see appendix C and D).  
Following this data collection commenced.  Application for extension of data collection was 
sought after one year as only 46 participants were recruited at this time.  Both the hospital 
HREC and QUT UHREC granted extension of data collection. 
 Participants consenting and recruited to the study were de-identified and a study 
number was assigned to each participant at the beginning of data collection.  Data collection 
tools were locked in a secure cabinet to which only the principal investigator having access 
via key.  Participant codes were entered into SPSS only.  The SPSS data file remains on a 
secure computer owned by the principal investigator which requires access passwords.  All 
data collection tools will remain locked at the hospitals nursing research centre where they 
will be destroyed after seven years, as per current protocols. 
 
3.11 CONCLUSION 
 This study used a prospective observational design to determine the incidence and 
predictors of lower limb split skin graft failure and primary closure dehiscence.  The study 
occurred over a 20 month period at one study site.  This chapter reported the methodology 
underpinning this study’s research objectives and design.  Dependent and independent 
variables were defined in this chapter and an explanation given as to why suspected risk 
factors were selected pertaining to the study outcome.  This chapter then further defined the 
study’s data collection tools and methods, data analysis and ethical considerations.  The 
following chapter, chapter four, will present the results of this study. 
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Chapter 4: Results 
4.1 INTRODUCTION 
 Chapter three presented the methodological approach and procedures for this 
study.  This chapter now presents the major findings of this study under the 
following headings: surgical and participant demographics, research question one 
and research question two.  The section pertaining to surgical and participant 
demographics will also report on the independent variables which were collected 
during the study period, these are presented as frequency and percentages of the total 
sample population.  The section pertaining to research question two will explore the 
relationships between statistically significant independent variables with dependent 
outcome, followed by the study’s results for the main research question in a binary 
logistic regression model. 
 
4.2 SURGICAL AND PARTICIPANT DEMOGRAPHICS 
 A total of 73 study participants were recruited from the 2
nd
 of July 2010 till 
12
th
 of March 2012.  The flow of patients recruited into the study is presented as a 
modified CONSORT flow chart (Schulz, Altman & Moher, 2010) in Figure 4.1. 
 
Surgical demographics 
The research site is a teaching hospital and the surgical teams performing the 
procedures are comprised of mixed skilled staff.  Staff in charge of the procedure 
included predominately dermatology registrars 65.8% (n=48), dermatology 
consultants 32.9% (n=24) and nurse practitioner 1.4% (n=1).  The type of procedure, 
lesion diagnosis and location of the surgery of the study participants is presented in 
Table 4.1. 
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Figure 4.1 Summary of patient flow and participant recruitment 
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Table 4.1 Study participants and surgical demographics 
Variable Frequency (%) 
Type of procedure 
Primary closure 
Split skin graft 
 
23 (31.5) 
50 (68.5) 
Lesion diagnosis 
Basal cell carcinoma 
Squamous cell carcinoma 
Melanoma 
Other Malignancy 
Non-Malignancy 
 
26 (35.6) 
31 (42.5) 
3 (4.1) 
6 (8.2) 
7 (9.6) 
Location 
Shin 
Gaiter 
Calf 
Foot 
Malleolus 
 
33 (45.2) 
17 (23.3) 
12 (16.4) 
7 (9.6) 
4 (5.5) 
 
Participant demographics 
The majority of study participants were male 61.1% (n=45) and the median 
age was 73 years (range 37-90 years).  Participant demographics, diagnostic 
comorbidities and current medications are presented in Table 4.2.   
Participant general health including smoking, nutritional status and lower 
limb assessment is reported in Table 4.3.  The majority of the patients (90.4%, n=66) 
had an ‘at risk’ waist-hip-ratio (WHR), with one third of the patients exhibiting signs 
of lower limb oedema (n=24) and having varicose veins (n=24).  Over one quarter 
(28.8%, n=21) of the patients recruited had a previous failed lower limb split skin 
graft or primary closure dehiscence, and three of the four participants who had 
previously diagnosed PVD, were placed into low grade compression therapy.   
Surgical site infection was recorded in 13.7% (n=10) of participants and 20.5% 
(n=15) developed haematoma.   
Approximately 59% (n=43) of participants in this study received post-
operative care by a family member or friend, while most participants 89% (n=69) 
reported compliance with post-operative bed rest and compression therapy (Table 
4.4).   
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The median number of days between surgical intervention and first review at 
the dressing clinic was seven days (range 4-18 days).  Most patients 63% (n=46) 
were reviewed two to three times (range 1-8) in the dressing clinic before being 
discharged or referred elsewhere.   
Most participants 42.5% (n=31) were discharged after their third review in 
the clinic, with a further 6.8% (n=5) staying in the care of nurses at the dressing 
clinic for extra post-operative care; 26.0% (n=19) were referred to the chronic wound 
clinic for ongoing care, 17.8% (n=13) were referred to their general practitioners or 
community nurses for ongoing care, 4.1% (n=3) continued to care for themselves, 
and a final 2.7% (n=2) required further assessment by plastic surgeons due to 
incomplete excision, however both these patients refused further surgery due to a 
history of failed surgeries on their lower limbs. 
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Table 4.2 Participant demographics, diagnostic comorbidities and current 
medications 
Variable Frequency (%) Median 
(range) 
Gender 
Male  
Female 
 
45 (61.1) 
28 (38.9) 
 
Age (years)  73 (37-90) 
Diagnostic comorbidities 
Diabetes (insulin and non-insulin dependent) 
Cardiac disease 
Hypertension 
Hypercholesterolaemia 
Inflammatory disease 
History of DVT 
Diagnosed PVD 
>3 of these comorbidities 
 
13 (17.8) 
18 (24.7) 
34 (46.6) 
28 (38.4) 
3 (4.1) 
2 (2.7) 
4 (5.5) 
23 (31.5) 
 
Surgical comorbidities 
Cardiac surgery 
Knee replacement/fracture* 
Vein stripping* 
Peripheral arterial bypass or amputation* 
 
11 (15.1) 
6 (8.2) 
5 (6.8) 
1 (1.4) 
 
Medications 
Corticosteroid or glucosteroid 
Immunosuppressant 
Anti-inflammatory 
Antiplatelet or anticoagulant  
Warfarin only  
Continuation of antiplatelet or anticoagulant 
medication from 26 patients  
 
3 (4.1) 
2 (2.7) 
7 (9.6) 
26 (35.6) 
6 (8.2) 
23 (88.5) 
 
 
Antibiotic prophylaxis  
Yes 
 
22 (30.1) 
 
*Surgeries performed on the same leg as the primary closure or split skin graft. 
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Table 4.3 Participants smoking, nutritional status and lower limb disease 
Variable Frequency 
(%) 
Median (range) 
Malnutrition and obesity 
WHR 
‘at risk’ WHR (n=70) 
Weight (kg) 
 
MST Score 0 (healthy appetite no recent weight loss) 
MST Score 1 (healthy appetite but recent weight 
loss) 
MST Score 2 (poor appetite and recent weight loss) 
 
 
66 (94.3)* 
 
 
65 (89) 
5 (6.5) 
 
3 (4.1) 
 
1.0 (0.70-1.14)* 
 
81.05 
(54.4-135.5)† 
 
 
 
Smoking 
During care for lower limb surgery 
 
8 (11) 
 
Clinical assessment of the lower limb 
Leg oedema 
Varicose veins 
Previous lower limb surgical site failure/chronic 
wound 
Haemosiderin staining 
Pale/shiny legs 
Venous stasis eczema 
Mottled legs 
Atrophe blanche 
Lipodermatosclerosis 
Leg cramps (nocturnal) 
Surgical site pain 
Claudication 
Chronic sharp shooting leg pain 
Throbbing pain 
Pain relieved through leg dependence (down) 
Pain relieved with medication 
Pain relieved with leg elevation 
Use of low grade post-operative compression (8-
10mmHg) 
 
24 (32.9) 
24 (32.9) 
21 (28.8) 
 
8 (11) 
6 (8.2) 
3 (4.1) 
3 (4.1) 
1 (1.4) 
1 (1.4) 
14 (19.2) 
12 (16.4) 
9 (12.3) 
8 (11) 
6 (8.2) 
19 (26) 
16 (21.9) 
4 (5.5) 
41 (56.2) 
 
 
*WHR was not recorded in three participants.   
†Weight (kg) was not recorded in five participants. 
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Table 4.4 Post-operative ambulation 
Variable Frequency (%) 
Post-operative ambulation 
Participants who received care by loved ones post-operatively 
(first week only) 
Participants who cared for themselves (first week) 
Participants who was a carer for someone else (first week) 
Participants returning to work day after minor procedure 
Post-operative transport home with loved one 
Post-operative transport home via ambulance or taxi 
Post-operative transport home via public transport 
Post-operative transport home via own car (self-drive) 
Perceived compliance by nursing staff (bed rest and 
compression) 
 
43 (58.9) 
 
23 (31.5) 
7 (9.6) 
1 (1.4) 
46 (63) 
15 (20.5) 
7 (9.6) 
5 (6.8) 
65 (89) 
 
 
4.3 RESEARCH QUESTION 1 
What is the incidence of lower limb split skin graft failure and primary closure 
dehiscence in day case surgical patients? 
Of the 73 participants recruited, the total incidence of lower limb skin graft 
failure and primary closure dehiscence was 53.4% (n=39).  However, there was a 
difference in incidence between the two types of surgeries, split skin graft and 
primary closure.  From a total of 23 primary closures the incidence of primary 
closure dehiscence was 26.1% (n=6), whereas from a total of 50 split skin grafts the 
incidence of split skin graft failure was 66% (n=33).  The odds of a patient having 
surgical site failure were 5.5 times more likely to occur if a split skin graft was 
performed compared with a primary closure (OR 5.5, 95% CI 1.83-16.51, X
2
=10.09, 
df=1, p<0.00). 
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4.4 RESEARCH QUESTION 2 
What are the predictors of lower limb split skin graft failure and primary closure 
dehiscence in day case surgical patients? 
 Bivariate analyses were conducted to establish statistically significant 
relationship between the independent variables with the study outcome of healed 
versus failed surgery.  Associations between risk factors and the dependent outcome 
variable were explored.  Those which were statistically significant were then 
investigated in a binary logistic regression model to determine the predictors of 
lower limb skin graft and primary closure dehiscence.  For ease of reporting and 
reading, these statistical relationships between dependent variable and independent 
variables are reported in Table 4.5 Intrinsic patient variables, Table 4.6 Extrinsic 
patient variables, Table 4.7 Extrinsic post-operative variables.  In answering research 
question two, this section will focus on the predictors of lower limb skin graft failure 
and primary closure dehiscence; the relationship with other variables and finally the 
model which best explains the failure of the surgical site.  
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Table 4.5 Statistical relationship between dependent variable and intrinsic 
patient variables 
Suspected predictors N Statistical test p value 
Participant demographics 
Split skin graft/primary closure 
Age 
Gender 
 
50/23 
73 
73 
 
X
2
=10.09  
r=0.253 
X
2
=0.252 
 
p=0.001 
p=0.031 
p=0.059 
Medical comorbidities 
Diabetes 
Cardiac disease 
Hypercholesterolaemia 
Hypertension 
Inflammatory condition 
History of DVT 
History of PVD 
>3 medical comorbidities 
 
13 
18 
28 
34 
3 
2 
4 
23 
 
X
2
=0.418 
X
2
=0.567 
X
2
=0.252  
X
=
=0.745  
 
 
 
X
2
=1.877  
 
p=0.518 
p=0.451 
p=0.615 
p=0.388 
p=1.000† 
p=1.000† 
p=0.333† 
p=0.171 
Surgical comorbidities 
Cardiac surgery 
Fracture or knee replacement* 
Varicose vein stripping* 
Peripheral arterial bypass/amputation* 
 
11 
6 
5 
1 
 
 
 
 
X
2
=0.466  
 
p=0.247† 
p=1.000† 
p=0.363† 
p=0.466 
Infection 
Yes 
 
10 
 
X
2
=10.102 
 
p=0.001 
Lower limb disease 
Leg oedema 
Varicose veins 
Atrophe blanche 
Lipodermatosclerosis 
Haemosiderin staining 
Venous stasis eczema 
Pale and shiny 
Mottled appearance 
Throbbing pain 
Leg cramps (at night) 
Claudication 
Chronic sharp shooting leg pain
‡. 
Surgical site pain 
Pain relieved with leg dependent 
Pain relieved with leg elevated 
Pain relieved with medication 
 
24 
24 
1 
1 
8 
3 
6 
3 
6 
14 
9 
8 
12 
19 
4 
16 
 
X
2
=0.346 
X
2
=1.183 
 
 
 
 
 
 
 
X
2
=0.082 
 
 
X
2
=2.687 
X
2
=0.006 
 
X
2
=0.678 
 
p=0.556 
p=0.277 
p=1.000† 
p=0.4668† 
p=1.000† 
p=0.243† 
p=0.679† 
p=0.243† 
p=0.206† 
p=0.775 
p=0.288† 
p=0.060† 
p=0.101 
p=0.936 
p=0.618† 
p=0.410 
Haematoma 
Yes 
 
15 
 
X
2
=12.084 
 
p=0.000 
* occurring on the same leg as the surgery.    
† p value reported only for two-tailed Fisher’s exact test for expected cell counts less 
than 5 
Clinically significant and statistically significant (p<0.05) results are highlighted in 
bold 
‡ Chronic sharp shooting leg pain is chosen based on clinically significant findings 
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Table 4.6 Statistical relationship between dependent variable and extrinsic 
patient variables 
Suspected predictors N Statistical 
test 
P value 
Medications 
Corticosteroids and glucosteroids 
Immunosuppressants 
Anti-inflammatories 
Anticoagulant and antiplatelet 
Warfarin only 
Cessation of anticoagulants and antiplatelet 
medications pre-operatively 
 
3 
2 
7 
26 
6 
23 
 
 
 
 
X
2
=1.068 
 
X
2
=1.104 
 
p=1.000* 
p=0.495* 
p=1.000* 
p=0.301 
p=0.412* 
p=0.576 
Prophylactic antibiotics 
Yes 
 
22 
 
X
2
=2.756 
 
p=0.097 
Malnutrition and obesity 
WHR 
‘at risk’ WHR 
Weight in kg 
MST 
 
70 
66 
68 
73 
 
r=0.053 
 
r=-0.108 
X
2
=0.578 
 
p=0.663 
p=0.337* 
p=0.381 
p=0.749 
Smoking 
Yes  
 
8 
  
p=1.000* 
* p value reported only for two tailed Fisher’s exact test for expected cell counts less 
than 5 
Clinically significant and statistically significant (p<0.05) results are highlighted in 
bold 
 
 
Table 4.7 Statistical relationship between dependent variable and extrinsic post-
operative variables 
Suspected predictors N Statistical 
test 
P value 
Early ambulation 
Transport on the day home 
Self-care post-operatively (social) 
Staff perceived compliance 
Compression therapy worn 
 
73 
73 
65 
41 
 
X
2
=3.173 
X
2
=2.784 
 
X
2
=0.002 
 
p=0.366 
p=0.249 
p=1.000* 
p=0.964 
* p value reported only for two tailed Fisher’s exact test for expected cell counts less 
than 5 
Clinically significant and statistically significant (p<0.05) results are highlighted in 
bold. 
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4.4.1 Predictors of lower limb skin graft failure and primary closure dehiscence 
The predictors of lower limb skin graft failure and primary closure 
dehiscence were identified as the surgical procedure of split skin graft (X
2
=10.9, 
p<0.00), increasing age (r=0.25, p=0.03), surgical site infection (X
2
=10.1, p=0.01) 
presence of haematoma (X
2
=12.08, p<0.00) and the presence of chronic sharp 
shooting leg pain (Fisher’s exact test p=0.06).   
 
Predictor one: Primary closure versus split skin graft 
The majority of failed surgeries were in the split skin graft group, 66% 
(33/50) compared with 26.1% (6/23) primary closures.  There was a trend towards a 
relationship between the type of surgical procedure, split skin graft and failed 
surgical outcome (X
2
=10.09, df=1, p<0.00).  An odds ratio was calculated and 
indicated that those who received split skin grafts were more likely (OR 5.5, 95% CI 
1.83-16.51, p=0.001) to develop surgical site failure than those participants who had 
received primary closure.  
 
Predictor two: Age 
 There was a suggested positive correlation between a patient’s age and 
surgical outcome, healed versus failed surgeries (r=0.25, n=73, p=0.03).  An 
independent sample t-test was performed to estimate the difference in mean of age 
between healed versus failed surgeries (t=-2.203, df=71, p=0.031).  Participants in 
the failed to heal surgical group had a mean age 6 ½ years older than those in the 
healed group (failed ẋ 74.21 [SE±1.73], healed ẋ 67.85 [SE±2.37]), implying that an 
increase in mean age increases the risk of surgical site failure.  Figure 4.2 provides a 
boxplot showing these results.   
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Figure 4.2 Difference in age between those with healed versus failed surgical 
sites 
 
Predictor three: Surgical site infection 
The percentage of participants who had a surgical site infection totalled 
13.7% (n=10).  There was a suggested association between surgical site infection and 
failed surgical outcome (X
2
=10.1, df=1, p<0.001).  Every patient who had an 
infection experienced skin graft failure or primary closure dehiscence.  An odds ratio 
calculation could not express this relationship as there was a cell count consisting of 
zero (Kirkwood & Sterne, 2010).   
The presence of infection is a predictor of a poor surgical site outcome.  
However those at greater risk of infection, as associated with other independent 
variables, included those with inflammatory conditions (Fisher’s exact test p=0.05), 
the presence of chronic throbbing leg pain (a symptom of venous disease) (Fisher’s 
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exact test p=0.03) and the absence of compression therapy (Fisher’s exact test 
p=0.02).  Surgical site infection was also associated with acute surgical site pain 
(Fishers exact test, p=0.05), which was relieved with analgesic medication (X
2
=5.34, 
p=0.02).  However independent variables, inflammatory condition, the presence of 
chronic throbbing leg pain and the absence of compression therapy, were not shown 
to be statistically significant with the study outcome of healed versus failed surgery.  
Of note, the use of prophylactic antibiotics was not associated with surgical site 
infection (X
2=
2.17, p=0.14).  
 
Predictor four: Haematoma 
The percentage of participants who developed surgical site haematoma was 
20.5% (n=15).  The majority of patients who developed haematoma experienced 
surgical site failure (n=14).  There was a statistically significant association between 
the presence of haematoma and surgical outcome, healed versus failed (X
2
=12.08, 
df=1, p<0.001).  An odds ratio was calculated and it was estimated that those who 
developed haematoma were less likely (OR 0.05, 95% CI 0.01-0.44, p<0.001) to 
have surgical site success compared with those patients who did not develop 
haematoma.  
Haematoma occurred in all participants (n=15) in the split skin graft surgical 
group (Fisher’s exact test p<0.001).  The results implied that those of greater risk at 
developing haematoma included participants with more than three medical 
comorbidities (X
2
=4.17, p=0.04) and prophylactic antibiotic use (X
2
=7.997, p=0.04).  
However these were not shown to be associated with the dependent variable, healed 
versus failed surgery, as reported in Table 4.6.  Chronic sharp shooting leg pain was 
correlated with haematoma (Fisher’s exact test p=0.01).  The use of antiplatelet and 
anticoagulant medications was not shown to be associated with the presence of 
haematoma (X
2
=2.58, p=0.11), nor warfarin alone (Fisher’s exact test p=0.08) or 
NSAIDs (Fisher’s exact test p=0.63), nor surgical site infection (Fisher’s exact test 
p=0.7). 
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Predictor five: Chronic sharp shooting leg pain 
The percentage of participants who reported chronic sharp shooting leg pain 
totalled 11% (n=8).  The majority of these patients had failed surgeries (n=7), 
whereas only one patient with these symptoms had a successful surgical outcome, 
despite this risk factor having a significance level of p=0.06 (Fisher’s exact test). 
Chronic sharp shooting leg pain is a symptom of disease changes in the lower 
limb and the variables which advocate this through association with chronic sharp 
shooting leg pain included participants with a history of varicose veins (Fisher’s 
exact test p=0.01), varicose vein stripping (Fisher’s exact test p=0.01) and legs put 
into a dependent position (down) to manage chronic leg pain (Fishers exact test 
p<0.00).  However, there was a demonstrated relationship between chronic sharp 
shooting leg pain and the development of haematoma as previously reported, with 
one third (33.3%) of participants who developed haematoma had a history of chronic 
sharp shooting leg pain. 
These suggested five predictors will now be assessed in binary logistic 
regression model. 
 
4.4.2 Predictors: Binary logistic regression 
 A binary logistic regression model was used to determine which five 
independent variables were predictors for the study outcome: failed split skin grafts 
and primary closure dehiscence.  The five suggested variables included participants 
with split skin grafts, increasing age, infection, haematoma and presence of chronic 
sharp shooting leg pain.  A backward elimination process was used to determine the 
most parsimonious model (Balakrishnan, 2006; Hong & Mitchell, 2007).  At each 
step the variable with the highest not statistically significant p value was removed 
and the AIC and deviance were assessed.  Model parsimony can be expected with a 
decrease in AIC and deviance (Balakrishnan, 2006; Hong & Mitchell, 2007). 
 In this sample population all participants who had an infection, experienced 
split skin graft failure or primary closure dehiscence.  As there was no variation with 
this independent variable, that is no participants with infection in the healed group.  
Therefore we could stipulate that infection was associated with surgical site failure 
  
Chapter 4: Results 91 
and hence was shown to be a confounder.  Also, when investigated in a binary 
logistic regression model; the SPSS database continued to report an error.  An 
example of this is in model one, Table 4.8.  The variable ‘infection’ was removed 
from the model due to confounding with no variation in expodentiated beta. 
 Two possible parsimonious models are model two and model four as reported 
in Table 4.8.  Due to less than expected participant numbers recruited into this study 
(n=73), the final model was not selected based on p value alone.  The model was also 
chosen based on clinical relevance due to the complexity of human physiology and 
complexity of the wound healing cascade which can be affected by many factors.  
However statistically, in assessing the AIC and deviance, there is <10 units 
difference between model two and model four (Table 4.8), with both models having 
p values close to statistical significant value (p=0.05).  The model chosen for 
parsimony and clinical relevance was model 2.   
The mathematical equation below was used to describe the predicted 
response for each four independent variables with dependent variable, describing the 
model of best fit, with ‘a’ representing the y axis intercept (scatterplot) (Dobson & 
Barnett, 2008).  
 
Failed surgical site =  
a + (β1 4.1 split skin graft) + (β2 0.95 age) + (β3 0.11 haematoma) + (β4 0.07 chronic 
sharp shooting leg pain) 
 
The predictors for split skin graft failure and primary closure dehiscence 
include: surgical closure with split skin graft, increasing age, the presence of 
haematoma and the presence of chronic sharp shooting leg pain.  The odds of failure 
increasing with a split skin graft (adjusted OR 4.1, 95% CI 1.08-15.48, p=0.04), 
increase in age by one year (adjusted OR 0.95, 95% CI 0.9-1.00, p=0.05), presence 
of haematoma (adjusted OR 0.11, 95% CI 0.01-0.95, p=0.04) and presence of 
chronic sharp shooting pain (adjusted OR 0.07, 95% CI 0.01-1.06, p=0.05). 
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Table 4.8 Binary logistic regression – backward elimination  
Model number: Predictors P value Expodentiated-beta 
(confidence intervals) 
Model 
deviance,  
AIC 
Model 1 
Split skin graft 
Increasing age 
Chronic sharp shooting leg pain 
Infection 
Haematoma 
 
0.020 
0.163 
0.106 
0.999 
0.060 
 
7.142 (1.370-37.238) 
0.960 (0.907-1.017) 
0.075 (0.003-1.734) 
1.563E (0.000)* 
0.117 (0.13-1.093) 
 
46.970, 
67.288 
Model 2 
Split skin graft 
Increasing age 
Chronic sharp shooting leg pain 
Haematoma 
 
0.038 
0.052 
0.055 
0.045 
 
4.097 (1.084-15.482) 
0.947 (0.897-1.000) 
0.073 (0.005-1.056) 
0.105 (0.012-0.947) 
 
53.639 
73.579 
Model 3 
Split skin graft 
Increasing age 
Haematoma 
 
0.100 
0.078 
0.017 
 
2.714 (0.827-8.904) 
0.951 (0.912-1.005) 
0.071 (0.008-0.622) 
 
55.212 
74.538 
Model 4 
Increasing age 
Haematoma 
 
0.035 
0.005 
 
0.950 (0.907-0.996) 
0.048 (0.006-0.404) 
 
50.249 
69.124 
*confounding occurred between infection and surgical site outcome and therefore 
was removed from the model  
 
4.5 CONCLUSION 
 The incidence of lower limb split skin graft failure and primary closure 
dehiscence occurred in over half of the study participants.  Despite failure to recruit 
the required sample size the results of this study suggest a five times higher surgical 
site failure incidence with those who had split skin grafts compared with primary 
closure.  The predictors for surgical site failure in this population included split skin 
graft, increase in age, the presence of haematoma, the presence of infection and the 
presence of chronic sharp shooting leg pain.  However, when a binary logistic 
regression model was used the most parsimonious and clinically relevant model 
identified split skin graft, increase in age, presence of haematoma and the presence of 
chronic sharp shooting leg pain.  
 The next chapter, chapter five will present a discussion of study findings in 
relation to current literature and the conceptual framework. 
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Chapter 5: Discussion 
5.1 INTRODUCTION 
 The previous chapter presented the results from this study.  This chapter will 
discuss these findings compared with empirical literature reported in chapter two.  
This discussion will report study participant demographics followed by sections 
underpinning the study’s two research questions.  The section pertaining to research 
question two will report on the predictors and risk factors for lower limb split skin 
graft failure and primary closure dehiscence which were identified in the study’s 
conceptual framework and literature review.  These will then be compared with the 
findings of this study’s results with explanations for possible contradictions or 
similarities and a new model proposed.  Finally, limitations of this study will be 
presented. 
 
5.2 STUDY PARTICIPANT’S DEMOGRAPHICS 
 The majority of participants in this study were male (61.5%). Skin cancer 
development is not sex discriminative (Australian Bureau of Statistics, 2010).  
However females are more likely to seek earlier medical attention than males, so 
lesions may get identified earlier, when they are smaller and able to be removed by 
the general practitioner which may explain why more participants in this study were 
male (61.5%) (Australian Bureau of Statistics, 2010; Bertakis, Azari, Helms, 
Callahan & Robbins, 2000).   Conversely, the results in this study may also be due to 
chance.  In three similar dermatological surgery observational studies, Henderson 
and colleagues (2009) reported a distribution of skin cancer diagnosis on 42% males 
and 58% females.  Similar to this was a study by Fernandz-Jorge and colleagues 
(2006) who reported a distribution of 43.5% males and 56.5% females for skin 
cancer removal.  Paradela and colleagues (2010) reported opposite distribution of 
skin cancer removal in the sexes, with 70.9% males and 29.1% females.  None of the 
three studies or this study, found an association between gender and surgical site 
failure or complication rates. 
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It is known that skin protection is paramount to cancer prevention (VCRCC, 
2010).  This involves covering the skin with appropriate clothing and sunscreens.  
With Queensland’s dry temperate to tropical climate, clothing revolves around 
cooling the body down rather than protection.  In saying this, most skin cancers 
occurred mid to upper lower limb (gaiter, 23.3%, calf 16.4%, shin 45.2%) when 
compared with the most distal aspect of the leg and foot (malleolus 5.5 %, foot 
9.6%). The latter may have been protected by socks and shoes.  Sun damaged skin 
will show changes later in life, and therefore an older mean age of skin cancer 
diagnosis and removal can be expected.  This reflects this study participant’s median 
age of 73 years (range 37-90). 
The most common form of skin cancer diagnosis in Australia is basal cell 
carcinoma (BCC), followed by squamous cell carcinoma (SCC) then melanoma 
(VCRCC, 2010).  The diagnostic rates are 70%, 25% and 5% respectively (VCRCC, 
2013).  In this study group SCC accounted for the highest rates (42.5%), followed by 
BCC (35.6%) then other malignancies such as intra-epidermal carcinoma (IEC) 
(8.2%).  Melanoma accounted for 4.1% of skin cancer diagnoses.  BCC did not 
account for the highest rate of diagnosis in this study group.  A valid reason for this 
is that BCC is usually contained and slow growing with excellent prognosis (Green, 
Williams, Neale et al., 1999; Rubin, Chen & Ratner, 2005).  This type of cancer may 
be easily detected and removed by the local general practitioner and in this instance 
may be a plausible reason why this study did not experience higher rates of this type 
of skin cancer.  On the other hand, a higher rate of SCC was excised at the study site.  
Potentially this could be attributed to the aggressive nature and increased complexity 
of removal of the lesion which requires the attention of a specialist clinician, such as 
the dermatologist (Green et al., 1999). 
 Primary closure is a favoured method of surgical site closure than split skin 
graft due to lower complications such as bleeding, infection, and the additional 
complications of loss of graft (graft failure) and nerve damage which are associated 
with split skin grafting (Carville, 2005; Leung & Fish, 2009; Shimizu & Kishi, 
2012).  However if the skin cannot be easily approximated, the split skin graft is used 
to minimise risk of primary closure dehiscence (Carville, 2005; Marek et al., 2005; 
Leung & Fish, 2009).  In this study, twice as many split skin grafts occurred than 
primary closures (68.5% versus 31.5%).  Potentially this is attributed to the absence 
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of excess skin and tension lines on leg skin but also the higher rates of split skin 
grafting maybe due to the size and diagnosis of the lesion removed or areas of bony 
prominences, such as the shin or ankle bone (malleolus). 
 
5.3 RESEARCH QUESTION 1 
What is the incidence of lower limb split skin graft failure and primary closure 
dehiscence in day case surgical patients? 
The results from this study found that the total incidence of split skin graft 
failure and primary closure dehiscence was 53.4% with most of the failed surgical 
sites occurring in the split skin graft group (66% versus 26.1%).  Only two other 
studies have reported the incidence of surgical site complications of dermatological 
surgeries in the lower limb (Amici et al., 2005; Henderson et al., 2009).  This study’s 
split skin graft failure rate of 66% is similar to that reported by Henderson and 
colleagues study (2009) who found a 65% split skin graft failure rate on the lower 
limb.   
The split skin graft is reported to be prone to bleeding, infection, loss of graft 
(graft failure) and nerve damage (Carville, 2005; Leung & Fish, 2009; Shimizu & 
Kishi, 2012).  This may be due to the nature of the procedure with increased size of 
the surgical site compared with lesions able to be removed and closed by primary 
closure.  It may also be related to the transfer of donor skin to the site which requires 
the adhesion of tissue to the wound bed (Leung & Fish, 2009; Shimizu & Kishi, 
2012).  Whereas stitched edges of the primary closure are highly vascularised, 
improving circulation and minimising complications (Marek et al., 2005). 
In contrast, a study by Amici and colleagues (2005) reported a significantly 
lower incidence of surgical site complications.  An incidence of 5% (n=34) was 
reported from 667 participants.  However all data on limb surgeries was provided as 
aggregate data with no differentiation between upper and lower limb.  Nor were 
these results separated by type of surgical procedure (primary closure, split skin graft 
and skin flap).  This makes interpretations of Amici and colleagues (2005) study 
difficult as the upper limb is not subjected to the same physiological changes that the 
lower limb exhibits.  If most of the surgeries in Amici and colleagues (2005) study 
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occurred on the upper limbs this may provide another possible explanation for this 
difference in complication incidence rates.  Comparison between the Amici and 
colleagues (2005) study data and this study is therefore limited.  
In regards to post-operative care of the lower limb cohort, interestingly in this 
study the participant population were ‘day cases’ and discharged home the day of 
their surgery.  Conversely, Henderson and colleagues (2009) stated that the lower 
limb split skin grafts had greater risk of complication and their participants were 
treated as inpatients for >24hours up to 15 days.  However the surgical site failure 
rate from both this study (66%) and Henderson and colleagues (2009) study (65%) 
were similar despite this important difference in post-operative care.  Costs 
associated with inpatient versus outpatient care were not explored in either study, 
however a significant financial, staffing and resource burden is placed on the health 
care system for inpatient treatment (Tappen, Muzic & Kennedy, 2001).  Furthermore, 
associated complications from inpatient stay include the potential risk of MRO 
colonisation which can impact negatively on patient morbidity and success of the 
surgical site (Babcock & Grekin, 2003; Moorhead & Torres, 2009). 
 
5.4 RESEARCH QUESTION 2 
What are the predictors of lower limb split skin graft failure and primary closure 
dehiscence in day case surgical patients? 
 Predictors of lower limb split skin graft failure and primary closure 
dehiscence have not been previously reported in the literature.  Despite failure to 
recruit the required sample size the results from this study suggest a trend towards 
four risk factors that may predict surgical site failure.  These included the use of split 
skin graft to close the surgical wound, increasing age (>74yrs), presence of chronic 
sharp shooting leg pain and presence of haematoma.  Surgical site infection also had 
a strong association with surgical site failure however confounding existed between 
these two variables, with all participants who developed a surgical site infection 
requiring prolonged care for surgical site failure.  These predictors and confounder 
will be compared with current empirical literature in section 5.4.1 and 5.4.2 
respectively.  The remaining risk factors identified in the conceptual framework and 
literature review will be discussed in section 5.4.3. 
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5.4.1 Predictors of lower limb surgical site failure 
Predictor one: Split skin graft 
The results of this study suggest that participants who received a split skin 
graft experienced higher incidence of failure (graft loss) when compared with 
primary closure dehiscence (66% versus 26.1%).  This was discussed in section 5.3.  
This appears to be a consistent trend with the few studies which reported surgical site 
closed via primary closure demonstrated lower complication rates (Amici et al., 
2005; Rogues et al., 2007; Dixon et al., 2006).  However these outcomes related to 
rates of infection and will be discussed in the section pertaining to surgical site 
infection (Amici et al., 2005; Rogues et al., 2007; Dixon et al., 2006).   
 
Predictor two: Age 
 WHO (2008) and AWMA (2010) guidelines report that increasing age is a 
risk factor for poor surgical outcomes and poor wound healing.  The results of this 
study support a trend that increasing age decreases the likelihood of a successful 
surgical outcome.  With participants who experienced surgical site failed having a 
mean age 6 ½ years older (x=74) than those in the healed group (x=67.5).  Although 
this study requires further research, study outcomes advocate theoretical models that 
propose the aged skin has a reduction in elastin, collagen, disorganisation of the 
capillary network and thinning of capillary walls, and hormonal changes which 
impede protein synthesis and predispose the elderly patient to increased risk of 
infection (Ramos-e-Silva, Boza & Cestari, 2012; Talbot & Schaffner, 2005). 
 Only one previous study reported age and the association with the lower limb 
dermatological surgical site failure.  Paradela and colleagues (2010) reported no 
statistical relationship between surgical site failure and increasing age.  It is 
important to note the cohort in this study were greater than 85 years of age.  A study 
population consisting of solely 85 years and greater, is not representative of the 
general population.  This has introduced bias in the Paradela and colleagues (2010) 
study results and consequently this cannot be generalised to a broader population and 
compared with this study. 
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Predictor three: Haematoma 
 The results from this study show that the presence of haematoma decreased 
the chance of surgical site success in a lower limb dermatological surgery cohort.  
This study suggested an association between split skin graft failure which may result 
from haematoma formation.  There are no studies which have specifically 
investigated graft failure from haematoma development.  However three studies 
(Bordeaux et al., 2011; Nelms et al., 2009; Otley et al., 1996) were reported in the 
literature review in regards to antiplatelet and anticoagulant use and minor 
complications, including haemostasis and haematoma formation.  Anticoagulants 
reduce vitamin K which prevent coagulation at the surgical site and prevent 
haemostasis (Khalifeh & Redett, 2006; Stables & Lawrence, 2002).  Antiplatelet 
medications such as clopidogrel, aspirin and NSAIDs inhibit platelet aggregation and 
clotting during the haemostatic phase of wound healing (Bordeaux et al., 2011; 
Stewart & Langtry, 2009).   
This study did not find a relationship between haematoma formation with 
antiplatelet and anticoagulation therapy, or warfarin therapy alone.  During data 
collection for this study there were no participants on clopidogrel.  This study’s 
findings were similar to a study by Nelms and colleagues (2009) who also did not 
find a relationship between surgical site complications and warfarin.  However 
Nelms and colleagues (2009) research did not include participants with surgeries on 
the lower limbs.  Also, Nelms and colleagues (2009) reported outcomes 
predominately for primary closures (Nelms et al., 2009).  Due to these differences it 
is difficult to make comparisons or similarities with this study’s population.   
 Inconsistent with results from this study were those of Bordeaux and 
colleagues (2011).  They found a relationship between warfarin and clopidogrel with 
increased bleeding complications post-operatively for the general population.  
However, when examining the lower limb population in their study there was also no 
association between antiplatelet and anticoagulant use and poor surgical site 
outcomes (bleeding, infection and tissue necrosis).  Similar to Bordeaux and 
colleagues (2011) study, Otley and colleagues (1996) reported a relationship between 
warfarin and moderate to severe haemostasis complications intra-operatively.  
However, post-operative lower limb haematoma development was not reported with 
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these patients on warfarin therapy (Otley et al., 1996) and it was not in the scope of 
this study to investigate the effects of these medications during the intra-operative 
phase with the lower limb cohort. 
Possible explanations to explain discrepancy in these findings may be 
impacted by comparison of a wide variety of surgical site body locations which all 
have differing vascularity and physiological needs for healing (Otley et al., 1996; 
Bordeaux et al., 2011).  There was also ambiguous description of complications, for 
example terms included ‘mild’, ‘moderate’ and ‘severe’ (Otley et al., 1996).  These 
complication terms are broad and open to the interpretation of the researcher 
especially in retrospective chart audits (Oleckno, 2008; Otley et al., 1996).  
Aggregated data was reported for intra-operative complications and post-operative 
complications (Otley et al., 1996).  Therefore it was difficult to compare the outcome 
of interest; post-operative surgical site complications. 
 In regards to haematoma; another finding in this study was the association 
between haematoma with prophylactic antibiotic use.  Antibiotic use has been 
reported to lower antiplatelet effects (Fass, Copelan, Brandt, Moeschberger & 
Ashton, 1987; Kadurina, Bocheva & Tonev, 2003).  Haematoma was also associated 
with multiple diagnostic comorbidities.  Multiple diagnostic comorbid changes may 
impede haematological coagulation possibly due to side effects from 
pharmacological treatments treating these medical conditions; these may exacerbate 
delayed platelet aggregation resulting in post-operative haematoma (Karukonda et 
al., 2000a; Karukonda et al., 2000b).   
Haematoma formation can be complex and multifaceted; unfortunately this 
study’s results do not provide clarity into its formation.  Interestingly, one of the 
participants who developed haematoma had a successful surgical outcome.  Plausible 
reasons for this may be due to re-adherence of the primary closure edges or split skin 
graft or unknown casual effect (Pagan & Hunter, 2011).  In saying this, this study 
does support theoretical literature that haematoma development remains a poor 
surgical outcome (Basheer et al., 2008; Franz et al., 2007; Lawrence, 1996; Mangram 
et al., 2006; WHO, 2009).  It also supports consistent trend in theoretical and 
empirical literature that the use of antiplatelet and anticoagulant medications are safe 
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in dermatological surgeries (Bordeaux et al., 2011; Nelms et al., 2009; Otley et al., 
1996; Stewart & Langtry, 2009; WHO, 2009). 
 
Predictor four: Chronic sharp shooting leg pain (lower limb disease) 
The results in this study imply that the forth predictor for split skin graft 
failure and primary closure dehiscence was the presence of chronic sharp shooting 
leg pain.  The pathology of lower limb disease can manifest with many symptoms.  
The development of chronic sharp shooting leg pain may be symptomatic of 
circulatory problems resulting in decreased oxygen perfusion and neuropathic 
changes.  This has commonly been associated with arterial disease or peripheral 
neuropathy but can be the results of other chronic disease changes, such as venous 
disease (Bonham, 2003; Rayner, Carville, Keaton, Prentice & Santamaria, 2009; 
Taverna, Closs & Briggs, 2011).   
This study found associations between chronic sharp shooting leg pain with 
previous varicose vein stripping, presence of varicose veins, pain managed with 
analgesic medication and also patients putting their legs into a dependent position to 
assist with relieving pain (which is described to be associated with PVD) (Bonham, 
2003; Rayner et al., 2009; Taverna et al., 2011).  These associations may indicate the 
presence of mixed arterial and venous disease with neuropathic changes.  There have 
been no studies to date which have investigated lower limb chronic pain as a 
predictor of surgical site complications, however two studies did report on the 
suspected presence of arterial disease (Henderson et al., 2009; Paradela et al., 2010) 
and one study (Henderson et al., 2009) reported on the presence of venous disease 
with surgical site complications in the dermatological surgical cohort.  These will 
now be discussed.  
In the study by Henderson and colleagues (2009), the relationship between 
venous disease and arterial disease in lower limb dermatological surgery patients was 
investigated.  They did not find an association between these disease changes and 
lower limb surgical site failure.  Similar to this, this study also did not find an 
association between PVD and lower limb surgical site failure.  In saying this there 
was however a distinct difference between the two studies.  In Henderson and 
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colleagues study (2009) PVD was assessed by the absence of pedal pulses; whereas 
participants in this study were reported to have PVD if they had been previously 
diagnosed by formal studies, such as arterial duplex, ABPI or by a vascular surgeon.  
Diagnosis of PVD is multifaceted and cannot be made on one diagnostic tool alone, 
such as pulse palpation (Armstrong, Tobin & Mantagi, 2010; Criqui, Fronek, 
Klauber, Barrett-Connor & Gabriel, 1985).  The dorsalis pedis pulse may be 
congenitally absent or lower limb oedema may be present, inhibiting the palpation of 
arterial pulses, leading to misclassification bias as patients were incorrectly 
diagnosed (Armstrong et al., 2010; Criqui et al., 1985; Oleckno, 2008). 
A study by Paradela and colleagues (2010) also failed to find an association 
between artherosclerosis and surgical site failure.  In Paradela and colleagues (2010) 
athersclerosis was diagnosed based on the presence of the following comorbidities, 
stroke, ischaemic coronary disease and peripheral arteriopathy.  CVA and IHD were 
risk factors collected in this study; however no associations between these comorbid 
variables and surgical site failure. 
 In further investigation of the predictor, chronic sharp shooting leg pain, the 
patient may have underlying arterial or venous disease (Bergan et al., 2006; Eklof et 
al., 2004).  Current post-operative surgical management of the patient includes the 
application of low level compression therapy (8-10mmHg), single tubular bandage.  
However, in the presence of venous disease best practice guidelines stipulate that 
high levels of compression therapy (30-40mmHg) is required to improve venous 
return (Finlayson, Edwards & Courtney, 2010; Harding, Comerata & Partsch, 2008; 
Jones & Nelson, 2010).  Contrary to this and in the presence of mild arterial disease 
(ABPI >0.8), the use of lower grades of elastic compression or short stretch are 
required (Hampton, 1997; Harding et al., 2008).   
In the presence of significant arterial disease (ABPI <0.4-0.6), compression 
therapy is not recommended and can lead to tissue necrosis and severe limb 
ischaemia if applied (Rooke et al., 2011).  In this study a total of 56.2% (n=41) 
participants were placed into low level compression therapy.  A diagnosis of venous 
or arterial disease was not determined in this patient group, despite an association 
with chronic sharp shooting leg pain indicating the possibility of disease (Finlayson 
et al., 2010; Harding et al., 2008; Jones & Nelson, 2010; Rooke et al., 2011). 
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Three of the four participants with diagnosed PVD were placed into this level 
of compression therapy (8-10mmHg). Interestingly, guidelines for patients with PVD 
stipulate that no compression therapy should be worn, however only one patient in 
compression therapy experienced a failed surgical site.  However this study did not 
collect data on the degree of PVD in these participants. Further, other participants 
may have had undiagnosed PVD and this may have led to an under-reporting or 
misdiagnosis of participants in this study.   
 This study did not find any association between the use of compression 
therapy and surgical site outcome however this may be due to a non-therapeutic level 
delivered.  All the studies highlighted in chapter two, literature review indicated that 
compression therapy may be an important adjunct therapy to lower limb 
dermatological surgeries, with one study using a rigid compression system with 
compression levels ranging from 15-20mmHg (Wells et al., 1995), another study 
which used single layer Tubigrip
TM
 (5-10mmHg) (Woods & Lees, 1994) another 
reported on double layer Tubigrip
TM
 (10-15mmHg) (Budny et al., 1993) and a 
Cochrane review (Jones & Nelson, 2010) highlighting the importance of 
compression therapy in the lower limb when surgical intervention occurred.  
Henderson and colleagues (2009) stipulated that patients with PVD and venous 
disease received ‘meticulous care’ and therefore no association was found in their 
study, between these factors and graft failure.  In saying this they also highlighted the 
importance of compression therapy and leg elevation for venous disease patients. 
 Currently, there is no literature identifying the effects of compression therapy 
on split skin grafting and primary closure of the lower limb.  However, in regards to 
chronic sharp shooting lower limb pain as a predictor for surgical site failure and 
explanations given for pain aetiology, a recommendation from this study is made.  
This recommendation supports current theoretical frameworks of lower limb disease 
management; which imply a thorough patient assessment may determine the 
presence of disease and compression therapy level appropriate for the disease state 
(Bergan et al., 2006; Criqui et al., 1985; Eklof et al., 2004; Harding et al., 2008).  
Thorough patient assessment may assist with surgical site success. 
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5.4.2 Confounder of lower limb surgical site failure 
Cutaneous surgical site infection can include cellulitis or the presence of 
inflammation, purulent discharge, heat, surgical site dehiscence or graft failure, and 
occurring within 30 days of the surgical intervention (Mangram et al., 1999; WHO, 
2009).  All participants in this study who developed surgical site infection also 
experienced surgical site failure.  This lack of variation in participant numbers 
between surgical outcomes was therefore unable to be evaluated statistically.  In 
saying this, surgical site infection was considered a confounder of surgical site 
failure. 
Confounder: Surgical site infection and surgical site failure 
 In this research, all 10 participants who had surgical site infection 
experienced split skin graft failure or primary closure dehiscence.  All four studies in 
the literature reviewed (Amici et al., 2005; Bordeaux et al., 2011; Dixon et al., 2006;  
Heal et al., 2006) reported higher infection rates in the dermatological surgeries on 
the lower limb when compared with other areas of the body.  However, these studies 
did not elaborate on other surgical wound outcomes such as graft failure, necrosis or 
dehiscence.   
Three of these studies (Bordeaux et al., 2011; Dixon et al., 2006; Heal et al., 
2006) reported high incidence of infection in the lower limb population when 
compared with other surgical sites.  In a study by Heal and colleagues (2006), of 74 
infections the majority occurred on the lower limb, 34% (n=25).  Dixon and 
colleagues (2006) also reported higher rates of infection in the lower limb when 
compared with the total incidence of infection, 6.92% and 1.47% respectively.  
Similar to these findings was a study by Bordeaux and colleagues (2011) who 
reported that lower limb dermatological procedures in their cohort were 4.28 times 
more likely to have surgical site infection when compared with other areas of the 
body.  Results from this study support that, the lower limb is at risk of surgical site 
infection, and meticulous monitoring and controlling of risk factors of surgical site 
infection is needed. 
In this study surgical site infection was associated with symptoms of chronic 
throbbing pain and surgical site pain.  In addition, there was an association between 
infection and pain relieved with the use of analgesia.  The use of pain relief is a 
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typical treatment for pain associated with surgical site infection (Arpery & Whitaker, 
2001; WUWHS, 2008b).  In this study there was also an association between 
inflammatory diseases and infection, which is a well-established risk factor in 
medical literature (Franz et al., 2007; Heal et al., 2006; Mangram et al., 1999; 
Williams & Harding, 2003; WUWHS, 2008b).   
Surprisingly, in regards to preventative measures for infection, there was no 
association between the absence of infection and the prescription of prophylactic 
antibiotics; with 5/10 participants in this study on oral antibiotics also exhibiting 
signs of infection.  One study by Rogues and colleagues (2007), identified in the 
literature review, reflected on the relationship between antibiotic prophylaxis and 
infection.  They reported there was no association between prophylactic antibiotic 
use and surgical site infection, however further details into this relationship were not 
divulged.  The focus of Rogues and colleagues (2007) study was to report 
dermatological surgery infection control practices rather than relationships with 
comorbid conditions.  In saying this, it is therefore difficult to truly compare this 
study with Rogues and colleagues (2007) results. 
 
Summary 
Sections 5.4.1 and 5.4.2 discussed the statistically significant and clinically 
significant relationships between the predictors and confounder of surgical site 
failure which were reported in chapter four, results.  The following section will 
discuss this study’s findings with the remaining risk factors which did not find an 
association with surgical site failure in the study’s participant population compared 
to empirical literature reported in chapter two, literature review. 
 
5.4.3 Risk factors not associated with surgical site failure 
Four risk factors were identified as predictors for lower limb split skin graft 
failure and primary closure dehiscence, with one risk factor determined to be a 
confounder.  The remaining risk factors which were not found to be associated with 
split skin graft failure of primary closure dehiscence included diagnostic 
comorbidities, surgical comorbidities, medication, prophylactic antibiotics, 
malnutrition, smoking and early ambulation.  These will now be discussed. 
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Diagnostic comorbidities not associated with lower limb surgical site failure 
 In this study there was no association between diagnostic comorbidities and 
split skin graft failure or primary closure dehiscence.  However, the required sample 
size was not reached and this may have impacted on this result because of the low 
incidence of risk factors.  The medical comorbidities investigated as risk factors in 
this study included hypertension, hypercholesterolaemia, IHD, PVD, DVT, 
inflammatory disease processes and diabetes.  Two studies (Henderson et al., 2009; 
Paradela et al., 2010) reported on medical comorbidities related to dermatological 
surgeries found similar results to this research.  Henderson and colleagues (2009) 
found no association between diabetes or PVD and surgical site complications.  
Similarly, Paradela and colleagues (2010) reported on hypertension, CVA, IHD, 
peripheral arteriopathy, hypercholesterolaemia, diabetes and congestive heart failure, 
and also did not find a statistically significant relationship between these 
comorbidities and surgical site complications.   
It is difficult to truly investigate the effects of disease processes in the 
presence of medications which control comorbidities (Rang, Dale, Ritter, Flower & 
Henderson, 2012; Sibbald & Woo, 2008; Wing et al., 2007).  This may provide a 
plausible reason as to why these findings were not significant in these studies.  
Unfortunately this study did not have the scope to investigate or assess the effects of 
uncontrolled disease processes, such as taking blood pressure or reviewing blood 
samples, which may have given an indication of a patients true state of ill-health 
(Sibbald & Woo, 2008; Talley & O’Connor, 2012; Wing et al., 2007).  Examples of 
this include cholesterol or HbA1C which is a true indication of glucose level over a 
two-three month period (Sibbald & Woo, 2008; Talley & O’Connor, 2012; Wing et 
al., 2007).   
 
Surgical history was not associated with lower limb surgical site failure 
 It was suspected that previous lower limb surgeries may affect circulation and 
alter movement to the limb undergoing dermatological surgery.  However this study 
did not show any statistically significant association between surgical site failure and 
surgical history.  This may have been a result of low participant numbers recruited in 
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these groups.  There were no other studies identified which compared surgical 
history with lower limb dermatological surgical outcomes. 
 
Medication was not associated with lower limb surgical site failure 
 Results of this study did not demonstrate an association between medication 
and surgical site complications.  Four studies identified medication as potential risk 
factors for poor surgical site outcomes (Bordaeux et al., 2011; Henderson et al., 
2009; Nelms et al., 2011; Otley et al., 1996).  All four studies (Bordaeux et al., 2011; 
Henderson et al., 2009; Nelms et al., 2011; Otley et al., 1996) reported on antiplatelet 
and anticoagulant medication with surgical site outcomes, such as intra-operative 
haemostasis, haematoma development, tissue necrosis and graft loss.  Henderson and 
colleagues (2009) reported that of 35 participants on antiplatelet medication only 
four experienced graft failure (p=0.17).  Nelms and colleagues (2009) did not find an 
association between warfarin and surgical site failure; although, statistical data was 
not provided in this study.  A study by Otley and colleagues (1996) investigated 
surgical site outcomes with both antiplatelet and anticoagulant medication.  Despite 
generally low complication rates reported in Otley and colleagues (2009) study, 
when a comparative analysis was performed between medication, it was determined 
that warfarin had a greater complication rate than NSAIDs and aspirin (X
2
=11.8, 
p<0.02, df=4).  However, aggregated data was reported for intra-operative 
complications and post-operative complications (Otley et al., 1996).  Thus it was 
difficult to compare results of this study with Otley and colleagues (2009) on the 
outcome of interest, that being post-operative surgical site complications.   
Similar to Otley and colleagues (1996), Bordeaux and colleagues (2008) 
reported an overall low complication rate in their dermatological surgery cohort 
taking antiplatelet and anticoagulant medication (0.89%, n=17).  They also reported a 
higher complication rate in the warfarin and clopidogrel group when compared with 
aspirin and NSAIDs (p<0.05, p>0.05).  Possible explanations for these differences 
have been discussed in section 5.4.1 predictor, haematoma.  In regards to Henderson 
and colleagues (2009) study, a possible explanation for a lack of association between 
outcome and risk factor variables may be due to low participant numbers. 
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The results from this study did not indicate an association with 
immunosuppressant medication and split skin graft failure or primary closure 
dehiscence, which was similar to findings by Henderson and colleagues (2009).  
However in both studies, sample numbers were low and cannot be generalised to a 
larger population.  Theoretical literature and empirical literature on surgical site 
healing and the use of immunosuppressants have reported increased infection rates, 
which were not identified in this study nor in the 2009 study by Henderson and 
colleagues (Fuerst, Mohl, Baumgartel & Ruther, 2006; Howe, Gardner & Kadel, 
2006; Luessenhop et al., 1996).  
 
The use of prophylactic antibiotics was not associated with lower limb surgical site 
failure 
 The results of this study were unable to find an association between 
prophylactic antibiotics and split skin graft failure or primary closure dehiscence.  
This was similar to a study by Rogues and colleagues (2007) who did not find an 
association between antibiotic prophylaxis and differences in infection rates between 
those who received antibiotics compared with those who did not.  However it is 
important to note that in both this study and the study by Rogues and colleagues 
(2007), there was inadequate sample sizes which may have contributed to an inability 
to determine inferences between variables.  The development of infection is 
multifaceted and broad spectrum antibiotics tend to be favoured and recommended in 
high risk patients, such as those with prosthetic joints, heart valves and the 
immunosuppressed (Babcock & Grekin, 2005, WHO, 2009).  In the general surgical 
population the use of antibiotic prophylaxis is essential to reduce normal flora in 
surgical areas such as the bowel, but otherwise there appears to be no benefit in the 
dermatological surgery cohort without these ‘risk factors’ (Babcock & Grekin, 2003; 
Maragh et al., 2005; Moorhead & Torres, 2009; Rogues et al., 2007). 
 
Malnutrition was not associated with lower limb surgical site failure 
 The results of this study did not indicate an association between malnutrition 
or obesity and poor surgical outcomes.  One study (Penington & Morrison, 2007) 
reported on obesity, measured as an elevated BMI or WHR and split skin graft 
outcome. However in this study population the surgical site consisted of only head 
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and neck patients (Penington and Morrison, 2007).  Unfortunately it is difficult to 
make comparisons between these two studies as the head and neck has differing 
vascularity and exposure to disease changes when compared with the lower limb.   
Despite this it is worth noting that Penington and Morrison (2007) found that WHR 
greater than one (which is highlighted in both male and female patients at risk of 
endocrine and cardiovascular disorders) was able to predict skin graft failure of the 
head and neck.  However, this remains relevant to this study on a theoretical level, as 
the lower limb is predisposed to accelerated changes related to endocrine disorders 
and cardiovascular disease which lead to circulatory complications of limbs (Callum 
& Bradbury, 2000; Hinchliffe et al., 2011; Rooke et al., 2011). 
A potential source of confounding in this study was that most participants 
(94.3%, n=66) were overweight, with a median WHR of 1.0 (range 0.7-1.14).  
Therefore it is not surprising that there was no association with split skin graft failure 
and primary closure dehiscence as there were very few ‘healthy’ or ‘underweight’ 
participants to compare.   
 
Smoking was not associated with lower limb surgical site failure 
 The results of this study did not indicate an association between smoking and 
surgical site failure.  Limitations to these findings were the small number of 
participants who were current smokers during the course of the procedure and post-
operative treatment.  Only one tenth (11%) of the participants in this study were 
smokers.  Current AIHW (2012) data indicates that there has been a significant 
reduction in the prevalence of smoking within the Australian population.  In 2001 
smokers accounted for 19.5% of the population (AIHW, 2012).  This is the lowest 
ever reported in Australia and reports suggest those figures continue to reduce 
(AIHW, 2012).  This study’s prevalence of smokers may be representative of a 
current trend, however with small study numbers it is difficult to ascertain.   
In regards to research in this area, a large meta-analysis of smoking and 
surgical site outcomes by Mill and colleagues (2010), the complications associated 
with smoking included infection, dehiscence, and tissue necrosis including a 
multitude of chronic diseases.  However another important finding reported by Mill 
and colleagues (2010) was a significant reduction in surgical site complications with 
four weeks pre-operative cessation of smoking. 
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Post-operative ambulation was not associated with lower limb surgical site failure 
 The results of this study did not imply an association between risk factors 
which may have prevented a patient from elevating their legs and split skin graft 
failure and primary closure dehiscence.  Examples of concordance issues with leg 
elevation may have arisen from a patient’s immediate return to work post-surgery, 
driving themselves home after the procedure or being a carer for someone else.  
However, this was also reliant on patient self-reporting and reporting bias may have 
affected the outcome (Oleckno, 2002).  The empirical literature (Henderson, et al, 
2009) around this issue suggests no potential benefit to post-operative inpatient 
management for minor dermatological procedures when compared with this study’s 
findings.  However it was reiterated that the use of supportive compression therapy 
for the ambulatory patient, to assist with lower limb graft stability and reduction of 
tissue oedema was an imperative aspect of post-operative care (Budny et al., 1993; 
Henderson et al., 2009; Jones & Nelson, 2010; Wells et al., 1995; Woods & Lees, 
1994).  The role of compression therapy in surgical site management was discussed 
in section 5.4.1. 
 
Summary 
 Four predictors for lower limb split skin graft failure and primary closure 
dehiscence identified from the results of this study were discussed in relation to 
current empirical literature.  It was suggested that increasing age and split skin graft 
continued to indicate a trend as predictors for poor surgical site outcomes.  The 
results from this study also suggested that the presence of haematoma and the 
presence of chronic sharp shooting leg pain may predictor lower limb surgical site 
failure.  Neither of these have previously been reported in the literature as predictors 
for lower limb dermatological surgery site failure.  The remaining risk factors which 
were not associated with surgical site complications were also discussed. A summary 
of findings including a proposed conceptual framework, followed by limitations to 
this study will now be reported. 
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5.5 SUMMARY OF FINDINGS: CONCEPTUAL FRAMEWORK REVISED 
It was hypothesised that the lower limb is at high risk of surgical site 
complications.  However, a dearth of empirical literature exists to support this 
hypothesis.  Thus, the aim of this study was to address this hypothesis and also 
determine predictors of lower limb split skin graft failure and primary closure 
dehiscence.   
This study demonstrated that the lower limb had a high risk of surgical site 
failure, with a greater proportion of complications occurring in the split skin graft 
group.  This finding adds weight to the argument that the lower limb is at great risk 
for surgical site complications.   
In regards to predictors for surgical site failure, this study was able to suggest 
four predictors and one confounder for this cohort.  The suggested four predictors 
included: the use of split skin graft to close the surgical site, increasing age, the 
presence of haematoma and the presence of chronic sharp shooting pain.  In this 
study infection was a confounder with surgical site failure, as all of those with 
infection had surgical site failure.  However, the required sample size was not 
reached and therefore results should be treated with caution.  In saying this, the study 
results are able to provide support to other empirical literature and wound healing 
and surgical guidelines which highlight the ‘at risk’ patient.  
In chapter two, literature review, empirical literature also identified that the spit 
skin graft had a higher complication rate than primary closure.  Other risk factors for 
surgical site failure included warfarin, clopidogrel, increasing waist-hip-ratio and 
smoking.  Whilst post-operative ambulation in the presence of compression therapy 
for lower limb surgeries may have assisted with success of the surgical site.  In 
regards to risk factors identified by wound healing, determinants of health and 
surgical guidelines highlight poor diet, low physical activity and obesity, smoking, 
alcohol misuse, hypertension and hypercholesterolaemia which contribute to adverse 
health effects and poor outcomes (AIHW, 2012; WHO, 2009).   
Figure 5.1 highlights suspected predictors and confounder found in this study 
in relation to the conceptual framework introduced in chapter two.  The suspected 
predictors are highlighted by red arrows including the addition of surgical site 
closure via split skin graft (red box).  The suspected confounder is highlighted by an 
orange arrow. However this revised framework requires further testing for validation. 
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5.6 LIMITATIONS 
 Limitations of this study will now be discussed under the following headings, 
selection bias and sample bias, measurement bias and finally a comment on statistical 
analysis.  
This study used a descriptive, prospective observational approach.  Currently 
there is no research identifying predictors for lower limb split skin graft failure or 
primary closure dehiscence and therefore this study design was ideal in assisting to 
collect data on all suspected risk factors.  However, the choice of this study design 
inhibited the recruitment of the required sample size due to time constraints and 
unpredictability of patient numbers flowing through the dressing clinic (Oleckno, 
2008). 
 
Selection bias and sample size 
Prior to the commencement of the study during the ethics application phase 
of this research it was estimated that the research site’s dressing clinic averaged 150 
patients attending the clinic annually for lower limb dermatological surgeries, 
however it was predicted that this may fluctuate due to the uncertainty of lower limb 
skin cancer diagnosis.  Due to recent changes at the research site in post-operative 
management of minor surgical procedures, patients now attend follow-up care with 
their general practitioners.  This led to a decline in numbers attending the clinic and 
directly affected study recruitment.  As an example, in 2008 there were 107 lower 
limb surgical patients reviewed in the dressing clinic and in 2009 only 58 lower limb 
surgical patients presented for review to the dressing Clinic.   
According to ORMIS Data Manager (June 2010-June 2011) 150 patients had 
lower limb surgeries through the day case surgical unit.  However the majority of 
these patients did not return to the dressing clinic for review, as seen by the numbers 
recruited to this study during this period.  This may have led to selection bias where 
the characteristics of this study’s participant population may differ, for example 
disease chronicity, to those who were sent home to be reviewed by the local 
physician (Oleckno, 2008).  
The sample size for this study was based on the conceptual frameworks 
identified nine suspected predictors and a binary outcome: healed versus failed lower 
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limb dermatological surgery sites.  It was calculated that a total number of 113 failed 
surgical sites was required to find an association with each of the nine predictors.  
However only 73 participants were recruited of which 39 had failed surgeries.  Data 
collection ceased after 20 months due to low recruitment and constraints of the 
researcher’s higher research degree timeframes.  Consequently this study was 
underpowered to identify ‘true’ predictors of lower limb surgical site failure. 
 
Measurement bias 
Measurement bias may have occurred as currently there is no standardised 
definition for surgical site failure (Oleckno, 2008). This may be due to the difficulty 
in quantifying and describing this type of unsuccessful surgery including split skin 
graft failure and primary closure dehiscence.  In this study, surgical site failure was 
defined as a greater than 20% graft loss or primary closure dehiscence which was 
selected based on one study by Henderson and colleagues (2009).  This may have led 
to measurement bias.  However, this study demonstrated that the use of a >20% 
failure rate was an appropriate level to indicate a failed surgical site, as all 
participants who had split skin graft loss or a primary closure dehiscence of 20% or 
greater required prolonged care, which is essential in assisting with healing when the 
surgical site fails.   
 Another measurement bias may have occurred through the presence of 
arterial disease which was reported in section 5.4.1 predictor four, chronic sharp 
shooting leg pain (clinical assessment of the lower limb).  A full assessment on each 
participant, including ABPI and arterial Doppler, was not completed due to cost 
(both financial and staffing) and time constraints during data collection.  Therefore 
there may have been an under-reporting of the actual prevalence of lower limb 
disease. 
 
Statistical analysis 
A binary logistic regression model was used to determine the risk factors for 
lower limb split skin graft failure and primary closure dehiscence.  The sample size 
calculated for a binary logistic regression with nine predictors did not take into 
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account the demographical data of surgical type (split skin graft, primary closure) 
and patient demographics (age), which were included in data analysis and which may 
have required a greater sample size to show true effect.  Due to limitations in sample 
size and low participant numbers recorded in some of risk factors (cell count <5) the 
Fisher’s exact test was used to determine associations between study outcome and 
risk factor variables.  The final model was selected based on statistical and clinical 
significance. The decision to use clinically significant findings allowed for 
meaningful inferences between predictors of surgical site failure and the lower limb, 
within this small sample size which would have led to potentially higher p values 
(Salkind, 2010). 
 
5.7 CONCLUSION 
 This chapter highlighted the four predictors of lower limb split skin graft 
failure and primary closure dehiscence and provided a discussion for these based on 
current empirical literature reported in chapter two, Literature review.  The 
remaining risk factors were also reported and similarities or differences were 
identified between this research and empirical literature reported in chapter two, 
literature review.  Up until now there has been no research that identifies predictors 
for lower limb split skin graft failure and primary closure dehiscence and although 
this study had limitations of a small sample size, associations between variables were 
still determined and reported which may benefit future studies and clinical decisions.  
This chapter discussed this study’s finding in relation to current empirical literature 
and presented the limitations to this study.  Chapter six will conclude this research.
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Chapter 6: Conclusion 
6.1 INTRODUCTION 
Removal of the cancerous lesion is essential in reducing morbidity and 
mortality rates associated with skin cancers (Henderson et al., 2009; Paradela et al., 
2010; VCRCC, 2004-2008). However, surgical intervention to remove cancerous 
lesions, are not without complications, particularly when surgery involves the lower 
limb.  In dermatological literature the lower limb exhibits some of the highest rates 
of surgical site complications (Amici et al., 2005; Henderson et al., 2009; Paradela et 
al., 2010; VCRCC, 2004-2008).  However, despite these high complication rates, 
very little was known about the predictors of lower limb surgical site complications, 
which facilitate the change from an acute surgical wound to a chronic wound. 
 The purpose of this study was twofold.  Firstly to determine the incidence of 
lower limb split skin graft failure and primary closure dehiscence.  Secondly to 
explore the predictors of poor wound healing in the lower limb which contributes to 
post-operative split skin graft failure or primary closure dehiscence in the 
dermatological surgery day-case cohort. 
 This chapter highlights the major findings of this study, and outlines 
implications and recommendations for clinical practice, education and research. 
 
6.2 THE INCIDENCE OF LOWER LIMB SPLIT SKIN GRAFT FAILURE 
AND PRIMARY CLOSURE DEHISCENCE IN DAY CASE SURGICAL 
PATIENTS 
This study supported current literature that there is a high incidence of 
surgical site complications occurring on the lower limb after dermatological surgery.  
A important finding of this study was that the split skin graft exhibited the highest 
incidence of lower limb surgical site failure when compared with primary closure.  In 
regards to surgical site ‘failure’, the incidence of split skin graft failure was similar to 
that of a study by Henderson and colleagues (2009).  However a significant 
difference between these studies was that Henderson and colleagues (2009) treated 
their lower limb dermatological patients as inpatients, whereas this study’s cohort 
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was sent home the day of their procedure.  Despite low participant numbers in both 
studies, this difference is still an important finding and should be considered in the 
post-operative management of dermatological surgeries.  This difference includes the 
financial, staffing and resource costs associated with treating the dermatology patient 
as an inpatient which would be far greater than the cost of managing outpatient post-
operative management.  From this, perhaps with a holistic pre-operative and post-
operative assessment and management, the risks can be controlled and complications 
can be minimised in the ambulatory patient. 
 
6.3 THE PREDICTORS OF LOWER LIMB SPLIT SKIN GRAFT 
FAILURE AND PRIMARY CLOSURE DEHISCENCE IN DAY CASE 
SURGICAL PATIENTS 
 It would not be prudent to ignore that the small sample size of this study may 
have led to false positives and false negatives in determining predictors of lower limb 
split skin graft failure and primary closure dehiscence (Zaslavsky, 2001).  However 
these findings add weight to the argument that the lower limb is at high risk of 
surgical site failure and causes of this need to be better understood.  The most 
important finding of this study advocates support behind the study’s theoretical 
frameworks.  In saying this, it was demonstrated that the complexities of acute 
wound healing and that the lower limb surgical site success is dependent on many 
aspects of the patient which need to be considered pre-operatively and post-
operatively.   
A binary logistic regression model was used to determine predictors of this 
cohort.  Four predictors and one confounder were shown to be correlated with a 
surgical site failure.  The four predictors of lower limb surgical site failure indicated 
split skin graft, increase in age, the presence of haematoma and the presence of 
chronic sharp shooting leg pain.  Surgical site infection was correlated with surgical 
site failure, but in using a binary logistic regression model it was determined to be a 
confounder, with all patients who had surgical site infections also developing 
surgical site failure.  We were unable to determine if infection proceeded surgical 
site failure or if surgical site failure then led to infection. 
 This first predictor, the split skin graft, supports theoretical concepts that the 
split skin graft is at risk of bleeding, infection, loss of graft (graft failure) and nerve 
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damage (Carville, 2005; Leung & Fish, 2009; Shimizu & Kishi, 2012).  The second 
predictor was increasing age which is consistent with theoretical and empirical 
literature (AWMA, 2010; Franz, Steed & Robson, 2007; Gosain & DiPietro, 2004, 
Paradela et al., 2010; WHO, 2009).  This is due to disease changes, skin and cellular 
dysfunction which occur with increasing age and therefore leading to surgical site 
failure (Franz, Steed & Robson, 2007; Gosain & DiPietro, 2004).   
The third suggested predictor was haematoma.  It was interesting that post-
operative haematoma development and ultimately surgical site failure was not 
associated with the use of anticoagulant and antiplatelet therapies, which reduce 
coagulation and platelet aggregation and lead to increased bleeding; this finding is 
similar to dermatological literature (Bordeaux et al., 2011; Nelms et al., 2009; Otley 
et al., 1996).  This finding contributes to the efficacy that continuing antiplatelet and 
anticoagulant medication throughout the procedure is considered ‘safe’ practice 
(Bordeaux et al., 2011; Nelms et al., 2009; Otley et al., 1996).   
The final suggested predictor, which has not been previously explored or 
reported in the literature, was the presence of chronic sharp shooting leg pain.  Other 
variable associations with chronic sharp shooting leg pain are suggestive of the 
presence of mixed arterial and venous disease (Bergan et al., 2006; Bonham, 2003; 
Eklof et al., 2004; Carville, Keaton, Prentice & Santamaria, 2009; Taverna, Closs & 
Briggs, 2011).  Unfortunately assessments to confirm pain aetiology were not carried 
out, as it was not in the scope of this study to investigate this.  However it is 
important that this variable is specific to the lower limb and may contribute to future 
research and confirmation with larger sample size. 
 
6.4  FUTURE DIRECTIONS 
 This study demonstrated a trend supporting that the lower limb is at high risk 
of surgical site failure.  The elderly and lower limb disease changes can be identified 
as risk factors pre-operatively.  In addition, post-operative haematoma and surgical 
closure via split skin graft may require additional post-operative care.  From this, the 
lower limb requires pre-operative and post-operative attention when dermatological 
surgeries are performed to minimise surgical site complications.  From results of this 
study, implications are offered and recommendations made for health care 
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professionals for clinical practice, education, and recommendations are made to 
guide future research. 
 
6.4.1 Implications and recommendations for clinical practice 
Implications for clinical practice 
Results from this study add weight to clinical discussion, on possible 
predictors for lower limb surgical site complications.  From these findings, the 
associated predictors further support that the trajectory of acute surgical wound 
healing is multifaceted and complex.  In surgeries of the lower limb, clinical practice 
may involve management of lower limb disease processes, which may need 
identification through lower limb and holistic assessment.  This suggests that a 
holistic approach to the management of patients undergoing dermatological surgeries 
in the ambulatory setting may be useful in identifying predictors of poor wound 
healing and surgical site failure.  However more research is required in this area. 
Recommendations for clinical practice 
This population exhibited high rates of surgical site failure especially when 
the split skin graft was performed.  Current clinical practice indicates that the use of 
primary closure is preferable when compared with split skin grafting, however this is 
only when the edges can be approximated to minimise the risk of dehiscence (Amici 
et al., 2005; Dixon et al., 2006; Leung & Fish, 2009; Marek et al., 2005; Rogues et 
al., 2007; Shimizu & Kishi, 2012).  The results from this study support this.  To 
assist the clinician in identifying risk factors or predictors of surgical site failure 
requires diligent pre-operative assessment.  The results from this study suggest that 
the lower limb requires extra attention and perhaps this would require time in which 
the ‘skilled’ clinician can perform tests, such as an ankle-brachial index, and initiate 
individualised care, such as compression therapy, for patients undergoing 
dermatological surgery of the lower limb.   
Clinical practice regarding the post-operative management of the patient 
relates to the predictor, haematoma.  The use of wound care therapies to reduce 
surgical site haematoma, such as bolster dressings or negative pressure therapy, may 
provide increased graft stability at the surgical site.  In regards to surgical site 
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infection which was a confounder in this study, perhaps clinicians should consider 
the use of antimicrobials, such as silver impregnated wound care products.  The use 
of these dressings would be particularly useful in high risk patients, such as diabetics, 
the immunosuppressed or the aged.  In regards to the aged population, as highlighted 
by Paradela and colleagues (2010) “old age is not acceptable cause of exclusion for 
dermatological surgery and the delay in the surgical treatment of skin diseases 
increases the risk of complications”. 
 
6.4.2 Implications and recommendations for education 
Implications for education 
 The results from this study should be distributed to day case surgical units to 
highlight the ‘at risk’ patient undergoing dermatological surgeries.  Although study 
predictors should be considered with caution, due to the low sample size, study 
incidence outcomes demonstrate patients undergoing lower limb surgeries as high 
risk for failure.  Therefore it is not only the nursing profession who would benefit 
from the results of this study, who care for the pre-operative and post-operative 
patient, but should include allied health staff who are often responsible for lower 
limb movement and exercises, application and prescription of compression therapy 
and nutrition and dietetics assessment and management.  It is important to include 
the medical and surgical doctors who ultimately direct patient care, alter medications 
and perform the surgeries. 
Recommendations for education 
 Despite the health care professional being the ultimate director of patient 
care, it is important that the patient be the centre and take responsibility of their 
health.  Lower limb specialities are vast, including vascular surgeon specialists, 
chronic wound clinics, podiatrists; education in these areas is specialised.  In saying 
this, education for both health care professional and patient is necessary to optimise 
the surgical site and minimise surgical site complications.  For health care 
professionals, the completion of post-graduate courses or education sessions related 
to high risk patients should be attended.  For patients, self-help and pre-operative 
education sessions and hospital and clinic posters could be presented and utilised.  
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Education sessions should be holistic, as acute surgical wound healing is complex 
and multifaceted and can be negatively affected by one or many risk factors, to 
promote awareness, self-help and concordance. 
 
6.4.3 Recommendations for research 
 From this research, suggestions are made for future studies to explore 
relationships with lower limb dermatological surgeries and surgical site success 
includes: 
1. Replication of this study with adequate power; 
2. Future research to collect data at a multitude of clinical and surgical sites, 
including those with plastic surgeons, who also attend to lower limb skin 
cancer removal, but in fact, may care for patients with a higher level of 
chronicity than dermatological surgery patients;    
3. Additional research to focus on exploring the level of limb disease, using 
ABPI and skilled clinicians for lower limb health and skin assessment, and 
predictors for surgical site failure related to this; and   
4. Future research investigating patient adherence to limb movement and limb 
elevation once discharged to the home setting. 
In regards to surgical site failure and associated predictors, including split skin 
graft, haematoma, the presence of chronic sharp shooting leg pain, and confounder, 
surgical site infection, suggestions for future research include the investigation of 
interventions to improve surgical site success.  These require experimental studies 
and include:  
1. Future research to compare the use of different compression systems with 
their role on improved graft stability, reduced graft haematoma and ultimately 
improve surgical site outcomes;  
2. Future research to compare the use of negative pressure wound therapy with 
traditional treatment regimens, such as acriflavin wool, an iodine and paraffin 
oil cotton wool dressing (Storch & Rice, 2005), adjunct to supportive 
bandaging, to reduce surgical site haematoma; and 
3. Future research to compare the use of antimicrobial wound therapy, such as 
silver dressings with acriflavin cotton wool bolster dressings, adjunct to 
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supportive bandaging, to reduce infection rates and surgical site 
complications.  
 
6.5 SUMMARY 
 This was the first study to investigate the incidence and predictors of lower 
limb split skin graft failure and primary closure dehiscence in day case 
dermatological surgery patients. 
 Quantitative methodology was applied to answer the study’s research 
questions which were derived from the study’s aims and objectives.  Due to the 
complexity of acute wound healing and suspected differences between general risk 
factors for surgical site failure and lower limb surgical site failure a conceptual 
framework was developed to guide the search for theoretical and empirical literature.  
The conceptual framework, theoretical and empirical literature also informed the 
selection of variables and instrumentation used to measure and answer the study’s 
research questions.   
A prospective observational study design allowed for the accurate collection 
of variables and data to be collected and then analysed.  The findings of this study 
were then analysed.  Despite a dearth of empirical literature around this study’s 
research questions, the results from this study were compared with empirical 
literature specific for each predictor and risk factor of lower limb split skin graft 
failure and primary closure dehiscence in day case dermatological surgery patients. 
 Outcomes from this study demonstrated that dermatological surgeries of the 
lower limb are at high risk of surgical site failure, especially when the split skin graft 
is the surgical mode of closure.  This study suggested that predictors for surgical site 
failure include patients who were receiving split skin grafts, who were older than 74 
years with increasing risk with increasing age of one year, in the presence of chronic 
sharp shooting leg pain and who developed post-operative haematoma.  
Recommendations have been made to improve the care for patients undergoing lower 
limb dermatological surgeries and highlight the need for further research.   
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